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GENERAL INTRODUCTION
Healthcare generally aims to reduce patients’ symptoms, minimize disability, and improve 
quality of life. These aspects of patients’ health can be measured with patient-reported outcome 
measures (PROMs): questionnaires completed by a patient about any aspect of their health 
status [1]. It is increasingly being recognized that patient-reported outcomes are important 
outcomes to evaluate in addition to clinical outcomes, for example in clinical trials. In the past 
decade there has also been increasing interest in using PROMs in clinical practice [2]. There, 
individual PROM results can be used in the care for individual patients: for example, they can 
help bring forward the patients’ perspective of their health during consultations, and can be 
used to evaluate individual treatment effects and adapt the treatment if necessary [3]. PROM 
data collected in clinical practice can also be used on an aggregated level to study quality of 
care, e.g. by comparing outcomes between healthcare providers [4]. This thesis focuses on the 
use of PROM data for individual patients with obstructive sleep apnea (OSA). Many studies have 
been conducted in which a PROM is implemented in the regular clinical practice of different 
healthcare professionals, but their results are inconsistent regarding the usefulness of PROMs 
[5-10]. There is especially much to learn still about how and why PROMs do or do not result in 
improvements in patient care. In this thesis, I describe the development of a PROM for patients 
with OSA, implement this PROM in clinical practice, and study whether this PROM is beneficial 
to the care of these patients – and particularly why or why not.
 In this chapter I will first describe what different kinds of PROMs exist, how they can 
be used in regular clinical practice, and what is known about their effectiveness to improve 
care. Then, I will introduce obstructive sleep apnea. Lastly, I will describe the main objective 
and the outline of this thesis.
1 Patient-reported outcome measures
The increased interest in PROMs has led to development of many kinds of PROMs in the past 
decades, measuring different things in different patient groups. There are PROMs that aim 
to assess one symptom, for example sleepiness, which can be used in patients with different 
conditions for which this symptom is important. The Epworth Sleepiness Scale (ESS) [11] is an 
example of this type of PROM (Figure 1). There are also PROMs that aim to measure patients’ 
broader well-being, for example “health-related quality of life” (HRQoL). This is defined as 
quality of life relative to one’s health or disease status [12]. PROMs measuring HRQoL usually 
contain questions about several topics (called “domains”) that assess physical, emotional 
and social aspects of a patient’s functioning. They can either be tailored to specifically fit 
the symptoms and impact on function of a certain patient group (“disease-specific” PROMs) 
or aim to be relevant for all patients, irrespective of their disease (“generic” PROMs). Well-
known examples of generic PROMs are the EQ-5D and the SF-36 [13, 14]. Generic PROMs are 
especially useful for comparing outcomes across different patient groups.
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Figure 1. Part of the Epworth Sleepiness Scale (ESS), measuring sleep propensity [11]
When selecting a PROM to measure an outcome in a certain situation, it is important that 
this PROM has been validated for the intended purpose and preferably also for the specific 
patient group in which the PROM will be used. Validation of a PROM means assessment of 
its validity, reliability and (for PROMs measuring change over time) responsiveness. Validity 
means that the PROM measures what it is supposed to measure. A reliable PROM is accurate 
in its measurements and has a low measurement error. Responsiveness means that the PROM 
is able to accurately show change over time. These kinds of characteristics of a PROM are 
called its measurement properties.
2 Individual and aggregate PROM data in clinical practice: possibilities and impact
Individual PROM data can be used in clinical practice to communicate information about 
a patient’s symptoms or (health-related) quality of life to a healthcare professional. For 
this purpose, patients are usually asked to complete a digital questionnaire before their 
consultation, either at home or in the waiting room. In the literature, three main ways in which 
this individual PROM data can be employed have been described [15]: as a screening tool, 
e.g. to detect patients suffering from depression in primary care; as a monitoring tool, e.g. to 
assess whether the current treatment plan for a patient with a chronic condition is working; 
and/or as a tool to increase the patient-centeredness of care. When used to increase patient-
centeredness of care, the goal of the PROM is to bring the patient’s HRQoL to the forefront of 
the discussion during a consultation, and facilitate patient involvement in care planning and 
decision-making [16].
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 There are many studies in different patient groups that have looked at the potential 
impact of the use of individual PROM data in clinical care, which have been summarized 
in a number of systematic reviews [5-10]. Their general conclusions: there is evidence for 
improvements in communication between patient and healthcare professional, the detection of 
problems, as well as the patient-doctor relationship. However, the available evidence regarding 
changes to patient management and a positive impact on health outcomes is weak.
 Aggregate PROM data collected in clinical practice can also be used to directly 
or indirectly improve patient care. For example, by benchmarking the data of individual 
professionals within one department, or benchmarking the data of hospitals, and feeding 
back this information to these parties. The idea behind this kind of feedback is that those with 
relatively low scores will want to work towards improving their care, for instance by learning 
from those with high scores. So far, no impact of this type of feedback of outcomes data in 
general (not necessarily PROM data) has been found on patient outcomes [17-21]. This may be 
partly due to a lack of timeliness and low interpretability of the data, and also because of a lack 
of clarity on how to go about improving care based on the outcomes data. Benchmarked PROM 
data could also be shared publically, in which case the healthcare providers with relatively bad 
outcomes will likely experience more pressure to work towards improving their care and their 
outcomes. A recent review on whether the public reporting of outcomes data (not necessarily 
PROM data) improves patient outcomes shows mixed results, with more positive results in 
more competitive contexts [16].
 Another way in which aggregated PROM data collected in clinical practice can be used 
to improve care is by increasing scientific knowledge. For example by comparing the results 
of different treatments, to increase knowledge on the effectiveness of treatments in practice. 
Aggregated PROM data can also be used to help make better choices regarding whether 
patients should be selected for a certain procedure [4]. Studying baseline PROM results of a 
large group of patients could, for instance, provide information on whether a patient with hip 
osteoarthritis and a certain level of impaired function is likely to benefit from a hip replacement. 
In this latter case, both individual PROM data and aggregated PROM data is used to come to 
improvement of care.
 This thesis is focused on the use of individual PROM data in clinical practice. In our 
view, implementing PROMs of which the data is meaningful in clinical practice, for individual 
patients, is the basis for a good PROM measurement system. If patients are able to see their 
own results and personally benefit from their effort, this is likely to increase their motivation to 
complete the PROM. This might lead to higher response rates than when patients are asked to 
complete a PROM that does not potentially benefit their own care. Furthermore, physicians will 
get more of a ‘feel’ for the PROM data. The PROM data that is collected for the care of individual 
patients can, as a second step, then also be interpreted on an aggregate level.
Chapter 1
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3 Individual PROM data in clinical practice – how do they work?
The reviews on the impact of individual PROM results on the care for patients, mentioned in 
section 2, have looked only at quantitative evidence. These are often health outcomes. However, 
rather than setting up studies to only assess whether PROMs in clinical practice work, it is also 
important to study how and why PROMs (do or do not) work. An important reason for this is that 
what is considered as one intervention in these reviews (PROM results fed back to a healthcare 
provider) is actually a diverse group of interventions: studies use different kinds of PROMs, 
methods of results feedback, settings and patient groups, and type of healthcare provider to 
which results are fed back. Finding out which aspects of the intervention and the setting in 
which it is implemented influence its usefulness is key in understanding how to go forward with 
implementing PROMs in clinical practice. 
 The ways in which individual PROM data can potentially benefit clinical practice 
are complex. To illustrate this complexity, Greenhalgh et al. [3] developed a model out of the 
(often implicit) assumptions that are made in empirical studies (Figure 2). It shows how it is 
assumed in studies that provision of PROM data to clinicians helps them to monitor treatment 
response and to detect unrecognized problems, and should lead to differences in doctor-
patient communication. This will then potentially effect changes in the clinician’s management 
of patients, as well as cause changes in a patient’s own health behavior. This could result in 
improved patient satisfaction and health outcomes.
A more recent framework, focused on how PROMs can influence the care specifically of 
patients with chronic conditions, was created by Santana et al. [22] (Figure 3). A difference 
with the previous model is that it assumes that the PROM results are not only shared with 
and used by clinicians, but also patients and family members, who are a more explicit actor in 
the working mechanisms of PROMs. Furthermore, Santana’s framework places a larger focus 
on the role of communication as an essential intermediate factor to bring about changes in 
patient management and health outcomes. The model shows how the completion of PROMs 
influences communication between patients, clinicians and family members, which, through 
increased patient engagement, could lead to changes in the decision-making process, patient 
management, and adherence to treatment. This has the potential to result in better patient 
outcomes.
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detect problems or monitor treatment changes, or
that this extra information is gained as a result of the
HRQoL measure prompting discussion with the
patient.
3. On detecting a problem or a decrease in HRQoL in
response to treatment, the clinician will intervene in
some way to address this. This might be in the form of
changes to treatment, referrals to other agencies,
ordering of tests to investigate the problem further or
the provision of advice on how the patient might
manage their problems.
4. The very act of monitoring responses to treatment, or
through discussing the problem with their clinician or
actual treatment changes (for example, to address side
effects) may result from or lead to changes in patient
behaviour, such as visits to the clinician or adherence to
treatment.
5. In turn, the provision of HRQoL information may lead
to improvements in the patient’s health status or
satisfaction with their care.
The model demonstrates the complexity of the
intervention. For the more distal outcomes of patient
health status and satisfaction with care, numerous
intermediate processes need to occur before any impact
could be registered. What is not so apparent from the
ARTICLE IN PRESS
Fig. 1. Outcomes and hypotheses in the trials evaluating the impact of health status measures on clinical decision making.
J. Greenhalgh et al. / Social Science & Medicine 60 (2005) 833–843 835
Figure 2 Model of hypotheses and outcomes in the trials evaluating the impact of health status measures 
on clinical decision making [3]
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Snyder et al.11 argued that providing PROMs information to clinicians may improve the efficiency of the
consultation by highlighting issues that require addressing:
The PRO results may be used to help prioritize the issues that require addressing in the clinic visit and
promote efficiency.11
Santana and Feeny287 went on to envisage that improved communication stimulated by the use of PROMs
may result in patients feeling more involved in their own care. Furthermore, clinicians may use PROMs to
educate patients about their condition, which could further enhance patient engagement:
We think that PROMs could improve communication between patient and clinicians involving patients
in their own care. In situations in which clinicians use the PROMs data to discuss and educate patients,
the use of PROMs data could have the potential to enhance patient engagement and activation.287
Armed with increased knowledge about the patient’s perspective, this, in turn can influence how clinicians
make decisions about patient care management:
A potential effect of completing the PROMs may be that patients more frequently talk about the issues
with the clinician and the clinician gains insight about patients’ perspectives. Consequently, once
clinicians recognize the issues as clinically important, they could initiate changes (ordering new tests,
changing medications and dosages, and referring patients to other specialists) and monitor patients’
Completion of PROMs and sharing of results with
clinicians and family members
Communication
Patient outcomes
Clinician–clinician Patient–clinician Patient–relative Clinician–relative
Decision-making
Patient adherence
Clinician
satisfaction
Patient engagement
Patient
management
Patient
satisfaction
FIGURE 20 How PROMs completion can support the management of people with long-term conditions.
Reproduced from Quality of Life Research, Framework to assess the effects of using patient-reported outcome
measures in chronic care management, vol. 25, 2014, pp. 1505–13, Santana M, Feeny D, © Springer Science
+Business Media Dordrecht 2013,287 with permission of Springer.
DOI: 10.3310/hsdr05020 HEALTH SERVICES AND DELIVERY RESEARCH 2017 VOL. 5 NO. 2
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Greenhalgh et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
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Figure 3 Framework to assess the effects of using patient-reported outcome measures in chronic care 
management [22]
4 Obstructive sleep apnea
One of the conditions for which a PROM can be potentially useful in clinical practice is obstructive 
sleep apnea (OSA). Patients with OSA experience collapses of the upper airway during their 
sleep, resulting in breathing stops that can last from ten seconds up to one minute. Breathing 
resumes once the brain triggers an arousal from deep sleep to light sleep. This disruption of 
deep sleep can happen up to hundreds of times per night, and can cause severe sleepiness 
and exhaustion during the day. Patients often also experience problems in their social lives, 
due to their loud snoring and their lack of energy, as w ll as at work, where they may not 
function optimally [23-25]. OSA has also been related to mental problems such as depression 
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and anxiety [26, 27]. Furthermore, OSA has been shown to be related to comorbidities such as 
high blood pressure, heart failure, diabetes, and stroke. Prevalence of OSA has been reported 
to be 6% to 38%, depending on the exact definition of OSA and the population studied [28].
 Severity of OSA and necessity for treatment has historically been based on the number 
of (partial) breathing stops per hour: the apnea-hypopnea index (AHI) [29, 30]. However, there is 
no linear association between AHI and severity of symptoms or the presence of comorbidities 
[31-35]. There is also little evidence that treating patients with mild OSA (based on AHI) or 
patients with low sleepiness is useful in preventing cardiovascular disease or incidents [36-
39]. In the past few years there has therefore been international discussion regarding new 
approaches to diagnose “clinically relevant” OSA [40, 41]. This discussion has also made its 
way into recent Dutch guidelines for OSA, [42] in which it is recommended that there should be 
a greater focus on the presence of potentially related comorbidities, as well as the experienced 
burden of disease for individual patients. The goal of treatment is the improvement of these 
aspects of OSA.
 A PROM could help with shifting focus to a patient’s experienced burden of disease, 
and - as presented in the previously mentioned models – could potentially lead to changes 
in communication and patient management, improve patient adherence to treatment, and 
improve patient satisfaction and health outcomes.
5 General and specific objectives
The general objective of this thesis is to provide more insight into how individual PROM results 
work when implemented in routine clinical practice. We studied this with OSA as an empirical 
example. In this context we had the following specific aims:
 •  To study whether a PROM of sufficient quality is available for patients with OSA, 
which measures OSA-related quality of life;
 •  If no existing PROM, measuring OSA-related quality of life, is available and of 
sufficient quality: to develop a new PROM for patients with OSA specifically for use 
in clinical practice, with the goal to be suitable for use on both an individual patient 
and aggregate level;
 •  To develop a ‘patient-friendly’ way of presenting the results of the PROM, in order to 
make them easy to interpret;
 • To assess the validity, reliability and responsiveness of the PROM in a Dutch setting;
 •  To study the impact of individual results of the PROM on the care of patients with 
OSA, and study why this impact is or is not found.
Chapter 1
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6 Thesis outline
Chapter two provides and overview of the different PROMs that have been validated in patients 
with OSA, and their measurement properties. Chapter three is a reflection on the assessment 
of validity of PROMs in systematic reviews, and offers suggestions for future reviewers of 
measurement properties. After concluding that none of the PROMs in our review was suitable 
in its current form for our purpose, we describe in chapter four how we developed a new 
PROM together with patients and healthcare professionals, specifically designed for use in 
clinical practice. In chapter five, a validation study is presented which shows the measurement 
properties of the newly developed PROM. Finally, in chapter six, the new PROM is implemented 
in clinical practice and its effects are studied by means of interviews, a patient survey, and a 
patient record study. In this way, we can study both the impact of individual PROM results on 
clinical practice, and why this impact is or is not found. In chapter seven, we describe and 
reflect on our main findings, and offer future perspectives for PROMs in the clinical practice of 
OSA and for evaluating the impact of PROMs in general.
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CHAPTER 2
Measurement properties of patient-reported 
outcome measures (PROMs) in adults with 
obstructive sleep apnea (OSA): 
a systematic review
Inger L. Abma, Philip J. van der Wees, Vik Veer, Gert P. Westert, Maroeska Rovers
Published in Sleep Medicine Reviews 28:14–27 (2016)
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ABSTRACT
This systematic review summarizes the evidence regarding the quality of patient-reported 
outcome measures (PROMs) validated in patients with obstructive sleep apnea (OSA). We 
performed a systematic literature search of all PROMs validated in patients with OSA, and 
found 22 measures meeting our inclusion criteria. The quality of the studies was assessed 
using the consensus-based standards for the selection of health status measurement 
instruments (COSMIN) checklist. The results showed that most of the measurement properties 
of the PROMs were not, or not adequately, assessed. For many identified PROMs there was no 
involvement of patients with OSA during their development or before the PROM was tested 
in patients with OSA. Positive exceptions and the best current candidates for assessing 
health status in patients with OSA are the Sleep Apnea Quality of Life Index (SAQLI), Maugeri 
Obstructive Sleep Apnea Syndrome (MOSAS) questionnaire, Quebec Sleep Questionnaire (QSQ) 
and the Obstructive Sleep Apnea Patient-Oriented Severity Index (OSAPOSI). Even though there 
is not enough evidence to fully judge the quality of these PROMs as outcome measure, when 
interpreted with caution, they have the potential to add value to clinical research and clinical 
practice in evaluating aspects of health status that are important to patients. 
 
Systematic review PROMs for patients with OSA
25
2
1 INTRODUCTION
Obstructive sleep apnea (OSA) is characterized by repeated episodes of complete obstruction 
of the upper airway, resulting in oxygen desaturation and arousal from sleep. The prevalence 
of OSA is 2-5% in adult women and 3-7% in adult men [1]. The symptoms that these patients 
may experience are sleepiness, morning headaches, tiredness and fatigue, reduced vigilance 
and executive function, memory impairment, depression and impotence. Untreated OSA 
has been shown to be associated with cardiac pathologies (heart failure, arrhythmias, and 
ischemic heart disease) and stroke, as well as diabetes [1-3]. Specifically related to daytime 
sleepiness, the risk of road traffic accidents, near miss events and falling asleep at the wheel 
is significantly increased in severe OSA [4]. There is also evidence that untreated patients use 
more health services, take more medication, and are more often unemployed [4, 5].
 Successful treatment of OSA is often defined as demonstrating a reduction in the 
number of obstructive events occurring during each hour of sleep [6, 7]. This is, however, 
weakly (or not at all) correlated with quality of life and daytime symptoms as experienced by 
patients with OSA [8-10]. To determine outcomes of treatment relevant to the experience of 
patients, patient-reported outcomes should be included for measuring the views of patients on 
their health and health-related quality of life [6, 8, 11]. 
 These outcomes can be measured with patient-reported outcome measures (PROMs); 
questionnaires consisting of one or more multi-item scales, or single-item measures. These 
can be disease-specific, or generic. Disease-specific PROMs focus on the symptoms and/
or impact on functioning related to a specific disease [12]. Generic PROMs aim to measure 
important general (aspects of) health-related quality of life or general functioning, such as 
mobility, or the degree to which the presence of health problems affects social functioning.
 Initially, PROMs were developed for use in research, but in recent years their use has 
expanded to other areas, closer to clinical practice. That is, they can be used to assess the 
patient’s health status prior to treatment and to support clinical decision-making. They may 
also be used after treatment to evaluate individual patient benefit by comparison with pre-
treatment scores. When PROMs are operationalized as performance measures, they can be 
used to assess whether treatments by healthcare providers (and organizations) improve the 
health of patients [12, 13].
 For a valid and patient-centered evaluation of health status it is important that 
PROMs measure aspects of health status that are important to patients with OSA, and that 
their measurement characteristics are adequate for the specific patient population. Several 
literature reviews have assessed the measurement properties of different PROMs used in 
patients with OSA [14-18]. However, none of them provided an overview of the quality of all 
PROMs for outcome measurement in the specific target group of patients with OSA.
 In this systematic review we therefore provide an overview of the quality of PROMs 
for health outcomes measurement which are validated in patients with OSA. This provides 
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an evidence base for the choice of a PROM in clinical practice, for quality assessment, and in 
clinical research trials. 
2 METHODS
2.1 Identification of PROMs and validation studies
Literature search
A systematic search of the electronic databases MEDLINE, EMBASE and CINAHL from 
inception up to November 4th 2014 was conducted to identify all validation studies of PROMs 
assessed in patients with (suspected) OSA. Search terms used were “obstructive sleep apnea”, 
“patient-reported outcome measure” and commonly used synonyms, acronyms, and related 
terms (Appendix 1). Additionally, we used the search filter for studies describing measurement 
properties developed by Terwee et al. [19] for our PubMed search, which has a sensitivity of 
97.4%. For the other databases we developed a comparable filter with a similar approach to 
the PubMed version. 
 For each PROM identified in these studies we conducted an additional search to 
identify validation studies that our original search may have missed. We also performed a 
reference and related article search. Duplicate articles were manually filtered using the 
bibliographic EndNote database, version X5 (Thomas Reuters, New York City, NY, USA). 
2.2 Selection of studies
Inclusion criteria for PROMs and validation studies
We included PROMs that have one or more eligible validation studies in adult patients with 
OSA and have outcome measurement as (one of) their aims. This means they are potentially 
suitable for use in evaluative situations. Furthermore, the PROMs needed to have been named, 
allowing identification. The aim of the PROM should be to capture general aspects of health 
status (such as functional status, general health-related quality of life), OSA-related quality of 
life, or symptoms associated specifically with OSA, including sleepiness and fatigue, snoring 
and restless sleep, and anxiety and depression [20].
 Validation studies were included if they studied the PROM in its original language of 
development, and if they were published as original and full text studies in English or Dutch. 
Furthermore, the findings needed to be presented for patients with OSA separately from any 
other study population, such as patients with other disorders causing sleepiness.
 Two reviewers (IA and VV) independently assessed the eligibility of the identified 
PROMs and papers. Any disagreements were resolved by discussion with a third reviewer (PW). 
Where necessary we contacted study authors for clarification and additional information to 
inform study selection.
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2.3 Measurement properties
We used the taxonomy of measurement properties as constructed by the COSMIN panel [21]. 
There are three domains of measurement properties: reliability, validity and responsiveness. 
We assessed all aspects of these domains, except cross-cultural validity, as we did not include 
translated PROMs. Additionally, we assessed interpretability, which is not a measurement 
property in itself but is an important characteristic of a measurement instrument.
Reliability
The reliability of a measurement instrument expresses to which extent scores are free from 
measurement error. It consists of three measurement properties:
 •  Internal consistency: measures to what extent items in a one-dimensional (sub)scale are 
related. It is commonly reported with the parameter Cronbach’s α, which expresses the 
correlation between the items in the (sub)scale. A separate factor analysis (see construct 
validity) is needed to assess the dimensionality of a scale before Cronbach’s α can be 
interpreted [22].
 •  Reliability: expresses the variance in the measurements which is due to true differences 
among patients, i.e. the score without measurement error. For PROMs this is usually 
assessed by test-retest reliability: the extent to which patients who have had no change 
in the construct have the same score at repeated measurements. This can be reported 
with the intraclass correlation coefficient (ICC) or weighted Kappa.
 •  Measurement error: All error (systematic and random) in a measurement that is not 
due to true differences in the construct that is measured. Whether the measurement 
error is acceptable is determined by comparing the minimally important change with the 
smallest detectable change or the limits of agreement.
Validity
Validity is the extent to which a measurement instrument measures what it purports to 
measure. In this domain three measurement properties can be distinguished:
 •  Content validity: the extent to which the content of the instrument adequately reflects the 
construct to be measured in a certain population. This involves a judgment by the target 
population itself on the relevance and comprehensiveness of the items of a PROM.
 •  Construct validity: the extent to which an instrument validly measures the construct it 
purports to measure. This includes: 
  °  Structural validity: the extent to which is the extent to which instrument scores are 
an adequate reflection of the dimensionality of the construct, as assessed by factor 
analysis.
  °  Hypothesis testing: the degree to which a measurement instrument produces 
outcomes consistent with hypotheses. These hypotheses state expected outcomes 
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when assuming that the instrument validly measures its construct. Hypothesis testing 
can be used to assess convergent validity (the degree to which scores on instruments 
with related constructs correlate), known-groups validity (the ability of an instrument 
to distinguish between groups that are expected to differ with respect to the construct 
to be measured) and discriminant validity (assessing whether instruments with 
unrelated constructs have low correlations).
  °  Criterion validity: the extent to which a measurement instrument is an adequate 
reflection of a gold standard. For PROMs, a gold standard only exists when a shorter 
version of a PROM is created from a longer version, in which case the gold standard is 
the longer version of the PROM [23].
Responsiveness
Responsiveness is the ability of an instrument to detect change over time in the construct to 
be measured. To assess responsiveness, hypotheses should be constructed about the change 
scores of the instrument under study in correlation to the change scores of other instruments, 
as in hypothesis testing for construct validity [23]. 
Interpretability
Interpretability assesses to what extent qualitative meaning can be given to a score or change 
score of an instrument. Issues that can be considered in the context of interpretability are floor 
and ceiling effects (<15% of the respondents achieved the highest or lowest possible scores), 
scores and change scores in different (sub)groups, and the minimal important change (MIC) 
which expresses when a change score is clinically relevant.
2.4 Data extraction
We reviewed the included studies in duplicate (IA and PW) and extracted all reported aspects of 
reliability, validity and responsiveness, as well as interpretability of the PROMs.
2.5 Assessing the quality of the studies
We used the consensus-based standards for the selection of health status measurement 
instruments (COSMIN) checklist [24] to assess the methodological quality of the included 
studies. This checklist contains multiple questions to critically appraise the methods for 
each reported measurement property, and uses a 4-point scale [16] (“poor”, “fair”, “good” 
and “excellent”). The lowest score counts as the overall score for that property. The quality 
assessment was performed by two independent reviewers (IA and PvdW). Any disagreements 
were resolved by discussion with a third reviewer (MR).
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2.6 Assessing the quality of the PROMs
The reported results of the measurement properties of the PROMs were judged by criteria 
based on Terwee et al. 2007 [25] (Table 1).
 For construct validity as well as responsiveness, the quality criteria call for a 
comparison of the findings with hypotheses constructed by the authors of the papers 
assessing these measurement qualities. However, such hypotheses appear to be scarce. We 
therefore decided to follow the strategy of a recent systematic review [16], in which the authors 
devised their own hypotheses where needed. We only devised hypotheses for the comparator 
instruments that we thought were suitable for adding valuable information to the evidence. We 
considered comparator instruments unsuitable if the expected relation with the construct of 
interest was unclear, or if the comparator instrument had a (very) different construct than the 
one under study. A detailed overview of the hypotheses can be found in Appendices 2 and 3.
2.7 Data synthesis
The level of evidence, based on the number and the quality of the studies, as well as the 
consistency of the findings, was summarized for each measurement property based on the 
method used in Schellingerhout et al. [26] (Table 2). The outcomes table provides positive, 
negative or indeterminate evidence scores based on the quality criteria for the measurement 
properties and the level of evidence. The COSMIN scores concerning the descriptions of 
(measurement properties of) comparator instruments, addressed in “hypothesis testing” 
and “responsiveness”, assess the quality of the reporting of background information rather 
than the methodological quality of the study. When determining the level of evidence for these 
measurement properties, we therefore did not take “poor” scores for these descriptive items 
into account. Instead they were approached as “fair” scores.
 There are no quality criteria for interpretability in the COSMIN checklist, which means 
the level of evidence cannot be determined with the method described above. The data on 
interpretability is presented in the text.
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Table 1 Quality criteria for measurement properties [25]
Property Rating Quality criteria
Reliability
  Internal consistency +
?
-
(Sub)scale unidimensional AND Cronbach’s α(‘s)   0.70
Dimensionality not known OR Cronbach’s α not determined
(Sub)scale not unidimensional or Cronbach’s α(‘s) <0.70
  Measurement error +
?
-
MIC > SDC OR MIC outside the LOA
MIC not defined
MIC  SDC OR MIC equals or inside LOA
  Reliability +
?
-
ICC/weighted Kappa  0.70
ICC/weighted Kappa not determined
ICC/weighted Kappa < 0.70
Validity
  Content validity +
?
-
The target population considers all items in the questionnaire 
  to be relevant
No target population involvement
The target population considers items in the questionnaire to 
  be irrelevant OR considers the questionnaire to be incomplete
  Construct validity
     Structural validity +
?
-
Factors should explain at least 50% of the variance
Explained variance not mentioned
Factors explain < 50% of the variance
     Hypothesis testing +
?
-
(Correlation with an instrument measuring the same construct  
   0.50 OR at least 75% of the results are in accordance with 
  hypotheses) AND correlation with related constructs is higher  
  than with unrelated constructs
Solely correlations determined with unrelated constructs
Correlation with an instrument measuring the same construct  
< 0.50 OR < 75% of the results are in accordance with the 
  hypotheses OR correlation with related constructs is lower 
  than with unrelated constructs
  Criterion validity +
?
-
Convincing arguments that gold standard is ‘‘gold’’ AND 
  correlation with gold standard > 0.70
No convincing arguments that gold standard is ‘‘gold’’
Correlation with gold standard < 0.70, despite adequate design  
  and method
Responsiveness
  Responsiveness +
?
-
(Correlation with an instrument measuring the same construct 
   0.50 OR at least 75% of the results are in accordance with 
  hypotheses OR AUC  0.70) AND correlation with related 
  constructs is higher than with unrelated constructs
Solely correlations determined with unrelated constructs
Correlation with an instrument measuring the same construct 
  construct < 0.50 OR < 75% of the results are in accordance 
  with the hypotheses OR AUC < 0.70 OR correlation 
  with related constructs is lower than with unrelated constructs
AUC=area under the curve, ICC=intraclass correlation coefficient, LOA=limits of agreement, MIC=minimal 
important change, SDC=smallest detectable change
+ positive rating, ? indeterminate rating, - negative rating
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Table 2 Levels of evidence for the overall quality of a measurement property [26] 
Level Rating Criteria
Strong +++ or --- Consistent findings in multiple studies of good methodological quality OR 
in one study of excellent quality
Moderate ++ or -- Consistent findings in multiple studies of fair quality OR in one study of 
good methodological quality
Limited + or - One study of fair methodological quality, or one or more studies with 
COSMIN score “poor” only due to poor quality of reportinga
Conflicting ± Conflicting findings
Unknown ? Only studies with a COSMIN score of “poor” due to doubtful design or 
methoda
COSMIN= consensus-based standards for the selection of health measurement instruments
+ positive result, - negative result
a. the COSMIN scores of item 7 and 8 of hypothesis testing and of items 11 and 12 of responsiveness, 
concerning the descriptions of (measurement properties of) comparator instruments, assess in their 
“poor” scores only the quality of the reporting of background information. Therefore we approach “poor” 
scores on these items as “fair” scores for the purpose of determining the level of evidence.
Statistical pooling was performed for all measurement properties which were assessed in 
more than one study with at least a COSMIN score of “fair”, or a score of “poor” due to a 
small study population. For hypothesis testing and responsiveness the “poor” scores due to 
background information only were also included for pooling. Additionally, for hypothesis testing 
and responsiveness, we only pooled correlations between instruments measuring constructs 
that we considered suitable (Appendices 2 and 3). In cases of high heterogeneity (>50%), we 
used a random effects model; for low heterogeneity (<50%) we used a fixed effects model 
[27]. A random effects model is not feasible if only two studies can be pooled. In cases of high 
heterogeneity and only two available studies, pooling was not performed.
3 RESULTS
3.1 Selection of studies and PROMs
We identified 80 eligible validation studies in our primary search, which all assessed one or 
more measurement properties of a total of 39 PROMs (Figure 1). Additional searches and the 
reference check resulted in six new validation studies.
 After full-text screening of all the validation studies, 44 studies and 17 PROMs were 
excluded because they did not meet our inclusion criteria. This left a total of 42 included 
studies, assessing 22 PROMs (Table 3). PROMs were divided into three categories: OSA-related 
quality of life, single OSA-related symptoms, and generic health-related quality of life.
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 We identified eight OSA-related quality of life PROMs, which were assessed in 11 
studies [28-37].  For all the PROMs in this category we identified and included the original 
development study, except for the symptoms of nocturnal obstruction and related events-25 
(SNORE25).
 We identified eight PROMs on single OSA-related symptoms which were (partly) 
validated for patients with OSA assessed in 27 studies [30, 38-63] and six PROMs on generic 
health-related quality of life assessed in nine studies [30, 47, 55, 57, 64-68]. The former 
group includes PROMs which aim to measure sleep propensity/fatigue, snoring, anxiety, and 
depression.
3.2 Quality of the included studies
The results of the quality assessment of the studies with the COSMIN checklist are presented 
in Table 4. The most common scores were “poor” and “fair”. For four of the measurement 
properties, most studies scored “poor”: internal consistency (10 out of 16 studies), content 
validity (7 out of 11 studies), criterion validity (3 out of 3 studies) and responsiveness (19 out of 
26 studies). For structural validity, convergent validity, known-groups validity and discriminant 
validity, “fair” was the most common score. Only content validity and structural validity had one 
or more “excellent” scores.
 The studies with poor methodological quality for internal consistency did not provide 
information on the factor structure of the PROM before calculating Cronbach’s α, or calculated 
Cronbach’s α for the whole PROM rather than separately for each subscale. For content validity, 
the “poor” scores were assigned because of a lack of patient involvement in the design of the 
PROM or a lacking description of the development of the PROM in its development article. For 
responsiveness, the most common methodological flaw was that none of the presented data 
was suitable for determining the validity of the change score. For example, when the results 
of comparator instruments were not presented in such a way that they could be related to 
the instrument under study. One of the studies on convergent validity scored “poor” solely 
because of a missing description of (measurement properties of) the comparator instrument. 
For criterion validity, all studies scored “poor” because they used the data of their criterion 
to calculate the scores of the short version of the PROM that was under study, rather than 
collecting the data for the latter separately. All other studies that scored “poor” for any of the 
measurement properties either had a study population of less than 30 patients, or suffered 
from a variety of other methodological flaws.
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Unique articles identified in all 
databases:
5639
Excluded based 
on title/abstract:
5557
Potentially relevant studies: 80
Potentially suitable PROMs: 39
Potentially relevant studies: 86
Potentially suitable PROMs: 39
Exclusion criteria:
Health outcomes measurement not a goal of 
PROM:
- 22 studies excluded
- 10 PROMs excluded
Translated PROM:
- 14 studies excluded
- 2 PROMs excluded (no validation studies in 
patients with OSA in original language)
Not a validation study:
- 3 studies excluded
- 0 PROMs excluded
No seperate analysis for patients with OSA:
- 3 studies excluded
- 3 PROMs excluded
PROMs not identifiable by name:
- 2 studies excluded
- 2 PROMs excluded
Included validation studies: 42
Included PROMs: 22
Additional search 
& reference check:
6 new studies
2 double 
publications
excluded
Figure 1 Flow chart for identification of relevant PROMs and validation studies
OSA=obstructive sleep apnea; PROM=patient-reported outcome measure
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3.3 Measurement properties of the PROMs
The results for the measurement properties of the included PROMs considering their level of 
evidence can be found in Table 5. None of the studies in this review assessed measurement 
error, and therefore this property was removed from the results table. The results for all 
studied measurement properties with a score of “fair” or better are described below in more 
detail. The only data meeting our criteria for pooling were for convergent validity, the results of 
which are presented in Appendix 4. 
OSA-related quality of life PROMs
None of the OSA-related quality of life PROMs was fully validated. Content validity, convergent 
validity, internal consistency and responsiveness were assessed for most these PROMs, 
whereas data on most other measurement properties is not available. The evidence that is 
available is often either indeterminate or of limited strength, due to low study quality. However, 
most of the PROMs in this category were developed specifically for OSA patients, and four out 
of eight PROMs have strong positive evidence in favor for their content validity. 
 There is strong positive evidence of content validity for the Maugeri Obstructive 
Sleep Apnea Syndrome (MOSAS) questionnaire, the Obstructive Sleep Apnea Patient-Oriented 
Severity Index (OSAPOSI), the Quebec Sleep Questionnaire (QSQ), and the Sleep Apnea Quality 
of Life Index (SAQLI).
 For the Functional Outcomes of Sleep Questionnaire (FOSQ) there is limited positive 
evidence of structural validity and internal consistency (Cronbach’s α=0.86-0.91 for the five 
factors [29]). For the MOSAS questionnaire, there is limited negative evidence for these 
properties (factors explained 31% of the variance [37]).
 A limited and moderate positive evidence of test-retest reliability is available for the 
SAQLI and the visual analogical well-being scale (VAWS), respectively; the ICC of the SAQLI 
being 0.92 [35] and that of the VAWS being 0.83 [33].
 For the MOSAS questionnaire, SAQLI and VAWS there is limited positive evidence 
for convergent validity. For the FOSQ, evidence on convergent validity is conflicting. Weaver 
at al. [29] showed weaker than expected correlations with the short-form 36 (SF-36), while 
the correlations found in Billings et al. [28] matched our hypotheses. Due to high statistical 
heterogeneity, as well as the observation that all correlations were stronger in Billings et al. 
[28] than in Weaver et al. [29], we did not pool the correlations for five out of seven comparisons 
(Appendix 4). However, we could not identify a possible explanation for why there was a 
consistent discrepancy in these studies. 
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BAI= Beck anxiety inventory, EQ-5D=Euroqol-5D, ESS=Epworth sleepiness scale, FLP=functional limitations 
profile, FOSQ=functional outcomes of sleep questionnaire, HADS=hospital anxiety and depression scale, 
MOSAS=maugeri obstructive sleep apnea syndrome, NHP=Nottingham health profile, OSA=obstructive 
sleep apnea, OSAPOSI= obstructive sleep apnea patient-oriented severity index, PGI=patient-generated 
index, PROM=patient-reported outcome measure, QSQ=Quebec sleep questionnaire, SAQLI =sleep 
apnea quality of life index, SF-12=short form 12, SF-36=short-form 36, SNORE=symptoms of nocturnal 
obstruction and related events, SOS=snore outcomes survey, SQS=sleep quality scale, SWIFT= sleepiness-
wakefulness inability and fatigue test, ToDSS= time of day sleepiness scale, VAWS= visual analogical well-
being scale
a. The scores in this table were constructed as described in Table 2. “na” – not available; no studies were 
performed on this measurement property for this PROM.
b. The measurement property “measurement error” was removed from this table because it was not 
assessed for any of the instruments.
c. Criterion validity is not relevant for this questionnaire.
d. The VAWS is a one-item PROM, meaning that internal consistency and structural validity are not relevant 
for this PROM.
e. Due to the conflicting results of the factor structure of the ESS in (suspected) OSA patients, evidence on 
internal consistency results cannot be clearly interpreted
f. The positive score is for the mental health component of the SF-36. The physical component was 
only compared with unsuitable comparator instruments so its validity in patients with OSA could not be 
determined.
For the QSQ, less than 75% of the hypotheses for convergent validity were met. Many 
correlations did not meet the expectations stated in its validation article [32]. Therefore, there 
is limited negative evidence for convergent validity for this PROM.
 There is limited positive evidence for known-groups validity of the FOSQ-10, as 
patients with OSA had a lower average score than normal subjects, as was expected. 
 For the FOSQ, SAQLI and VAWS there is limited positive evidence for responsiveness.
With regard to interpretability, for the SAQLI and VAWS no obvious floor or ceiling effects are 
reported [33-35]. However, for the QSQ, the distribution of scores indicates there might be 
floor and ceiling effects in several of its domains [32]. For the FOSQ, QSQ, and SAQLI, MICs 
are reported for the separate domains of the PROMs [28, 32, 35]. For the FOSQ and FOSQ-
10, scores are presented for patients with OSA and normal subjects [29, 36], for the VAWS 
of patients before and after treatment with continuous positive airway pressure (CPAP) [33], 
and for the MOSAS questionnaire for patients differing in CPAP adherence [37]. For the other 
PROMs, floor and ceiling effects, MIC, and subgroup scores were not reported.
PROMs on single OSA-related symptoms
None of the PROMs on single OSA-related symptoms was fully validated, but the Beck Anxiety 
Inventory (BAI) has the most evidence in its favor. Internal consistency and convergent validity 
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were assessed for most the PROMs in this category. However, for three PROMs convergent 
validity does not seem to be adequate, and for another three the evidence is indeterminate. 
Data on most other measurement properties is not available for these PROMs. The evidence 
that is available is often either indeterminate or of limited strength, due to low study quality.
 For the BAI there is limited positive level of evidence for structural validity and for 
internal consistency (one factor, Cronbach’s α=0.92 [52]). For the Time of Day Sleepiness 
Scale (ToDSS) there is a limited negative level of evidence for structural validity and internal 
consistency, as the variance explained by the factors was below the required 50% for two of the 
three subscales [58]. There are conflicting findings about the factor structure of the Epworth 
Sleepiness Scale (ESS). Johns [46] found a one-factor structure, Smith et al. [78] reported that 
two items on low somnificity should be omitted for a sufficient one-factor fit, and Olaithe et al. 
[49] showed a sufficient one-factor fit as well as sufficient three-factor fit. Due to the conflicting 
evidence on the factor structure, the evidence for the internal consistency of the ESS is also 
conflicting.
 Moderate positive evidence for convergent validity is reported for the BAI and the 
ESS (see Appendix 4 for pooled correlations of the ESS). There is limited negative evidence 
for this property for the Hospital Anxiety and Depression Scale (HADS), the Snore Outcomes 
Survey (SOS), and the Rotterdam Sleepiness Scale. The correlation of the overall HADS with 
an instrument that measures depression was stronger than the correlation with the HADS 
depression subscale only [60], which was not as expected. There is negative evidence for 
convergent validity for the Rotterdam Sleepiness Scale and the SOS because less than 75% of 
hypotheses were met.
 There is a limited positive evidence base for known-groups validity of the Sleepiness-
Wakefulness inability and Fatigue Test (SWIFT) and Sleep Quality Scale (SQS), as patients with 
OSA had a higher average score on these PROMs than normal subjects, as expected. Known-
groups validity for the ESS showed conflicting evidence. Of the six studies that compared ESS 
scores of different groups, four studies found expected differences [42, 43, 45, 54], and two 
studies did not [39, 57].
 For the BAI, discriminant validity was assessed by determining whether the BAI 
could be distinguished from the depression score of the Beck depression inventory (BDI) by 
performing a factor analysis on all items of both questionnaires simultaneously. The items of 
the BAI and BDI were shown to load on different factors [52], providing limited positive evidence 
that they measure different constructs.
 With regard to interpretability, no MIC for patients with OSA is reported for any of the 
PROMs in this category. The ESS does not show floor or ceiling effects, as can be concluded 
from the ranges of scores and their graphical presentation in many of the included studies 
[38, 41, 45, 46, 48, 50, 51, 53, 57]. For no other instruments there is information on floor or 
ceiling effects for patients with OSA. Scores of subgroups were presented for the BAI (male and 
female patients with OSA) [52], the ToDSS (patients with OSA before and after treatment with 
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CPAP) [58], and the SQS and the SWIFT (normal subjects and OSA patients) [61, 63]. Scores of 
subgroups are also available for the ESS (normal subjects and/or patients with different OSA 
severity [39, 42-46, 49, 50, 54, 57], patients with OSA before and after treatment with CPAP [44], 
and for ethnicities and different genders [42]).
Generic health-related quality of life PROMs
Most measurement properties were not assessed in patients with OSA for general health-
related quality of life PROMs, which means there is very little information available on their 
quality in this patient group. Only  responsiveness was assessed for five out of six PROMs, but 
the evidence was either indeterminate or negative.
 There is limited positive evidence for convergent validity and known-groups validity 
for the mental health component of the SF-36 (see Appendix 4 for pooled correlations of the 
SF-36). For the SF-36 and Patient-Generated Index (PGI) there is limited negative evidence for 
responsiveness because correlations with unrelated constructs were stronger than with related 
constructs. For the EuroQOL-5D (EQ-5D) there is limited negative evidence for responsiveness 
because less than 75% of hypotheses were met.
 With regard to interpretability, no information on the MIC or floor and ceiling effects 
is available for the PROMs in this category. Subgroups of patients with OSA (before and after 
treatment with CPAP) were presented for the EQ-5D [67, 68], the Functional Limitations 
Profile(FLP) [67], PGI [68], and the SF-36 [67, 68]. For the Short-Form 12 (SF-12), scores were 
presented of the general population and OSA patients [65].
4 DISCUSSION
In this review we determined the evidence base for PROMs for health outcomes measurement 
in patients with OSA. We identified 22 PROMs validated in patients with OSA, categorized 
into three domains: OSA-related quality of life, single OSA-related symptoms, and generic 
health-related quality of life. None of the identified PROMs has been fully validated, and many 
validation studies were of insufficient quality. Especially the lack of established content validity 
for most of the PROMs is problematic for a patient-centered approach to measuring health 
status, because the items of these PROMs might not address the issues that patients with OSA 
consider relevant or most important. Furthermore, it is important to note that measurement 
error, which is particularly relevant for the use of PROMs in clinical practice, i.e. for individual 
patients, was not assessed for any of the questionnaires. Therefore the results of all PROMs 
should be used with caution when interpreting scores for individual patients. Rather than 
relying on composite scores of the domains, the individual questions of the PROMs might be 
more suitable for alerting a healthcare professional to the most important problems of these 
patients.
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The only PROMs with good content validity are four OSA-related quality of life PROMs: the 
OSAPOSI, MOSAS questionnaire, QSQ and SAQLI. Therefore, we consider these PROMs the 
most suitable for a patient-centered approach of health status and we consider all four 
potentially suitable for outcome measurement. Currently, the SAQLI has the most evidence 
for good quality, but its downside is that it contains many questions (n=56, plus 28 treatment-
related symptoms) and it is interview-administered, which makes it a less feasible option for 
use in clinical practice. The QSQ (n=32) or MOSAS questionnaire (n=16 plus 7 CPAP-related 
questions) might be more suitable for this purpose, as they can be filled out by the patient and 
are shorter. It should be noted that the MOSAS questionnaire does not contain any questions 
on nocturnal symptoms, a topic which is covered by the other three PROMs. Its CPAP-related 
questions may be relevant on an individual patient level, for those patients who get this 
treatment. The development article of the OSAPOSI (n=32)  reveals that this PROM contains 
some topics that were not covered in other PROMs (such as occupational impact, e.g. job 
loss), but the OSAPOSI is not publicly available or retrievable via the developer. Therefore our 
recommendation is to use the SAQLI for research purposes, when feasible, and either the QSQ 
or MOSAS questionnaire for use in clinical practice. 
The PROMs on single OSA-related symptoms all focus on symptoms which are also addressed 
in the OSA-related quality of life PROMs. None of the PROMs on OSA-related symptoms has 
been well-validated or assessed for content validity. For the ESS this oversight is specifically 
surprising as it had the greatest number of validation articles devoted to it in OSA patients (n=20 
studies), and is frequently used in both research and practice to measure sleep propensity. 
Similar to a recent systematic review on the ESS [16], we conclude that the evidence regarding 
the quality of this PROM is modest at best. The other PROMs in this category measuring sleep 
propensity/sleepiness do not have more evidence for their quality, but one could consider using 
the ToDSS or the SWIFT. The ToDSS contains the same questions as the ESS but for three 
different times of day. This may be beneficial for clinical practice to identify the time of day that 
a patient feels most sleepy, though in terms of outcome measurement there does not seem to 
be a clear benefit compared to the ESS. The SWIFT measures sleepiness in combination with 
fatigue and is a possible alternative to the ESS for measuring the main complaints related to 
OSA. The Rotterdam Sleepiness Scale we would not recommend: it is similar to the ESS but 
contains mostly yes/no questions and therefore its scores are likely to be less sensitive. The 
main benefit of the ESS compared to the other sleepiness PROMs is that it is used all around 
the world in both clinical practice and research, and will be familiar to those involved with OSA. 
  The SQS (on subjective sleep quality) and SOS (on experienced problems due to 
snoring) measure complaints that can be relevant to OSA, but are not likely to be the main 
complaints. Since there is no evidence that they are of better quality than other PROMs, we 
would not recommend them for patients with OSA.
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  The BAI (measuring anxiety) has limited positive evidence for several measurement 
properties, and based on current evidence we would recommend it over the use of the HADS. 
The HADS was the only PROM in this review that measures depression. Since evidence for this 
PROM in OSA patients is either not available or negative, a possibility is to look outside the 
scope of this review for other PROMs measuring depression.
 It should also be noted that if the use of a complete disease-specific QoL PROM 
is not preferred (for example because of a preference for a short PROM, or because only a 
specific symptom needs to be measured), another option is to use one or more domains of 
such a PROM, for example the “daytime sleepiness” domain of the QSQ. The benefit is that 
content validity is good for this PROM and that some of the other measurement properties 
were assessed separately for each domain, even we did not report our results at domain level 
in this review.
The main reason to use a generic health-related QoL PROM is to be able to compare PROM scores 
across diseases. These PROMs will by definition contain questions less relevant for the specific 
disease studied. Therefore we would not recommend the use of generic health-related quality of 
life PROMs for use in clinical practice, especially not when acceptable disease-specific PROMs 
are available, as this latter type of PROM will provide more relevant information for the disease. Of 
the PROMs in this review the only exception is the PGI, which asks patients to write down and score 
the areas of their life most affected by the disease, allowing for a more disease-specific approach. 
  Very little evidence was found regarding the quality of generic health-related QoL 
PROMs for patients with OSA. The mental health component of the SF-36 is the only PROM 
with a positive score for any of the measurement properties, and as such could be considered 
the best option. However, whether a generic PROM is suitable for outcome measurement for 
any specific disease greatly depends on content validity – which in this case could be described 
as the degree to which the questions are relevant for this disease. The negative evidence 
that we found for responsiveness for the SF-36, EQ-5D and PGI is likely related to a lack of 
content validity of these PROMs for OSA, although this has not been assessed in the included 
studies. We did identify potential issues related to a lack of content validity when devising 
our hypotheses, for example for the SF-36. In this PROM, the questions about daily activities 
and social functioning are assessed by asking about limitations due to “physical health” or 
“emotional problems”. In our view, neither of these categories clearly covers the main reasons 
for reduced functioning that patients with OSA experience (i.e. sleepiness and fatigue). It needs 
to be investigated whether problems with daily activities or social functioning will be detected 
with this PROM in patients with OSA. The only SF-36 domain that does address fatigue is 
the “vitality” domain, which is therefore most likely to be useful in measuring outcomes for 
patients with OSA.
  We have also noticed problems with content validity for the SF-12 and the EQ-5D. The 
FLP contains items relevant for OSA patients, but it is very long (n=136) and also contains a 
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great many items which are irrelevant. The NHP part II allows only yes/no answers to questions 
about how health affects daily functioning, which is not likely to provide sensitive scores. 
Furthermore, the FLP and NHP are not used often and would be of limited use when the aim is 
to compare scores across diseases. Finally, it may be hard to make a meaningful comparison 
of PGI scores across diseases due to the wide range of items that can be created by the patient. 
  Summarizing, the mental health component of the SF-36, and in particular the 
“vitality” domain, is probably the best generic health-related QoL PROM for OSA patients, 
though we remain doubtful about its content validity and recommend the use of a disease-
specific PROM alongside it.
We did not find many PROMs of which measurement properties could be statistically pooled. 
Studies on the same PROMs and properties were either of poor quality, or a given measurement 
property was only assessed in a single study. For the measurement properties of which we 
theoretically could pool data, heterogeneity appeared too high in about half of them to allow 
pooling. We did not find a plausible explanation for this high heterogeneity.
The main strength of this review is that we used the COSMIN checklist for a thorough evaluation 
of the quality of the included studies, and added to this our own critical assessment of which 
items on the COSMIN checklist assessed methodological quality, and which assessed quality 
of reporting. This allowed us to discriminate between studies of sufficient and insufficient 
methodological quality, when deciding which studies should contribute to the evidence base of 
the PROMs. Furthermore, we devised hypotheses for convergent validity and responsiveness 
where the authors of validation articles did not, which created the opportunity to use the 
available data to assess these measurement properties.
Limitations
Our study has a few limitations. First, we deviated slightly from our original protocol [79] in which 
we described two complementary search strategies, while we report only one. By broadening our 
original inclusion criteria for PROMs, no new PROMs were found with the second search strategy. 
We believe that this solution provides an article that is more easily readable, while being equally 
inclusive with regard to the PROMs suitable for outcome measurement in patients with OSA. 
  Second, the COSMIN checklist had very high standards regarding the assessment of 
the validation articles, resulting in low scores for many measurement properties. For example, 
the items about percentage and handling of “missing items” of the PROMs do not seem to 
follow current or historical standard practice. However, because the scores on these items had 
no impact on the evidence base, we did not change the way we handled these scores.
  Third, the more subjective items on the COSMIN checklist may cause discrepancies 
between reviews. A recent systematic review [16] that assessed the measurement properties 
of the ESS in all populations, assigned higher COSMIN scores than we did to more than half 
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of the measurement properties in the studies overlapping with our review. However, the 
differences on these items did only on a few occasions cause a different approach with regard 
to contribution to the evidence base for the ESS.
  Fourth, we chose not to create hypotheses when the comparator instruments (or their 
domains) had a construct that was too different from the construct under study. Since some 
 studies reported over 30 correlations between unrelated constructs, this would have resulted in 
many hypotheses predicting weak correlations. We consider hypotheses for related constructs 
more valuable than hypotheses for unrelated constructs, and decided to base our scores on 
only the former. 
  Finally, when discrepancies are found between hypothesized correlations and 
identified correlations for convergent validity and responsiveness, there is a possibility that the 
fault is not in the validity of the PROM, but in flawed hypotheses. This cannot be avoided, but 
by providing all of the hypotheses that we used to judge these measurement properties in the 
appendices, we do provide transparency into our results.
5 CONCLUSIONS
Our review found a lack of evidence for the quality of most measurement properties of the 
22 included PROMs validated in patients with OSA. We identified four OSA-related quality of 
life PROMs with thorough patient involvement in their development: the OSAPOSI, MOSAS 
questionnaire, QSQ, and SAQLI. These are the current best candidates for assessing health 
status in patients with OSA. Our recommendation is to use the SAQLI for research purposes 
and either the QSQ or MOSAS questionnaire for use in clinical practice. Even though there is 
not enough evidence to fully judge the quality of these PROMs, they can potentially add value 
to outcome measurement or clinical practice, when they are interpreted with caution. Future 
research should focus on the further validation of these PROMs, to estimate their suitability as 
outcome measure. Of the PROMs measuring only sleepiness and fatigue, the ESS is the most 
widely used PROM. However, the quality of this PROM is moderate at best. The SWIFT could 
potentially serve as an alternative or addition, if future research shows that this PROM is of 
higher quality.
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Appendix 1: search strategy
Category Search termsa
Patient-reported 
outcome measure
patient-reported outcome measure*[tiab] OR PROM[tiab] OR PROMs[tiab] OR quality of 
life[tiab] OR QoL[tiab] OR HRQoL[tiab] OR HRQL[tiab] OR questionnaire*[tiab] OR survey[tiab] 
OR surveys[tiab] OR instrument[tiab] OR instruments[tiab] OR scale[tiab] OR scales [tiab] OR 
checklist*[tiab] OR assessment*[tiab] OR computer adaptive test*[tiab] OR self-report*[tiab] 
OR diary[tiab] OR diaries[tiab] OR log[tiab] OR logs[tiab] OR interview*[tiab]  OR questionnaires 
[Mesh] OR Quality of life[Mesh] OR self report [Mesh] OR interviews as topic [Mesh]
Obstructive sleep 
apnea
Sleep apnea[tiab] OR sleep apnoea[tiab] OR Obstructive sleep disorder*[tiab] OR OSA[tiab] OR 
OSAS[tiab] OR “Sleep Apnea Syndromes”[Mesh]
Filter validation 
studies[1]
instrumentation[sh] OR methods[sh] OR Validation Studies[pt] OR Comparative Study[pt] 
OR “psychometrics”[MeSH] OR psychometr*[tiab] OR clinimetr*[tw] OR clinometr*[tw] OR 
“outcome assessment (health care)”[MeSH] OR outcome assessment[tiab] OR outcome 
measure*[tw] OR “observer variation”[MeSH] OR observer variation[tiab] OR “Health Status 
Indicators”[Mesh] OR “reproducibility of results”[MeSH] OR reproducib*[tiab] OR “discriminant 
analysis”[MeSH] OR reliab*[tiab] OR unreliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR 
homogeneity[tiab] OR homogeneous[tiab] OR “internal consistency”[tiab] OR (cronbach*[tiab] 
AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] AND (correlation*[tiab] OR selection*[tiab] 
OR reduction*[tiab])) OR agreement[tiab] OR precision[tiab] OR imprecision[tiab] OR “precise 
values”[tiab] OR test–retest[tiab] OR (test[tiab] AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] 
OR retest[tiab])) OR stability[tiab] OR interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] 
OR intra-rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-
tester[tiab] OR interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR intra-
observer[tiab] OR intertechnician[tiab] OR inter-technician[tiab] OR intratechnician[tiab] OR 
intra-technician[tiab] OR interexaminer[tiab] OR inter-examiner[tiab] OR intraexaminer[tiab] 
OR intra-examiner[tiab] OR interassay[tiab] OR inter-assay[tiab] OR intraassay[tiab] OR intra-
assay[tiab] OR interindividual[tiab] OR inter-individual[tiab] OR intraindividual[tiab] OR intra-
individual[tiab] OR interparticipant[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR 
intra-participant[tiab] OR kappa[tiab] OR kappa’s[tiab] OR kappas[tiab] OR repeatab*[tiab] OR 
((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] OR measures[tiab] OR findings[tiab] 
OR result[tiab] OR results[tiab] OR test[tiab] OR tests[tiab])) OR generaliza*[tiab] OR 
generalisa*[tiab] OR concordance[tiab] OR (intraclass[tiab] AND correlation*[tiab]) OR 
discriminative[tiab] OR “known group”[tiab] OR factor analysis[tiab] OR factor analyses[tiab] OR 
dimension*[tiab] OR subscale*[tiab] OR (multitrait[tiab] AND scaling[tiab] AND (analysis[tiab] 
OR analyses[tiab])) OR item discriminant[tiab] OR interscale correlation*[tiab] OR error[tiab] 
OR errors[tiab] OR “individual variability”[tiab] OR (variability[tiab] AND (analysis[tiab] OR 
values[tiab])) OR (uncertainty[tiab] AND (measurement[tiab] OR measuring[tiab])) OR “standard 
error of measurement”[tiab] OR sensitiv*[tiab] OR responsive*[tiab] OR ((minimal[tiab] OR 
minimally[tiab] OR clinical[tiab] OR clinically[tiab]) AND (important[tiab] OR significant[tiab] OR 
detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR (small*[tiab] AND (real[tiab] OR 
detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR meaningful change[tiab] OR “ceiling 
effect”[tiab] OR “floor effect”[tiab] OR “Item response model”[tiab] OR IRT[tiab] OR Rasch[tiab] 
OR “Differential item functioning”[tiab] OR DIF[tiab] OR “computer adaptive testing”[tiab] OR 
“item bank”[tiab] OR “cross-cultural equivalence”[tiab] NOT (“addresses”[Publication Type] OR 
“biography”[Publication Type] OR “case reports”[Publication Type] OR “comment”[Publication 
Type] OR “directory”[Publication Type] OR “editorial”[Publication Type] OR 
“festschrift”[Publication Type] OR “interview”[Publication Type] OR “lectures”[Publication Type] 
OR “legal cases”[Publication Type] OR “legislation”[Publication Type] OR “letter”[Publication 
Type] OR “news”[Publication Type] OR “newspaper article”[Publication Type] OR 
“patient education handout”[Publication Type] OR “popular works”[Publication Type] OR 
“congresses”[Publication Type] OR “consensus development conference”[Publication Type] OR 
“consensus development conference, nih”[Publication Type] OR “practice guideline”[Publication 
Type]) NOT (“animals”[MeSH Terms] NOT “humans”[MeSH Terms]
a. Only the PubMed search strategy is presented in the table. The different categories were combined with AND.
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f m
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 b
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 b
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 c
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t c
on
si
de
r 
th
e 
ov
er
al
l s
co
re
s 
of
 th
e 
FO
SQ
 a
nd
 th
e 
SI
P
 to
 b
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, b
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 r
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 b
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 d
om
ai
n 
“d
iu
rn
al
 s
ym
pt
om
s”
 is
 e
xp
ec
te
d 
to
 c
or
re
la
te
 s
tr
on
ge
st
 w
ith
 th
e 
“v
ita
lit
y”
 
do
m
ai
n 
of
 th
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l p
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 c
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 c
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 b
e 
ve
ry
 u
nl
ik
el
y 
if 
th
ei
r 
ex
ac
t 
pr
ed
ic
tio
ns
 w
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l f
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nx
ie
ty
 a
nd
 d
ep
re
ss
io
n 
sc
al
e;
 M
O
SA
S=
M
au
ge
ri
 o
bs
tr
uc
tiv
e 
sl
ee
p 
ap
ne
a 
sy
nd
ro
m
e;
 M
SL
T 
– 
m
ul
tip
le
 s
le
ep
 
la
te
nc
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te
st
; M
W
T 
– 
m
ai
nt
en
an
ce
 o
f w
ak
ef
ul
ne
ss
 te
st
; N
H
P
=N
ot
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gh
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ea
lt
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pr
ofi
le
; O
SA
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tr
uc
tiv
e 
sl
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p 
ap
ne
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O
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uc
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e 
sl
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ap
ne
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tie
nt
-
or
ie
nt
ed
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ev
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de
x;
 P
G
I=
pa
tie
nt
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en
er
at
ed
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de
x;
 P
R
O
M
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 p
at
ie
nt
-r
ep
or
te
d 
ou
tc
om
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m
ea
su
re
; P
SQ
I –
 p
itt
sb
ur
gh
 s
le
ep
 q
ua
lit
y 
in
de
x;
 Q
D
-R
=d
ep
re
ss
io
n 
qu
es
tio
nn
ai
re
-r
ed
uc
ed
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rm
; Q
oL
 –
 q
ua
lit
y 
of
 li
fe
; Q
SQ
=Q
ue
be
c 
sl
ee
p 
qu
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tio
nn
ai
re
; S
AQ
LI
=s
le
ep
 a
pn
ea
 q
ua
lit
y 
of
 li
fe
 in
de
x;
 S
B
P
S=
sp
ou
se
 b
ed
 p
ar
tn
er
 s
ur
ve
y;
 
SC
L-
90
 –
 H
op
ki
ns
 s
ym
pt
om
 c
he
ck
lis
t 9
0;
 S
F-
12
 –
 s
ho
rt
-f
or
m
 1
2;
 S
F-
36
 –
 s
ho
rt
 fo
rm
 3
6;
 S
IP
 –
 s
ic
kn
es
s 
im
pa
ct
 p
ro
fil
e;
 S
N
O
R
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5 
– 
sy
m
pt
om
s 
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oc
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ru
ct
io
n 
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d 
re
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d 
ev
en
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-2
5;
 S
O
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y;
 S
Q
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sl
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al
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; S
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ie
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ve
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du
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d 
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; S
W
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T=
sl
ee
pi
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ss
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w
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ef
ul
ne
ss
 in
ab
ili
ty
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 fa
tig
ue
 te
st
; T
oD
SS
=t
im
e 
of
 d
ay
 s
le
ep
in
es
s 
sc
al
e;
 V
AW
S=
vi
su
al
 a
na
lo
gi
ca
l w
el
l-
be
in
g 
sc
al
e.
C
or
re
la
tio
ns
: w
ea
k:
 r
<0
.3
; w
ea
k 
to
 m
od
er
at
e:
 0
.2
<r
<0
.5
; m
od
er
at
e:
 0
.3
<r
<0
.7
; m
od
er
at
e 
to
 s
tr
on
g:
 0
.5
<r
<0
.8
; s
tr
on
g:
 r
>0
.7
a.
 P
ol
ys
om
no
gr
ap
hi
c 
m
ea
su
re
s 
ar
e 
de
te
rm
in
ed
 d
ur
in
g 
a 
sl
ee
p 
st
ud
y 
to
 m
ea
su
re
 th
e 
se
ve
ri
ty
 o
f O
SA
. T
he
 m
ea
su
re
s 
w
hi
ch
 a
re
 r
ep
or
te
d 
va
ry
 p
er
 s
tu
dy
.
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 c
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 c
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 m
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ife
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Th
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n 
w
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SF
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ph
ys
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al
 c
om
po
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nt
 s
co
re
 (P
C
S)
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 e
xp
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 b
e 
st
ro
ng
es
t, 
be
ca
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e 
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e 
do
m
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ns
 o
f t
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 E
Q
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D
 a
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 a
ll 
(m
os
tly
) f
oc
us
ed
 o
n 
ph
ys
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al
 h
ea
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rr
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at
io
n 
w
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 th
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SF
-3
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en
ta
l c
om
po
ne
nt
 s
co
re
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C
S)
 is
 e
xp
ec
te
d 
to
 b
e 
w
ea
ke
r.
W
e 
co
ns
id
er
 th
e 
ES
S 
an
d 
th
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P
G
I t
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be
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n 
un
su
ita
bl
e 
co
m
pa
ra
to
r 
in
st
ru
m
en
ts
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r 
th
e 
EQ
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D
 
be
ca
us
e 
th
e 
co
ns
tr
uc
ts
 a
re
 to
o 
di
ffe
re
nt
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co
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ra
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G
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N
o 
da
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 w
as
 s
ui
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bl
e 
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r 
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ak
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hy
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es
 a
bo
ut
 th
e 
va
lid
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 o
f t
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 c
ha
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e 
sc
or
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Th
e 
FO
SQ
 m
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s 
th
e 
im
pa
ct
 o
f s
le
ep
in
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s 
on
 fu
nc
tio
na
l s
ta
tu
s.
C
ha
ng
e 
sc
or
es
 o
f p
at
ie
nt
s 
w
ith
 O
SA
 w
ho
 u
se
d 
C
PA
P
 fo
r 
m
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e 
th
an
 fo
ur
 h
ou
rs
 p
er
 n
ig
ht
, a
nd
 
pa
tie
nt
s 
w
ith
 O
SA
 w
ho
 u
se
d 
C
PA
P
 le
ss
 th
an
 4
 h
ou
rs
 p
er
 n
ig
ht
, a
re
 c
om
pa
re
d.
 W
e 
ex
pe
ct
 a
 
la
rg
er
 in
cr
ea
se
 in
 s
co
re
 fo
r 
th
e 
to
ta
l F
O
SQ
 s
co
re
 a
nd
 a
ll 
th
e 
FO
SQ
 d
om
ai
ns
 fo
r 
th
os
e 
w
ho
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ed
 m
or
e 
th
an
 4
 h
ou
rs
 o
f C
PA
P
 p
er
 n
ig
ht
 c
om
pa
re
d 
to
 th
os
e 
w
ho
 u
se
d 
le
ss
 th
an
 4
 h
ou
rs
 o
f 
C
PA
P
 p
er
 n
ig
ht
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SQ
St
ro
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Th
e 
FO
SQ
-1
0 
m
ea
su
re
s 
th
e 
im
pa
ct
 o
f s
le
ep
in
es
s 
on
 fu
nc
tio
na
l s
ta
tu
s.
Si
nc
e 
th
e 
FO
SQ
-1
0 
is
 a
 s
ho
rt
er
 v
er
si
on
 o
f t
he
 F
O
SQ
 b
ut
 a
im
s 
to
 m
ea
su
re
 th
e 
sa
m
e 
th
in
g,
 w
e 
ex
pe
ct
 a
 s
tr
on
g 
co
rr
el
at
io
n.
O
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SI
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ra
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 to
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en
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O
SA
P
O
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ea
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re
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qu
al
ity
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f l
ife
 s
pe
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al
ly
 fo
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pa
tie
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w
ith
 O
SA
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Th
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co
rr
el
at
io
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be
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th
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O
SA
P
O
SI
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 c
ha
ng
e 
sc
or
es
 a
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 th
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“o
ve
ra
ll 
as
se
ss
m
en
t o
f 
re
sp
on
se
 to
 tr
ea
tm
en
t”
 (m
uc
h 
im
pr
ov
ed
, s
om
ew
ha
t i
m
pr
ov
ed
, n
o 
ch
an
ge
, s
om
ew
ha
t 
w
or
se
, m
uc
h 
w
or
se
) i
s 
ex
pe
ct
ed
 to
 b
e 
st
ro
ng
 a
s 
th
e 
O
SA
P
O
SI
 w
as
 d
ev
el
op
ed
 a
s 
an
 o
ut
co
m
e 
m
ea
su
re
 fo
r 
a 
cl
in
ic
al
 tr
ia
l a
nd
 s
ho
ul
d 
be
 a
bl
e 
to
 a
ss
es
s 
re
sp
on
se
 to
 tr
ea
tm
en
t. 
W
e 
ca
nn
ot
 
pr
ed
ic
t t
he
 d
ir
ec
tio
n 
of
 th
e 
co
rr
el
at
io
n 
as
 n
o 
in
fo
rm
at
io
n 
is
 g
iv
en
 o
n 
th
e 
sc
or
in
g 
of
 th
e 
ov
er
al
l 
as
se
ss
m
en
t o
f r
es
po
ns
e 
to
 tr
ea
tm
en
t.
P
G
I
ES
S
M
od
er
at
e 
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)
Th
e 
do
m
ai
ns
 in
 th
e 
P
G
I a
re
 d
et
er
m
in
ed
 b
y 
th
e 
pa
tie
nt
s 
w
ho
 fi
ll 
ou
t t
hi
s 
P
R
O
M
. T
he
 p
at
ie
nt
 
po
pu
la
tio
n 
of
 th
is
 s
tu
dy
 is
 s
el
ec
te
d 
fo
r 
ha
vi
ng
 O
SA
 a
nd
 it
s 
re
la
te
d 
su
bj
ec
tiv
e 
co
m
pl
ai
nt
s 
(li
ke
 
sl
ee
pi
ne
ss
), 
so
 th
is
 is
 li
ke
ly
 to
 b
e 
re
fle
ct
ed
 in
 th
e 
P
G
I. 
Th
er
ef
or
e 
a 
m
od
er
at
e 
co
rr
el
at
io
n 
is
 
ex
pe
ct
ed
 w
ith
 th
e 
ES
S,
 a
nd
 a
 w
ea
k 
to
 m
od
er
at
e 
co
rr
el
at
io
n 
w
ith
 th
e 
SF
-3
6 
m
en
ta
l s
co
re
.
Th
e 
ph
ys
ic
al
 c
om
po
ne
nt
 s
co
re
 o
f t
he
 S
F-
36
 a
nd
 th
e 
EQ
-5
D
 (+
EQ
-T
) w
e 
co
ns
id
er
 u
ns
ui
ta
bl
e 
co
m
pa
ra
to
r 
in
st
ru
m
en
ts
 b
ec
au
se
 th
ei
r 
co
ns
tr
uc
ts
 a
re
 to
o 
di
ffe
re
nt
 fr
om
 th
e 
P
G
I, 
as
 n
ei
th
er
 
of
 th
em
 a
dd
re
ss
 O
SA
-s
pe
ci
fic
 c
om
pl
ai
nt
s.
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Q
SQ
ES
S
W
ea
k 
to
 m
od
er
at
e 
(-
)
Th
e 
Q
SQ
 m
ea
su
re
s 
qu
al
ity
 o
f l
ife
 s
pe
ci
fic
al
ly
 fo
r 
pa
tie
nt
s 
w
ith
 O
SA
.
D
om
ai
ns
 o
f t
he
 Q
SQ
 a
re
 c
om
pa
re
d 
to
 (d
om
ai
ns
 o
f) 
ot
he
r 
in
st
ru
m
en
ts
 th
at
 th
e 
au
th
or
s 
of
 th
e 
pa
pe
r 
de
em
 r
el
ev
an
t. 
Th
ey
 h
yp
ot
he
si
ze
 th
at
 a
ll 
co
rr
el
at
io
ns
 w
ill
 b
e 
be
tw
ee
n 
0.
4 
an
d 
0.
7.
[2
]
To
 a
dd
 s
om
e 
m
or
e 
de
ta
il 
to
 th
es
e 
co
m
pa
ri
so
ns
, w
e 
ad
de
d 
so
m
e 
ad
di
tio
na
l h
yp
ot
he
se
s 
ba
se
d 
on
 th
e 
si
m
ila
ri
tie
s 
an
d 
di
ffe
re
nc
es
 o
f t
he
 c
om
pa
re
d 
do
m
ai
ns
. W
e 
ex
pe
ct
 th
at
 th
e 
Q
SQ
 d
om
ai
n 
“d
ay
tim
e 
sl
ee
pi
ne
ss
” 
w
ill
 c
or
re
la
te
 s
tr
on
ge
st
 w
ith
  t
he
 E
SS
, t
he
 “
vi
ta
lit
y”
 d
om
ai
n 
of
 th
e 
SF
-
36
, a
nd
 a
ll 
do
m
ai
ns
 o
f t
he
 F
O
SQ
, a
s 
th
ey
 h
av
e 
re
la
te
d 
co
ns
tr
uc
ts
. A
 w
ea
ke
r 
bu
t s
til
l m
od
er
at
e 
co
rr
el
at
io
n 
is
 e
xp
ec
te
d 
fo
r 
th
e 
“r
ol
e-
ph
ys
ic
al
” 
do
m
ai
n 
of
 th
e 
SF
-3
6 
an
d 
ev
en
 w
ea
ke
r 
fo
r 
th
e 
“p
hy
si
ca
l f
un
ct
io
ni
ng
” 
do
m
ai
n 
of
 th
e 
SF
-3
6.
 
Th
e 
Q
SQ
 d
om
ai
n 
“d
iu
rn
al
 s
ym
pt
om
s”
 is
 e
xp
ec
te
d 
to
 c
or
re
la
te
 s
tr
on
ge
st
 w
ith
 th
e 
“v
ita
lit
y”
 
do
m
ai
n 
of
 th
e 
 S
F-
36
, t
he
 “
ge
ne
ra
l p
ro
du
ct
iv
ity
” 
an
d 
“a
ct
iv
ity
 le
ve
l”
 d
om
ai
ns
 o
f t
he
 F
O
SQ
. 
Ag
ai
n,
 a
 w
ea
ke
r 
co
rr
el
at
io
n 
is
 e
xp
ec
te
d 
w
ith
 th
e 
“r
ol
e-
ph
ys
ic
al
” 
do
m
ai
n 
of
 th
e 
SF
-3
6,
 a
nd
 th
e 
w
ea
ke
st
 c
or
re
la
tio
n 
w
ith
 th
e 
“p
hy
si
ca
l f
un
ct
io
ni
ng
” 
do
m
ai
n 
of
 th
e 
SF
-3
6.
Th
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at
io
n 
of
 th
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Q
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 d
om
ai
n 
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oc
ia
l i
nt
er
ac
tio
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” 
w
ith
 a
ll 
th
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e 
co
m
pa
ri
so
n 
do
m
ai
ns
 
of
 th
e 
FO
SQ
, S
F-
36
 a
nd
 S
C
L-
90
 a
re
 e
xp
ec
te
d 
to
 b
e 
on
 th
e 
w
ea
ke
r 
en
d 
of
 m
od
er
at
e 
as
 th
ey
 
m
os
tly
 c
on
ta
in
 it
em
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w
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 a
 d
iff
er
en
t f
oc
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 th
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 th
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e 
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e 
Q
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 d
om
ai
n.
W
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SF
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m
ea
su
re
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th
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m
en
ta
l a
nd
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hy
si
ca
l a
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ec
ts
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of
 li
fe
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Th
e 
ph
ys
ic
al
 a
nd
 m
en
ta
l c
om
po
ne
nt
 o
f t
he
 S
F-
36
 a
re
 e
xp
ec
te
d 
to
 c
or
re
la
te
 m
od
er
at
el
y 
w
ith
 
th
e 
EQ
-5
D
 a
nd
 th
e 
EQ
-T
. T
he
 m
en
ta
l c
om
po
ne
nt
 o
f t
he
 S
F-
36
 is
 e
xp
ec
te
d 
to
 h
av
e 
a 
w
ea
k 
to
 
m
od
er
at
e 
co
rr
el
at
io
n 
w
ith
 th
e 
ES
S 
an
d 
P
G
I b
ec
au
se
 th
e 
co
ns
tr
uc
ts
 a
re
 le
ss
 c
lo
se
ly
 r
el
at
ed
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ot
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m
po
ne
nt
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pe
ct
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 c
or
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te
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ea
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od
er
at
el
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w
ith
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P
G
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nd
 E
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 fo
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on
 m
or
e 
sp
ec
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co
m
pl
ai
nt
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K
no
w
n-
gr
ou
ps
 a
pp
ro
ac
h
Ad
di
tio
na
lly
, c
ha
ng
e 
sc
or
es
 w
er
e 
co
m
pa
re
d 
of
 s
no
re
rs
, p
at
ie
nt
s 
w
ith
 m
ild
 O
SA
 w
ho
 r
ec
ei
ve
d 
no
 tr
ea
tm
en
t, 
an
d 
pa
tie
nt
s 
w
ho
 w
er
e 
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 C
PA
P
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t b
as
el
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e 
an
d 
at
 fo
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-u
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 p
at
ie
nt
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w
ith
 O
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ev
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en
ou
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 d
om
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 d
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ef
fe
ct
 is
 e
xp
ec
te
d 
fo
r 
th
e 
SF
-3
6 
do
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l f
un
ct
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 p
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od
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 p
ai
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 s
pe
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pa
tie
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ith
 O
SA
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Th
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iv
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se
ve
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f O
SA
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m
ea
su
re
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ol
ys
om
no
gr
ap
hi
c 
m
ea
su
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ill
 li
ke
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flu
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ua
lit
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of
 li
fe
, b
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 u
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 w
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t e
xt
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e 
co
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id
er
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ita
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e 
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m
pa
ra
to
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ABSTRACT
Purpose 
Convergent validity is one type of validity that is commonly assessed for patient-reported 
outcome measures (PROMs). It is assessed by means of ‘hypothesis testing’: determining 
whether the scores of the instrument under study correlate with other instruments in the way 
that one would expect. Authors of systematic reviews on measurement properties for PROMs 
may encounter validation articles which do not state hypotheses by which convergent validity 
can be tested. The information in these articles can therefore not be readily used to determine 
the adequacy of convergent validity. We suggest that in these cases, reviewers construct their 
own hypotheses. However, constructing hypotheses and interpreting outcomes is not always 
straightforward, and we wish to aid reviewers based on our own recent experiences with a 
systematic review on measurement properties.
Recommendations 
We have the following recommendations for authors of a systematic review on measurement 
properties who wish to construct hypotheses for convergent validity: take an active role in 
judging the suitability of the comparator instruments of validation articles; be transparent about 
which hypotheses were constructed, the underlying assumptions on which they are based, 
and whether they were constructed by the authors of the validation article or by the reviewer; 
discuss unmet hypotheses, especially if convergent validity is judged to be inadequate; and 
when synthesizing data, add up the results of all hypotheses for one instrument, rather than 
judging convergent validity per study.
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1 INTRODUCTION
Questionnaires about patients’ health and functioning filled out by the patient, also known as 
patient-reported outcome measures (PROMs), should be validated to ensure that they measure 
the topic (‘construct’) that they aim to measure (validity), and that they do this in a reliable way 
(reliability). There are several different aspects of validity and reliability that can be assessed 
to determine the quality of a PROM. The international Delphi panel of COnsensus-based 
Standards for the selection of health Measurement Instruments (COSMIN) reached consensus 
on a comprehensive terminology of these measurement properties, as well as on the content 
of the first user-friendly quality checklist for validation studies [1-3]. The COSMIN checklist 
and guidelines are frequently utilized: a search in PubMed for COSMIN shows 50 systematic 
reviews on measurement properties using the COSMIN checklist in 2015 alone. 
 One aspect of validity is construct validity, which is the degree to which the scores 
of a PROM are consistent with hypotheses, based on the assumption that the PROM validly 
measures the construct to be measured [4-7]. Convergent validity, a subtype of construct 
validity, verifies whether the scores of the instrument under study ‘make sense’ in relation 
to the scores of other, related instruments. Scores should correlate with scores of other 
instruments to the degree that one would expect. Assessing convergent validity is an iterative 
process: the more hypotheses are tested, the stronger the evidence towards the instrument 
being valid. Convergent validity is generally considered adequate if >75% of hypotheses are 
correct, or if a correlation with an instrument measuring the same construct is >0.50. The 
exact values of these cut-off points may be arbitrary, but they provide guidance when judging 
whether convergent validity is adequate. Furthermore, correlations with related constructs 
should be higher than with unrelated constructs [4, 8].
 When performing a systematic review on measurement properties, assessing and 
summarizing the data for convergent validity is often less straightforward than for many other 
measurement properties. Authors of validation studies do not always construct hypotheses 
when studying convergent validity: many studies present only correlation sizes, without 
interpreting these or using them to test expectations. Based on the COSMIN guidelines, this 
data cannot be readily used in a systematic review. Therefore, the authors of a recent systematic 
review [9] decided to construct their own hypotheses for convergent validity. In our own recent 
systematic review on the measurement properties of PROMs for obstructive sleep apnea (OSA) 
[10], we followed their example. 
 We believe that constructing hypotheses for convergent validity should become more 
common in systematic reviews for measurement properties in which the included studies 
do not present their own hypotheses. However, there are certain issues that will arise when 
approaching hypothesis testing this way, which include: how to deal with unsuitable or low-
quality comparator instruments; the different ways in which hypotheses can be constructed; 
interpreting the results and synthesizing the evidence, which are a general issues regardless of 
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the approach. These issues have not yet been discussed in the literature. The aim of this paper 
is to provide an overview of these issues regarding convergent validity, and to start a discussion 
on how they can best be handled in future systematic reviews. Additionally, we believe that the 
considerations of this paper will aid authors of future validation studies, who will be faced with 
many similar issues.
2 QUALITY OF COMPARATOR INSTRUMENTS
Ideally, it should be clear that comparator instruments validly and reliably measure what 
they should measure. In practice however, comparator instruments are often not extensively 
validated, or not validated in the target population. Furthermore, it is unclear when exactly a 
comparator instrument is ‘valid’ - there are no rules or suggestions about which measurement 
properties should be of sufficient quality for comparator instruments (and due to a sometimes 
limited availability of suitable comparator instruments, this may also not be desirable). 
The most practical approach for reviewers may be to exclude comparator instruments for 
insufficient quality only if there is no development or validation article available at all.
 However, there is one situation in which the quality of an instrument or scale may 
clearly limit its value as comparator instrument for convergent validity: when the questions of 
a scale do not all tap into the same construct. Sometimes scales claim to measure a rather 
‘diffuse’ topic, such as social functioning. In practice, the questions that comprise one ‘social 
functioning’ scale often differ greatly from the items of other similarly named scales, and one 
cannot necessarily assume their scores correlate to a great extent – which is problematic when 
trying to determine the validity of the instrument under study (for examples of this phenomenon, 
see Kemmler 1999 [11] or Lacasse 2004 [12]). It may be that ‘social functioning’ is simply not 
the right construct label for (one of) these scales, or not a precise enough description of the 
construct, or that the scales have different underlying theories about how to measure social 
functioning. Another possibility is that they are a collection of questions with different topics 
around the same general theme rather than one coherent construct. If factor analysis has 
been performed for the comparator scale, and/or if internal consistency of the scale has been 
determined, this can help identify scales for which this is the case. We would recommend 
to look at both the content of the scale and the available information on the measurement 
properties before deciding to disqualify a comparator scale or instrument due to problems 
with the coherency of the construct. In all cases, we would recommend to (briefly) discuss the 
quality of comparator instruments, as this may help put the results of convergent validity in 
perspective.
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3 SUITABILITY OF COMPARATOR INSTRUMENTS
The construct of the comparator instruments is important for convergent validity: its construct 
should ideally have a clear relation with the construct under study. This clear relation is not 
always present for the comparator instruments used in validation studies. Correlation sizes 
may therefore be hard to predict. An example from our review is the relation between subjective 
sleepiness and the objective severity of sleep apnea, which is not straightforward [13-15]. If the 
results from a study disprove any constructed hypothesis, this would do more to illustrate the 
confusion around the relation between these two constructs, than to provide information about 
the validity of the instrument. We recommend excluding comparisons with these ‘unsuitable’ 
constructs from the evidence base.
 Furthermore, sometimes comparator constructs are only vaguely related to the 
construct under study. An example from our review is the relation between sleepiness and 
quality of life. These constructs are likely somewhat related in patients that suffer from sleep 
apnea, a condition for which sleepiness is often the main complaint. However, hypotheses of 
low correlations for weakly related constructs are often correct, and reduce the impact of the 
hypotheses for more strongly related constructs – which is especially problematic in cases 
where the former outnumber the latter, and no clear rationale is provided for the choice of 
these weakly related comparator instruments or domains. We recommend using expected 
weak correlations only for the requirement that correlations with related constructs are higher 
than with unrelated constructs.
 Sometimes two instruments are employed to validate each other. This is not ideal, as it 
is unclear which instrument is ‘at fault’ if a hypothesis is not met. However, since it can be quite 
hard to interpret results either way (see the section ‘Interpreting outcomes’), reviewers may 
decide to include these studies and discuss unmet hypotheses in the context of the validation 
study in question.
4 CONSTRUCTING THE HYPOTHESES
COSMIN recommends constructing hypotheses for relative correlation sizes of the different 
comparator instruments. I.e. the correlation of the instrument of interest with instrument 
A is expected to be higher than its correlation with instrument B. However, the constructs 
of the comparator instruments may not always be suitable for making meaningful relative 
hypotheses. To be able to make hypotheses for each comparator instrument, it can be desirable 
to also construct hypotheses for the absolute magnitude of the correlations. In our review we 
put each comparator instrument in one of the following categories: either a weak (<0.3), weak 
to moderate (>0.2<0.4), moderate (>0.3<0.7), moderate to high (>0.6<0.8) or high correlation 
(>0.7). The overlap between these categories was on purpose, to allow more flexibility in 
hypotheses. For each correlation we also noted the expected direction of the correlation - 
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positive or negative. Note that we did not focus on the common requirement that convergent 
validity is adequate if the correlation with an instrument measuring the same construct is 
>0.50. We studied the instruments in detail, rather than relying only on the description of the 
comparator instruments, and when two instruments really measured the same construct we 
considered a more challenging hypothesis (correlation above >0.70) more adequate.
 If an included validation study does use hypotheses to appraise convergent validity, 
these hypotheses can be integrated with those of reviewers. If the original hypotheses are 
stricter than as constructed by the reviewers, they can be adjusted. For example, in our review 
we adjusted a prediction of exactly 0.3 to fit within our ‘weak to moderate’ (>0.2<0.4) category.
5 INTERPRETING OUTCOMES
When a hypothesis is correct, this contributes to the evidence that the instrument under study 
measures what it is supposed to measure. However, when a hypothesis is wrong, this can have 
several causes: 1) the instrument does not measure what it is supposed to measure, 2) the 
comparator instrument does not measure what it is supposed to measure, or 3) the theory 
or the assumptions underlying the hypothesis are incorrect [5]. It is not always clear which of 
these possibilities is true in any given situation, though authors may have their own ideas about 
the most likely cause. Ideally, possible reasons why a hypothesis was not met are discussed 
by authors.
 Hypotheses about correlations, especially when they measure different but related 
constructs, are to some extent a best educated guess. A different team of authors or reviewers 
will likely construct (slightly) different hypotheses, possibly leading to different conclusions. 
Therefore, we suggest a thorough reporting of the hypotheses that are tested.
6 EVIDENCE SYNTHESIS
Many systematic reviews about measurement properties report results by synthesis of the 
evidence. To determine the strength of the evidence for each measurement property, often the 
number of validation studies studying that measurement property is taken into account, as well 
as the quality of the studies [8, 16, 17]. The quality of the measurement properties themselves 
can have evidence that is positive, negative, indeterminate (when only studies of poor quality 
are available), or conflicting (when results of validation studies are mixed). While this approach 
makes sense for some measurement properties, for hypothesis testing, the number of studies 
may be less relevant than the number of hypotheses tested. For example: if there are two 
studies measuring convergent validity, and one study has only one hypothesis which was found 
to be inaccurate (negative evidence), and the other has three different hypotheses which are 
accurate (positive evidence), the scoring method would lead to a ‘conflicting’ overall score. 
However, 75% of hypotheses overall are accurate. As such, adding up the hypotheses of the 
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different studies would lead to a more sensible estimation of the convergent validity of an 
instrument. To incorporate the methodological quality of the different studies in the score one 
could assign more weight to the hypotheses of better studies, or one could simply decide that 
the studies all need to be of at least acceptable quality.
7 DISCUSSION
Constructing hypotheses for convergent validity in a systematic review requires effort, but is the 
only way to assess this measurement property if no hypotheses were previously constructed. 
This article has provided an overview of the issues that can arise in systematic reviews 
assessing measurement properties of PROMs. Our recommendations are summarized in Box 1. 
These may be useful for future reviewers and for authors of validation articles with regard to 
convergent validity as well as other measurement properties that are determined by means of 
hypothesis testing, such as known-groups validity and discriminant validity (both also subtypes 
of construct validity) and responsiveness.
 The importance of hypothesis testing lies in its ability to help understand the construct 
the PROM measures. A PROM labeled with an inaccurate construct is a problem which may 
otherwise remain unrecognized as it does not necessarily affect other measurement properties. 
Inadequate construct validity leads to the question which construct the PROM does measure, 
and one will have to look again at the content of the questionnaire, and put this in the context 
of its comparator instruments. Depending on the situation, either the items of the PROM can 
be adapted, or it can be decided to re-label the construct the PROM aims to measure. 
 Establishing convergent validity is prone to several problems: its results depend 
to an important extent on the choice of comparator instruments and which, and how many, 
hypotheses are constructed. However, because 75% of hypotheses need to be accurate rather 
than all of them, a single inadequate comparator instrument or hypothesis will not immediately 
prohibit a positive judgment of convergent validity. Furthermore, if results are interpreted 
critically, we are convinced that an accurate judgment of convergent validity is possible.
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Box 1
Recommendations for reviewers
 •  Take an active role in judging the suitability of the comparator instruments:
  °  Exclude comparator instruments which have an unclear relation with 
the construct under study, or which do not have a validation article.
  °  Do not construct hypotheses for comparator instruments with expected 
weak correlations with the instrument under study, but use them as 
‘unrelated constructs’ for the requirement that correlations with 
related constructs are higher than those with unrelated constructs.
 •  Be transparent about the constructed hypotheses and their underlying 
assumptions, and about whether hypotheses were constructed by the reviewers 
or the authors of the validation study.
 •  Discuss unmet hypotheses in the light of the comparator instruments and their 
quality, especially if convergent validity is judged to be inadequate.
 •  For data synthesis: add up the results of all hypotheses for one instrument, 
rather than judging convergent validity per study.
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ABSTRACT
Background 
Obstructive sleep apnea (OSA) is a chronic condition that can have a wide range of 
consequences for a patient’s health-related quality of life. Monitoring aspects of quality of life 
in clinical practice has the potential to improve the patient-centeredness of care for patients 
with OSA. The aim of this article is to describe the development of the Patient-Reported Apnea 
Questionnaire (PRAQ), a patient-reported outcome measure (PROM) that is designed for use in 
clinical practice on an individual patient level, as well as subsequent outcome measurement 
on an aggregate level.
Methods 
We used the items of available PROMs for OSA to create a new PROM with focus on its 
applicability in clinical practice. We used a tailored development process to come to a selection 
of domains and items. Patients and healthcare professionals were intensively involved in the 
development of the PRAQ via membership of the development team, online surveys and focus 
groups, as well as two rounds of cognitive validation.
Results 
This first version of the PRAQ consists of 43 items and 10 preliminary domains, and covers the 
aspects of quality of life that healthcare professionals and patients wish to discuss in clinical 
practice. Patients indicate that PRAQ is comprehensive and that its length is acceptable. 
Comprehensive patient involvement has ensured good content validity for the PRAQ.
Conclusions 
This article shows how a PROM can be developed with a method tailored towards the PROM’s 
applicability in clinical practice.
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1 INTRODUCTION
OSA is a highly prevalent, chronic condition in which temporary obstructions of the upper 
airway cause breathing stops while asleep [1]. Arousal of the brain in patients with OSA results 
in continuation of breathing, which often goes unnoticed by the patient but can happen up to 
hundreds of times per night. This causes fragmented sleep and can result in severe sleepiness, 
fatigue and impaired mood during the day, which in turn can affect a patient’s relationships, 
psychological well-being, cognitive functioning, and participation in work and other activities 
[2-7]. Furthermore, OSA has been recognized as an independent risk factor for hypertension, 
heart failure, and diabetes [8-10]. The general population prevalence of OSA has been reported 
to be 13% to 33% in men and 6% to 19% in women [11], but in practice OSA goes undiagnosed 
in many patients [3, 12, 13].
 The wide range of consequences and the chronic nature of OSA make focus on health-
related quality of life (HRQoL) during the care process highly relevant. HRQoL is quality of life 
relative to one’s disease status [14] and has been captured in several models [14-16]. Patient-
reported outcome measures (PROMs) are questionnaires which are filled out by patients with 
the aim of measuring symptoms, daily functioning or HRQol. Most of the currently existing 
PROMs were developed for research purposes, to measure the impact of interventions on 
perceived health in clinical trials [17]. In recent years, the use of these existing PROMs has also 
expanded to areas closer to daily clinical practice [18-20]. There, individual PROM scores are 
used for the detection of problems with HRQoL, monitoring a patient’s response to treatment, 
and to improve patient-centeredness of care by directing more attention to a patient’s quality of 
life during consultations with healthcare professionals [21]. Furthermore, PROMs can be used 
as outcome measures to assess the quality of treatments or providers [22]. The integrated use 
of PROMs for these different purposes, which includes PROM measurements at both intake 
and during follow-up, is expected to stimulate meaningful use in clinical practice and quality 
improvement [23].
 A recently published systematic review [24] identified three available PROMs that 
were developed specifically for and with patients with OSA, and which aim to measure quality 
of life. However, the focus during their development was only on outcome measurement. 
Furthermore, because of either practical reasons (the PROM has to be administered by an 
interviewer) or content reasons (omission of important aspects of quality of life, and unclear 
phrasing of some of the items) these PROMs did not seem suitable for use in clinical practice. 
Therefore, we decided to develop a new PROM that covers the topics that patients and clinicians 
find relevant to discuss with regard to apnea-related quality of life, and which is also suitable 
for outcome measurement.
 The aim of this article is to describe the development of a new PROM, the Patient-
Reported Apnea Questionnaire (PRAQ), that measures the different aspects of OSA-related 
quality of life. This PROM can help focus clinical practice on the HRQoL of an individual patient, 
and can subsequently be used as an outcome measure for quality assessment. 
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2 METHODS
In developing the new PROM we used a set of steps that would ensure thorough patient and 
clinician involvement. These steps follow the general PROM development process as described 
in the literature [25-27]: item generation based on patient interviews or focus groups, selecting 
the items, developing scales and scoring method, and pilot testing the items (cognitive 
validation). Our approach to item generation phase was different from that described in the 
literature, as we pooled the items of existing PROMs rather than generating items ourselves. 
However, the item generation of these PROMs was based on patient input [28-30]. Additionally, 
during the item selection process of the PRAQ, we also gathered information specifically on 
the suitability of the domains and items for a PROM which will be used in clinical practice. We 
undertook the following steps:
 1) forming a working group with different stakeholders;
 2)  creating a preliminary pool of items from existing PROMs and sorting these items 
into preliminary domains based on the topics of the items;
 3)  using a patient survey and healthcare professional survey to gather input for 
domain and item selection;
 4) selecting domains and items with the working group;
 5) discuss and adapt this selection in patient focus groups;
 6) performing two phases of cognitive validation.
Each of these steps is explained in further detail in the following paragraphs. The definite 
sorting of the PRAQ items into domains with the help of psychometric methods will be 
conducted after a follow-up study and is outside the scope of this article. 
2.1 Forming a working group
A working group was formed consisting of two researchers (IA and PW), a board member (MI) 
of the patient organization for OSA in The Netherlands (ApneuVereniging), and a pulmonologist 
specialized in OSA (BH), based at the Albert Schweitzer Hospital, The Netherlands. The working 
group made the necessary decisions for the PROM development throughout the development 
process, based on the input from patients and healthcare professionals whenever possible.
2.2 Creating preliminary pool of items
Three available PROMs which were previously developed for patients with OSA used patient 
input for the creation and/or selection of items [24]: the Sleep Apnea Quality of Life Index 
(SAQLI) [28], the Quebec Sleep Questionnaire (QSQ) [29, 31], and the Maugeri Obstructive Sleep 
Apnea Syndrom (MOSAS) questionnaire [30]. In the opinion of the working group, the QSQ and 
the MOSAS questionnaire appear to miss some important topics, e.g. items about emotions or 
symptoms, respectively. Furthermore, the phrasing of some items was deemed suboptimal. The 
SAQLI appears unfeasible for use in clinical practice because it is interviewer-administered, 
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but it does cover a very broad range of topics identified by patients in its development phase. 
Therefore, the working group decided to create a pool of items consisting of the items of 
these three PROMs, and use these items to create a new PROM which covers all relevant 
issues and which also suits our different purposes. We decided to use a 7-point Likert scale 
similar to that used in the QSQ and SAQLI. 7 response options have shown to be more reliable 
than 5 response options, possibly because raters do not like to choose the two most extreme 
response options of a scale [27]. After discussion in the working group we also decided to keep 
the 4-week recall period, because patients with OSA generally struggle with symptoms over 
longer periods of time and our patient representative indicated that shortening this period may 
feel too restrictive for patients. 4 weeks is the maximum recall period that is recommended for 
this type of questionnaire [32], is suited to the effects of therapy on a chronic illness [33] and is 
also used in well-known PROMs such as the SF-36 [34].
 The three PROMs were each translated into Dutch by two translators who are native 
Dutch speakers. The working group selected the translation considered optimal for each 
item. We did not perform a backwards translation because we did not aim to adhere to the 
exact phrasing of the items: we only wanted to keep the topics the same. The working group 
and particularly the patient representative paid specific attention to whether the translated 
items and topics made sense the context of measuring quality of life for patients with OSA, 
to ascertain that the translators had not made misinterpretations. Furthermore, the working 
group made sure that all items were suitable for patients that were suspected of having OSA, 
as well as patients already diagnosed with or treated for OSA, and that items were suitable to 
potentially measure change over time.
 All items of these three PROMs together formed our pool of items. When items from 
different PROMs were highly similar in both phrasing and topic, only one of the items was 
kept in our item pool. The working group then grouped the items into preliminary domains 
according to their topic, keeping in mind the conceptual model of health-related quality of 
life developed by Wilson and Cleary [16], separating the items on symptoms from those on 
functional status.
2.3 Gathering information for item selection: patient and healthcare professional survey
An online patient survey was distributed to gain input for item and domain selection, covering 
how important the different items are for patients with OSA (on a scale of 1 to 9); whether 
any items or domains are missing; and which topics patients would like to discuss with an 
OSA physician or nurse. Patients were also asked to comment on the phrasing of the items 
and to indicate if they found any items hard to understand or confusing. The survey was sent 
out to patients with OSA and partners of patients with OSA who are volunteers of the Dutch 
patient organization for OSA. These volunteers have encountered many patients with OSA in 
their volunteer work, and were asked to base their importance ratings for the individual items 
on their expertise based on this broad experience.
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 An online survey for healthcare professionals was set up to gain the following 
information per domain: to what extent respondents would want to know if their patients had 
these kind of problems; to what extent they thought treatment for OSA would reduce these 
problems; and to what extent they considered themselves at least partially responsible for 
helping to solve these problems for their patients – which includes the option of referring 
patients to another healthcare professional, such as a psychologist. Furthermore, the 
respondents were asked if they thought any domains were missing.
2.4 Preliminary domain and item selection
The working group selected the domains and subsequently the items of the PRAQ based on the 
surveys. We considered a domain relevant if more than 50% of both patients and healthcare 
professionals answered positively on the questions regarding whether a patient would want 
to discuss this domain with their healthcare provider, or the other way around, i.e. whether 
a healthcare provider was interested to learn more on this domain topic form the patient (a 
score of 7, 8 or 9 was considered positive). If this criterion was not met, the domain was up for 
discussion in the working group and patient focus groups.
 As a next step, the working group selected the items within the selected domains. 
We excluded all items considered important by less than 50% of patients, items considered 
important by 50 - 70% of patients were up for discussion in the working group. Additionally, 
items were adjusted and potentially included if there were specific comments explaining 
why the score of item was low, such as issues around comprehensibility of the item. Patient 
comments were also used to identify items which were considered highly similar, and we 
discarded those with the lowest importance score.
2.5 Discussing the preliminary item selection: patient focus groups
After the preliminary selection of items by the working group, two patient focus groups (n=9 
and n=5 participants, with at least two women in each) were held to discuss the results and the 
choices of the working group, and to reaffirm the relevance of the items for patients with OSA. 
Participants were volunteers of the OSA patient organization who had completed the survey.
2.6 Cognitive validation
Two phases of cognitive validation [35, 36] were carried out, each involving six patients with 
OSA or suspected OSA attending a consultation at a sleep centre, and if present, their partners. 
Ages of the patients ranged from 42 to 74, and highest education level ranged from primary 
school to undergraduate college. Half of the included patients were women. For one of the 
patients, Turkish was their first language. 
 The aim of the cognitive validation was to check whether all selected items were 
understood by patients as intended, and whether the answering options were complete and 
made sense. All patients were asked to think aloud while completing the PROM, and were 
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asked additional questions (probing) about their interpretation of the items. Items that were 
unclear were either removed or adjusted. Subsequently, a second phase of cognitive validation 
was carried out with the adjusted PROM.
3 RESULTS
The development of the PRAQ is summarized in the flow chart in Figure 1.
3.1 Creating preliminary pool of items
Our preliminary pool of items consisted of 63 items, which the working group sorted into 10 
preliminary domains: symptoms at night, sleepiness, tiredness, memory & concentration, 
unsafe situations, concerns about health, daily functioning, direct effect of apnea on others 
(e.g. bothering others due to snoring), social interactions (with sexuality as a subtopic), and 
emotions. 
3.2 Patient and healthcare professional surveys
The patient survey was sent out to 85 volunteers of the Dutch OSA patient organization, of 
which 35 people completed the survey (41%). The characteristics of the respondents can be 
found in Table 1.
 Most of the individual items were considered important (7 or higher on a scale of 
1-9) by a majority of respondents (70-90%). The items in the ‘social interactions’ domain had 
generally lower scores than the items in other domains, with a range of 29-71% of patients 
regarding them as important. Within this domain, the question about sexuality was considered 
important by the most respondents.
 There was a general desire to be able to discuss the ten domains in a consultation 
with an OSA healthcare professional. Looking at the percentage of patients that scored their 
desire to discuss a certain domain with at least 7, the highest scores were for the domains 
‘daily functioning’ (88%) and ‘symptoms at night’ (87%). The lowest scores were for direct effect 
of apnea on others (65%), social interactions (60%) and sexuality (55%).
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63 items
10 domains
+ 1 item
+ 1 domain
- 20 items
- 1 domain
17 items adjusted
Based on patient and 
HC professional surveys
1 item adjusted
- 1 item
+ 1 item
Patient focus groups
- 1 item
8 items adjusted
Cognitive validation 
with patients
44 items
10 domains
44 items
10 domains
43 items
10 domains
Figure 1 Flow chart of the PRAQ development process
HC=healthcare professional
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Table 1 Patient survey respondent characteristics
Total nr of respondents 35
Current patients with OSA 30
Former patients with OSA 3
Partners 2
Gender 29% female
Median age category 60-69
Patients only (n=30)
Treatment by CPAP/BPAP 100%
   CPAP with additional MRA or operation 13%
BPAP=bilevel positive airway pressure, CPAP=continuous positive airway pressure, MRA=mandibular 
repositioning appliance, OSA=obstructive sleep apnea
The healthcare professional survey was sent out to 55 OSA professionals of whom 30 
completed the survey (55%). The characteristics of the respondents can be found in Table 2. 
 For each of the domains, the majority of healthcare professionals indicated that they 
would want to know if their patients had problems with this topic (82%-100%). Most of them 
also felt at least partially responsible for helping to solve these problems, either by treating the 
patients themselves or referring the patient to another healthcare professional (72%-100%). 
Most healthcare professionals felt that treating their patients’ OSA would improve complaints 
about sleepiness, symptoms at night, and the direct effect of apnea on others (89-96%). For the 
other domains, opinions were more diverse. Problems with sexuality were considered ‘likely to 
improve’ by the fewest survey respondents (46%).
Table 2 Healthcare professional survey respondent characteristics
Respondents (n) 30
    Employed at n sleep centers 26
Median age category 50-59
Gender 53% female
Physician (n) 16
       Pulmonologist (n) 10
       Otolaryngologist (n) 2
       Neurologist (n) 4
OSA nurse (n) 12
OSA nurse practitioner (n) 2
OSA=obstructive sleep apnea
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3.3 Preliminary selection of topics and items
A majority of both healthcare professionals and patients wanted to be able to discuss each of 
the ten preliminary domains, so we considered all domains relevant for the PRAQ.
 We decided to keep the item asking about anxiety in the domain ‘emotions’ despite 
its relatively low importance scores on the patient survey (60% of patients considered this an 
important item to add, versus over 70% for other items), because anxiety is more common in 
female patients with OSA [37, 38] and women were slightly underrepresented in the sample.
 After item selection, only one item remained as part of the domain ‘direct effect of 
OSA on others’, so we decided to move this item to ‘social interactions’. 
 Patients indicated that additional items about sleep problems should be part of the 
PRAQ, which was supported by the results of the healthcare professionals. Therefore, we 
added the domain ‘quality of sleep’, covering the suggested sleep problems. This resulted in a 
total of ten preliminary domains and 44 items.
3.4 Patient focus groups
During the patient focus groups, the preliminary selection of domains and items was discussed. 
One item was adapted, and one item was added to the domain ‘emotions’ about experiencing 
sudden, intense emotions. One other item for this domain (‘how often did you feel you were 
unreasonable?’) was removed after discussion in the group. The participants felt that a patient 
was unlikely to admit to being unreasonable, and that this type of emotion would be sufficiently 
covered by the items about feeling irritable and losing one’s temper. 
 The number of answering categories was discussed, as several patients preferred to 
have ten answering categories rather than the proposed seven options, because this be similar 
to the scores of the Dutch version of a report card in school and thus would be more intuitively 
understandable. However, there was no consensus about this in the focus groups. We decided 
with the working group to maintain the 7-point Likert scale, for two reasons: scoring the PRAQ 
like a report card might give patients the idea that they are being judged on how well they are 
‘performing’, which is not desirable; and as stated before, in the literature seven answering 
categories are often thought to be optimal [27].
 Patients also commented on the recall period of the items: recalling symptoms of 
the past four weeks was generally seen as too short a time period. Newly diagnosed patients 
have often been experiencing symptoms for years, and choosing a long recall period, e.g. six 
months, would be more relevant for this particular group. However, follow-up appointments for 
CPAP users can be as early as four to six weeks after initiating treatment. Since we would like 
our PROM to be a useful addition to follow-up appointments as well as the intake appointment, 
using a recall period of more than four weeks is not desirable. To address the wishes of the 
patients, we therefore added an open text field at the end of each domain in which patients get 
the opportunity to describe past symptoms.
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 We also discussed the acceptable number of items for the new PROM. Patients of both 
focus groups felt that all remaining items were relevant and important, and that the length of 
the PRAQ was acceptable. The exception was the domain ‘sleepiness’ (containing eight items), 
which patients said could likely be further reduced without information loss. As there was no 
patient preference for which items should remain in the selection, we will perform the final 
selection of items for this domain with psychometric methods after a pilot study has taken place. 
 After the focus groups, there were 44 items left for the PRAQ.
3.5 Cognitive validation
Twenty-one patients were interviewed, aged between 42 and 74 years and with different 
education levels. There were several items in the PROM that were confusing to all or most 
of the interviewed patients, or that they understood in a way that was not intended, which 
were subsequently adjusted or removed. One example of a misunderstood item was ‘Were you 
concerned about your safety or that of others in traffic or while operating machinery?’. Several 
patients indicated concern about their safety in traffic because they thought other people were 
often bad drivers. We adjusted this question to include ‘due to your sleepiness’, to shift the 
focus of this item to the patient’s own potential problems due to OSA. During the second phase 
of the cognitive interviews, the meaning of the newly adjusted items as well as the other items 
in the current item selection was clear to the patients.
3.6 Final result
Based on the development process described in this paper, the current PRAQ comprises 
ten (preliminary) domains and 43 items, and takes approximately 15 minutes to fill out. The 
official English translation of this preliminary PRAQ can be found in Table 3. In a next stage of 
development, which involves a validation study assessing reliability, validity and responsiveness, 
final item selection and domain construction will take place.
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Table 3 English translation of preliminary PRAQa
Symptoms at night
During the past 4 weeks, did you have a problem with:
1. Snoring loudly?
2. Waking up frequently to urinate?
3. Waking up at night with the feeling that you are choking?
4. A feeling that you are sleeping restlessly?
5. Having a dry or painful mouth when you wake up?
6. Waking up in the morning with a headache?
Sleepiness
During the past 4 weeks, did you have a problem with:
7. Fighting to stay awake during the day?
8. Suddenly falling asleep?
9. Difficulty staying awake during a conversation?
10. Difficulty staying awake while watching something? (concert, movie, television)
11. Falling asleep at inappropriate times or places?
12. Difficulty staying awake while reading?
13. Fighting to stay awake when you are driving?
14. Did you feel like you needed to take a nap in the afternoon?
Tiredness
During the past 4 weeks, did you have a problem with:
15. Feeling very tired?
16. Lacking energy?
17. Still feeling tired when you wake up in the morning?
Daily activities
During the past 4 weeks:
18.  How difficult was it for you to do your most important daily activity? (such as your job, studying, 
caring for the children, housework)
19.  How often did you use all your energy to accomplish only your most important daily activity? 
(such as your job, studying, caring for the children, housework)
20.  Did you feel you have a decreased performance with regard to your most important daily 
activity? (such as your job, studying, caring for the children, housework)
21. How much difficulty did you have finding energy for your hobbies?
22. How difficult was it for you to get your chores done?
Unsafe situations
During the past 4 weeks:
23. Did you have problems while driving a car due to sleepiness?
24.  Were you concerned about your safety or that of others due to your sleepiness? (for example in 
traffic, or when operating machinery)
Memory and concentration
During the past 4 weeks:
25. Were you sometimes forgetful?
26. Did you sometimes have difficulty concentrating?
Quality of sleep
During the past 4 weeks, did you have a problem with:
27. Falling asleep when you go to bed at night?
28. Getting back to sleep after you woke up at night?
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Emotions
During the past 4 weeks:
29. How often did you feel depressed or hopeless?
30. How often did you feel anxious?
31. How often did you lose your temper?
32. How often did you feel that you could not cope with everyday life?
33. How often did you feel irritated?
34. How often did you have a strong emotional reaction to everyday events?
Social interactions
During the past 4 weeks:
35. Did you sometimes feel upset because others were disturbed by your snoring?
36.  Was it a problem for you that you sometimes had no energy or no desire to do things with your 
family or your friends?
37. Did you feel guilty towards your family or friends?
38. Did you feel upset because you argued frequently?
39. Did you sometimes experience problems in the relationship with your partner?
40. Did you feel upset because you could (maybe) not sleep in the same room as your partner?
41. Did you sometimes think up excuses because you were tired or sleepy?
42.  Did you have a problem with unsatisfying and/or too little sexual activity? (by yourself or with 
another)
Health concerns
43.  Were you concerned about other conditions that may be related to sleep apnea? (such as 
diabetes, high blood pressure, cardiovascular disease, being overweight)
a. The PRAQ was translated into English by an official translator who is a native English speaker, and by IA. 
The translator, IA and PW together reached consensus on the translation of each item. The English PRAQ 
was translated back into Dutch by another official native Dutch translator, and IA and PW  used input from 
this translator to adapt the English version where needed.
4 DISCUSSION
In this article we describe the development of a quality of life PROM for patients with OSA, 
the Patient-Reported Apnea Questionnaire (PRAQ). The PRAQ was developed with the goal 
of serving as a useful addition to daily clinical practice at an individual patient level, to help 
focus more attention on quality of life, and subsequently as an outcome measure for quality 
assessment. We developed the PRAQ by using the pooled items of existing PROMs for patients 
with OSA and subsequently adapted and selected items with the input of physicians and 
patients. This resulted in a preliminary PRAQ with 10 domains and 43 items.
 Item selection for the PRAQ is not yet entirely complete: within the domain of 
‘sleepiness’, patients felt that the number of items could be reduced. However, they had 
no opinion on which of the eight items should be removed, because they were all relevant. 
Psychometric methods will be used to reduce the number of items in this domain using the 
data of a pilot study on this preliminary version of the PRAQ.
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 Next to being used on an individual patient level in clinical practice, our aim for the 
PRAQ was to be able to use its outcomes for quality assessment at an aggregate level. One 
important PROM measurement quality specifically for quality assessment is that a PROM 
must be responsive, i.e. that it is able to measure changes in a patient’s condition over time. 
We took this into account in the development of the PRAQ by asking healthcare professionals 
whether they expected that different aspects of quality of life, as covered by the preliminary 
domains, would improve after treatment for OSA. The actual responsiveness of the PRAQ will 
be assessed in a validation study.
 When developing a PROM that can be used both on an individual patient level in 
daily clinical practice and as an outcome measure for quality, it is important to find a balance 
between the wishes of patients and the requirements for creating a feasible outcome measure. 
For example, the patients wished to communicate symptoms from as far as six months ago, 
which is not a feasible recall period for a a quality of life PROM [27, 32]. We believe that the 
solution the working group devised together with the patients – offering patients an open text 
field for each domain, which can be used in clinical practice, if not for the scoring of the PRAQ 
– is a reasonable compromise in this case.
 Patient input is very important during the PROM development process [39, 40]. For our 
patient input, we made use of the knowledge and experience of volunteers of the OSA patient 
organization in The Netherlands. Such volunteers are a relatively engaged population, and 
might therefore differ slightly from regular patients with OSA, but we do believe that they were 
able to give an accurate representation of what is important to this patient group. Furthermore, 
because we also used the input of healthcare professional and available literature, we do not 
believe that any important domains are missing.
 To develop the PRAQ we used the items of the SAQLI, QSQ, and the MOSAS 
questionnaire [28, 30, 31]. Even though the PRAQ contains many items that are similar to the 
items of these PROMs, it also differs from them substantially. Compared to the SAQLI, the 
PRAQ is shorter and easier to understand, allowing patients to complete the PROM without an 
interviewer. The PRAQ is more elaborate than the QSQ in its emotions and social functioning 
domains. Furthermore, quite a few items of the QSQ and MOSAS questionnaire were seen as 
unclear or less relevant by the patients with OSA in this study and were therefore not added 
to the PRAQ. Furthermore, the preliminary PRAQ has its items grouped into more domains 
than the other PROMs, because we split up the symptoms that patients can experience during 
the day in more separate domains than the other PROMs. We chose this approach because 
we wanted to create domains of which the scores are more easily interpretable by healthcare 
professionals. A future factor analysis, as part of the validation of the PRAQ, will have to show 
whether the way items are currently grouped into domains makes sense psychometrically. 
Based on the validation study, the items of the PRAQ will then be sorted into their final domains.
 The method used for developing this PROM, which includes forming an item pool out 
of the individual items of existing PROMs, can be employed by others as is, or can be adjusted 
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to fit the needs of a specific situation. The thoroughness of prior research and the number 
of PROMs and items available will have to be taken into account when deciding on the exact 
approach of the development process. If it is suspected that currently available PROMs do not 
cover all aspects which are important to the patient population, additional research may be 
warranted to expand the item pool, for example in the form of patient interviews. 
Future research
Our next step will be to perform a pilot study to finalize item selection and the formation of 
domains for the PRAQ. We subsequently study the measurement properties of the PRAQ, 
to estimate its suitability for measuring outcomes for individual patients and for quality 
assessment at an aggregate level. We will also develop a digital tool which summarizes the 
results of the PRAQ in a patient-friendly manner for use during consultations. 
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ABSTRACT
Background 
We previously developed the preliminary version of the Patient-Reported Apnea Questionnaire 
(PRAQ), a questionnaire measuring health-related quality of life in patients with (suspected) 
obstructive sleep apnea (OSA). This questionnaire was developed for clinical practice, where it 
can potentially serve two goals: use on an individual patient level to improve patient care, and 
use on an aggregate level to measure outcomes for quality improvement at a sleep center. In 
this study we aim to finalize the PRAQ, make a subselection of items and domains specifically 
for outcome measurement, and assess the validity, reliability and responsiveness of the PRAQ.
Methods 
Patients with suspected OSA were included and asked to complete the PRAQ and additional 
questionnaires one or more times. The collected data was used to perform the final item 
selection for clinical practice and for outcome measurement, create the domains for outcome 
measurement, and assess the measurement properties internal consistency, test-retest 
reliability, convergent validity and responsiveness.
Results 
180 patients were included in the study. The final version of the PRAQ for use in clinical practice 
contains 40 items and 10 domains. A subselection of 33 items in 5 domains was selected for 
optimal outcome measurement with the PRAQ. The results for the outcome measurement 
domains were: Cronbach’s α 0.88-0.92, ICC 0.81-0.88, and >75% of hypotheses correct for 
convergent validity and responsiveness.
Conclusions 
The PRAQ shows good measurement properties in patients with (suspected) OSA.
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1 INTRODUCTION
Patients with obstructive sleep apnea (OSA) experience breathing stops while asleep, causing 
symptoms during the day such as excessive sleepiness, tiredness, and irritability. This can have 
a large impact on daily functioning of patients, and often affects a patient’s relationships and 
psychological wellbeing [1-3]. Furthermore, OSA is a known risk factor for comorbidities such 
as diabetes and heart failure [4-6], and is also associated with depression and anxiety [7-9]. 
Gaining an overview of the problems that OSA patients may experience, before, during, and in 
evaluating treatment, may be a challenge.
 Patient-reported outcome measures (PROMs) are questionnaires for patients about 
symptoms or daily functioning. Most PROMs have been developed for use in clinical trials, but 
interest in their use in daily practice is growing [10, 11]. There, PROM scores can be used on 
an individual patient level to help bring patients’ problems to the forefront during consultations 
and to monitor treatment response, or on an aggregate level across groups of patients for 
quality improvement purposes [12]. Use of a PROM on an individual patient level may be 
especially relevant when patient symptoms are multiple and complex. We therefore believe 
that it would be beneficial to employ a PROM for patients with OSA in daily clinical practice.
 In a recently published article, we described the item generation and preliminary 
item selection of a PROM for patients with (suspected) OSA: the Patient-Reported Apnea 
Questionnaire (PRAQ) [13].We used the input of patients with OSA and healthcare professionals 
to select topics and items important for measuring quality of life for this patient group, which 
are also useful to discuss during an intake or follow-up consultation.
 There are two ways in which the preliminary version of the PRAQ requires further 
development. First, the item reduction for the topic ‘sleepiness’ has not yet taken place. During 
the item selection process of the PRAQ, patients indicated that the number of items on the 
topic of sleepiness could be reduced. Since the patients had no preference for which items 
to exclude, we decided to perform the final item reduction after studying the psychometric 
properties of the items. Second, the factor structure of the PRAQ has not yet been studied, and 
we wanted to find the optimal way to group (a subset of) the items of the PRAQ into domains for 
the purpose of outcome measurement. 
 Our aim is for the PRAQ to be employed in the following way: patients complete all 
items of the PRAQ before their consultation, the results of which can be discussed with a 
healthcare professional; and the aggregate outcomes of groups of patients can then be studied 
by making use of a subset of the completed items. This is beneficial for patients, who get 
feedback from clinicians on their results; for physicians, who get a quick insight into their 
patients’ main problems; and for sleep centers that wish to collect outcome data for quality 
improvement, because it ensures a steady stream of data due to integration in clinical practice.
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 In this article we describe the further development of the preliminary PRAQ. In 
addition, we aim to determine the reliability, validity and responsiveness of the PRAQ, with a 
focus on the domains that will be used for outcome measurement. 
2 METHODS
2.1 Population & method of completion of the PROMs
Baseline measurement: Patients referred to the sleep center of the Albert Schweitzer Hospital 
in Dordrecht, The Netherlands for suspected OSA received an invitation by email to complete 
the PRAQ and additional PROMs, 2-3 weeks before their intake consultation. They were 
informed that the results of the PRAQ would be discussed during their intake consultation. A 
reminder was sent one week later if the PROMs were not yet completed at that time. Patients 
who had not completed the PRAQ at home were offered the option of completing the PRAQ at 
the sleep center before their consultation. 
 Retest measurement: In order to assess test-retest reliability, patients who had 
completed the baseline measurement at home were asked to complete it again immediately 
before their intake consultation, on a computer in a private area of the sleep center. Only 
patients who had completed the retest no less than 7, and no more than 21 days after the 
baseline measurement were included for assessment of test-retest reliability.
 Follow-up measurement: A common measure to express the number of (partial) 
breathing stops experienced while asleep is the apnea-hypopnea index (AHI). We measured 
the responsiveness of the PRAQ in patients with an AHI≥15, which indicates moderate to 
severe sleep apnea [14], and who were prescribed continuous positive airway pressure (CPAP) 
after their intake consultation. CPAP is the preferred treatment for OSA [15]. If the patients 
were still using CPAP at the time of the first follow-up consultation (6-8 weeks after start of 
CPAP), they were included for responsiveness. They were asked to complete the PRAQ and the 
additional PROMs immediately before their follow-up consultation at the sleep center. Ideally, 
responsiveness should be determined in a patient group in which CPAP therapy is successful 
and therefore a substantial change is expected with regard to the patient’s symptoms. CPAP 
therapy is generally considered successful when compliance is ≥4 hours nightly [16].
 A secure website was used for the completion of the PROMs. For any of the 
measurements, patients who were unable or unwilling to use a computer were offered the 
option of completing a paper copy of the PROMs.
2.2 Final stage of PRAQ development
The development article of the preliminary PRAQ [13] shows how the initial 43 items were 
selected based on their relevance for clinical practice and were sorted into preliminary 
domains: symptoms at night (6 items), sleepiness (8 items), tiredness (3 items), daily activities 
(5 items), unsafe situations (2 items), memory and concentration (2 items), quality of sleep (2 
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items), emotions (6 items), social interactions (8 items), and health concerns (1 item) (Appendix 
1). All items are scored on a 7-point Likert scale (higher scores indicate worse problems), and 
the average item scores in a domain form its domain score.
 First, we performed item reduction on the sleepiness domain, as 8 items was deemed 
too much by patients. Then, we looked at how the PRAQ could be best used for outcome 
measurement. It is important that all items fit into a domain that is either ‘coherent’ in terms 
of clinical relevance, or (preferably) in terms of covariance matrix as determined by principal 
component analysis (PCA). Therefore, our aim was to identify which items of the PRAQ can 
be grouped into domains for outcome measurement after use of the results of the PRAQ for 
an individual patient. We describe below how we first reduced the number of items for the 
domain ‘sleepiness’, and then how from the remaining items a subset of items was selected 
for outcome measurement. 
Item reduction of the sleepiness domain
During the development of the PRAQ, patients indicated that they felt that the number of items 
on the topic of sleepiness could be reduced. Because they had no preference for which items 
should be excluded, we took a statistical approach. We first looked for items with a high inter-
item correlation (>0.9), indicating that one of these items can be removed without a substantial 
loss of information [17]. As a second step, we used exploratory factor analysis to identify 
potential items with lower factor loadings (<0.5), indicating that they do not cover the construct 
as well as the other items and are therefore more suitable for removal [17, 18].
Creating domains for the PRAQ-outcome
Two of our preliminary domains, ‘symptoms at night’ and ‘social interactions’, we considered 
formative rather than reflective domains: they do not aim to measure aspects of the same 
latent construct, but the items are grouped together based on clinical relevance. Grouping 
items in this way can be considered a ‘clinimetric’ approach, as opposed to a ‘psychometric’ 
approach which uses statistical methods to determine the dimensionality of a PROM [19]. 
We wanted to group these items together irrespective of their covariance matrix, because for 
content reasons we did not consider it desirable to combine these items with any of the other 
(potential) domains. Therefore, we excluded them from the PCA and kept these domains as 
they were.
 We performed a PCA with oblique rotation (because correlations between the 
different patient complaints were expected) on the 26 items of the other preliminary domains. 
Items that did not load on any domain with a factor loading of at least 0.5 or that had a factor 
loading of >0.3 on more than one factor [17], were then one by one removed from the analysis, 
starting with those items that for content reasons did not seem to fit well with the items they 
were grouped with in the PCA. Additionally, since domains should ideally consist of at least 
three items, we used this as a requirement for the PRAQ-outcome domains [17]. The one-
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dimensional domains that were identified by the analysis were added to the two clinimetric 
domains. Together, these domains form the subset of the PRAQ that can be used for outcome 
measurement.
2.3 Assessment of measurement properties
We studied the distribution of the individual items and the PRAQ domain scores at baseline to 
check for floor and ceiling effects (i.e. whether <15% of the respondents achieved the highest or 
lowest possible scores [20]). We assessed the reliability, validity and responsiveness of the PRAQ 
following the taxonomy of measurement properties as constructed by the COSMIN panel [21].
 We calculated the internal consistency parameter Cronbach’s α, which should have 
a value between 0.70 and 0.95 [20]. We assessed test-retest reliability by calculating the 
intraclass correlation coefficient (ICCCconsistency) for each PRAQ domain. ICC values of 0.7 are 
considered acceptable, but values of ≥0.8 are preferred [17]. Additionally, we calculated the 
standard error of measurement (SEM). 
 We used hypothesis testing to assess convergent validity, which involves studying 
the correlations of the scores of the PROM under study with the scores of other PROMs. We 
hypothesized on the size and direction of the (Spearman’s) correlations of the PRAQ domains 
with the (subscales of) PROMs with similar constructs (Appendix 2). We also hypothesized 
which PROMs should have a lower correlation with the PRAQ domain. Good convergent validity 
means that 75% of hypotheses are correct [20]. We used the following (subscales of) PROMs 
for convergent validity in their official Dutch translations:
 •  The Epworth Sleepiness Scale (ESS) [22], measuring daytime sleep propensity. For 
eight situations, a patient indicates the likelihood that they would fall asleep while in 
that situation. The measurement properties of the ESS have been studied in a sleep 
apnea population [23].
 •  The ‘vitality’ domain of the RAND-36 [24]. The (freely available) RAND-36, which 
is the predecessor of the well-known SF-36, measures general quality of life in 
several domains. The vitality domain of the RAND-36 contains 4 items about a 
patient’s perceived energy level. The items are identical to the items of the vitality 
domain of the SF-36, and the domain’s measurement properties have been studied 
in a sleep apnea population in that context [23].
 •  The following short-forms of the Patient-Reported Outcomes Measurement 
Information System (PROMIS) databank [25-27]: sleep disturbance (5 items), sleep-
related impairment (6 items), fatigue, satisfaction with participation in social roles, 
ability to participate in social roles, anger, anxiety and depression (the latter 6 all 
contained 4 items per short-form) [28-31]. For ‘sleep disturbance’ and ‘anger’ these 
were custom short-forms with fewer items than the standard short forms, in order 
to reduce the number of items that patients had to complete for this study.
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To assess responsiveness, we constructed hypotheses about the change scores of PRAQ in 
correlation to the change scores of the same instruments that were employed for hypothesis 
testing in construct validity (Appendix 2). 
3 RESULTS
3.4 Population characteristics
The baseline population consisted of 180 patients with suspected OSA who completed the 
baseline measurement. Of these patients, 105 completed the retest between 7 and 21 days 
(average 14 days), and 53 patients completed the follow-up measurement after 6-8 weeks 
of treatment with CPAP. Characteristics of these respective (sub)populations can be found in 
Table 1.
3.5 Missing data
Patients completing the online PRAQ were not allowed to leave any items open (no missings 
allowed). Eleven patients completed the PRAQ on paper one or more times, and in one of 
these completed PRAQs (for follow-up after CPAP), item 33 (Appendix 1) was missing from the 
domain ‘social interactions’. We computed the domain score for this patient as the average of 
the remaining items.
 Seven items allowed the response item ‘not applicable’ (see Appendix 1). Between 
19% and 46% of respondents selected this response category for the respective items. 
Table 1 Baseline characteristics of the study populations
Baseline population 
(n=180)
Test-retest 
population (n=105)
Population with follow-
up after CPAP (n=53)
Gender 31.7% female 38.1% female 25.0% female
Age (mean (SD)) 50.1 (12.6) 50.4 (13.0) 55.8 (10.9)
Baseline AHI (mean (SD)) 25 (23) (n=160a) 27 (25) (n=96a) 41 (22)
BMI (mean (SD)) 28.9 (4.7) 28.3 (4.6) 30.4 (4.2)
ESS score (mean (SD)) 9.9 (4.7) 9.6 (4.4) 9.8 (4.7)
ESS score ≥ 11 43% 42% 40%
Sleep study (type) 43% PG /57% PSG
(n=160*)
39% PG /61% PSG
(n=96*)
43% PG/ 57% PSG
CPAP compliance (mean (SD)) N/A N/A 6:46 hrs (1:40 hrs)
CPAP compliance ≥ 4hrs/night N/A N/A 96%
AHI with CPAP (mean (SD)) N/A N/A 2.6 (3.4)
AHI=Apnea-hypopnea Index, BMI=Body Mass Index, CPAP=continuous positive airway pressure, 
ESS=Epworth Sleepiness Scale, PG=polygraphy, PSG=polysomnography, SD=standard deviation 
a. 20 patients with suspected OSA of the total study population did for various reasons (choose to) not 
undergo a sleep study to determine their AHI.
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3.6 Final stage of PRAQ development
Finishing the item selection of the sleepiness domain
None of the inter-item correlations in the preliminary ‘sleepiness’ domain was higher than 0.9. 
Principal component analysis showed that the lowest factor loading was 0.65, well above 0.5. 
Therefore, we took practical elimination decisions: the two items with a ‘not applicable’ option 
were removed (about sleepiness while reading, and while driving a car) as well as an item 
about napping in the afternoon that had a different answering scale than the other items. This 
improves the homogeneity of the domain for patients. The final version of the PRAQ consists of 
10 domains and 40 items (Appendix 1).
Identification and grouping of items for outcome measurement
The results of the final PCA can be found in Table 2. The items of the PRAQ domains ‘memory 
& concentration’, ‘sleep quality’, and ‘concerns about health’ were removed because they did 
not have sufficient loading on any of the factors found in the PCA, or because the items loaded 
on more than one factor. The items of the PRAQ domains ‘tiredness’ and ‘daily activities’ loaded 
on a single factor rather than on two separate factors: these items were therefore combined in 
one domain called ‘energy & daily activities’ for the goal of outcome measurement. The items 
of the PRAQ domain ‘unsafe situations’ both loaded on one separate domain. However, since 
this domain contained only two items it was not added to the PRAQ-outcome.
 The 19 remaining items in the PCA form three one-dimensional domains: sleepiness, 
energy & daily activities, and emotions, which together explain 73% of the variance. The PCA 
showed intercorrelations of these domains of 0.36-0.57. The domains are added to the two 
formative domains ‘symptoms at night’ and ‘social interactions’, resulting in subset of 33 items 
in five domains. Figure 1 illustrates how the items and domains of the PRAQ result in the 
subselection of PRAQ items for outcome measurement. The domains that are present in both 
the full 40-item PRAQ and in the 33-item outcome subset overlap to a great extent.
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Symptoms at night
6 items
Symptoms at night
6 items
Sleepiness
5 items
Tiredness
3 items
Daily activities
5 items
Unsafe situations
2 items
Social interactions
8 items
Memory &
Concentration
2 items
Quality of sleep
2 items
Emotions
6 items
Sleepiness
5 items
Energy & daily
activites
8 items
Emotions
6 items
Social interactions
8 items
Items excluded
for outcome
measurement after PCA
Health concerns
1 item
Domains/items of the
PRAQ
Subselection of domains/items for
outcome measurement
Figure 1 The PRAQ domains for clinical practice and outcome measurement
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3.7 Measurement properties
In this section we describe the measurement properties of the domains that are used for 
outcome measurement; the results for the domains of the 40-item version can be found in 
Appendix 3. The average baseline scores, standard deviations, and percentages of lowest and 
highest scores of the five outcome domains can be found in Table 3. No floor- or ceiling effects 
were found, except for a floor effect in the ‘sleepiness’ domain (20% of subjects scored 1-1.5). 
The results of the different aspects of reliability (internal consistency with Cronbach’s α, test-
retest reliability with ICC, SEM) are also shown in Table 3. The values of Cronbach’s α and the 
ICC values are all above 0.8, indicating that these measurement properties are of good quality.
 The correlations of the outcome domains with comparator instruments, which 
were used to determine convergent validity, are presented in Table 4. The correlations with 
the (somewhat) similar constructs were all within the ranges that we hypothesized (n=14 
hypotheses), and the correlations of selected PRAQ-domains with the dissimilar constructs 
were all lower than those with the similar constructs (n=3 hypotheses), as expected.
 The absolute change scores of the PRAQ outcome domains after patients were treated 
with CPAP ranged from 0.76 (domain ‘emotions’) to 1.96 (domain ‘energy & daily activities’) 
(Appendix 4). The correlations of the change scores of the PRAQ and the change scores of 
the comparator instruments (Table 5) were generally in agreement with our hypotheses (n=17 
hypotheses). The exception was the ‘emotions’ domain of the PRAQ, which did not correlate 
as strongly with the change scores of the PROMIS domains about emotions (anger, anxiety, 
depression; r=0.26 – 0.43) as we had expected. When a hypothesis is not met, it is important 
to identify why the results are different than expected [32]. To gain more insight into these 
unexpected scores, we therefore ran an additional analysis on the correlation of the PRAQ 
scores and the PROMIS scores at the follow-up measurement, showing results of r=0.62-0.71. 
This shows that the discrepancy lies with the change score itself and not the absolute score of 
the follow-up measurement.
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4 DISCUSSION
In this article we present the finalized Patient-Reported Apnea Questionnaire (PRAQ). The 
PRAQ has a unique approach with regard to the integration of its use on an individual patient 
level and for aggregate outcome measurement: patients complete all items of the PRAQ before 
their consultation, the results of which can be discussed with a healthcare professional; and 
the aggregate outcomes of groups of patients can then be studied by making use of a subset 
of the completed items. The PRAQ contains all topics and items that patients and healthcare 
providers consider important to discuss in practice, and for this purpose includes 40 items in 10 
domains. For outcome measurement, a subset of 33 items of the PRAQ were selected, divided 
into two formative domains (items grouped together based on what makes sense clinically) 
and three one-dimensional subscales. These five outcome domains generally have good 
measurement properties in terms of internal consistency, test-retest reliability, convergent 
validity and responsiveness.
 PCA showed that items of the PRAQ domains ‘tiredness’ and ‘daily activities’ load 
on the same factor, which is why the items of these preliminary domains are combined into 
one domain for the purpose of outcome measurement. For use an individual patient level, 
however, we decided to keep the two domains separate. Even though we acknowledge that 
feeling tired (a symptom), and the extent to which daily activities can be performed normally (a 
consequence of that symptom), are closely related concepts, they may be relevant to discuss 
separately for an individual patient in clinical practice. We will test this assumption in future 
research, in which the PRAQ will be employed and studied empirically.
 The domains that are used for outcome measurement show good responsiveness. 
The one exception is the domain ‘emotions’, the change score of which showed a much weaker 
correlation than expected with the change scores of PROMs with similar constructs. We 
hypothesize that the discrepancy between expectation and results caused by the low scores of 
this domain at baseline (average 2.89) and the subsequent relatively small improvement that 
is achieved after treatment with CPAP (average 0.76). We do not doubt the construct validity of 
the domain, because the comparator PROMs show the same pattern in terms of low scores 
and small change scores, and because the correlation of the absolute scores after treatment 
with CPAP shows good convergent validity. However, because the change scores are small, it 
is likely that measurement error plays a relatively large role in the change scores of both the 
PRAQ domain and the comparator instruments, reducing the accuracy of the change scores 
and therefore also diffusing the correlation size. This means that that in terms of outcome/
quality measurement, emotional problems appear to be of less importance than the topics of 
the other domains and more difficult to accurately measure, because relatively few people with 
(suspected) OSA experience severe problems.
 Surprisingly, 20% of the study population had low scores (1-1.5) on the domain 
‘sleepiness’, while sleepiness is one of the main complaints of OSA. We think that this is 
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due to a relatively high difficulty of the sleepiness items of the PRAQ (such as falling asleep 
during a conversation) in combination with a generally low sleepiness in this population 
(average ESS<10). This reason for the low sleepiness in the population is probably twofold. 
First, the main complaint of some patients who were referred for suspected OSA in this study 
is probably (socially problematic) snoring rather than sleepiness or tiredness during the day. 
OSA treatment will reduce their snoring and is reimbursed by healthcare insurers, making 
it beneficial for these patients to visit the sleep center. Second, for logistical reasons some 
patients with suspected severe OSA were not included in the study. These patients followed 
a fast-track procedure to bypass the sleep center’s the waiting list, which meant they were in 
practice not always asked to join the study. This is a limitation of the study. What we can derive 
from the current results is that the sleepiness domain of the PRAQ seems more useful to 
detect cases of severe sleepiness, which definitely requires treatment, than to distinguish mild 
and moderate sleepiness. However, future research should take place in a more representative 
patient group to study how the sleepiness domain performs in this population.
 The PRAQ is designed for use in clinical practice, to help focus consultations on the 
problems that individual patients encounter. When using a PROM for this purpose, the ICC should 
preferably be very high (0.9-0.95 at individual level vs. 0.8 or higher at group level for aggregate 
outcome measurement [17]). The ICC values of the PRAQ are lower (0.81-0.88). However, the 
PRAQ is meant to open the conversation about a patient’s symptoms and functioning, not to 
serve as a ‘cut-off’ score. Any elevated score could therefore result in conversation about this 
topic, and we believe that the PRAQ can serve its purpose despite the slightly lower ICCs.
Methodological considerations
The domains for outcome measurement were created with a combination of the ‘clinimetric’ 
approach, in which items are grouped together based on clinical relevance; and the 
‘psychometric’ approach, which groups items together based on PCA [33-35]. The combination 
of these two approaches is uncommon. We believe that scores of psychometric domains, with 
a clear one-dimensional construct, are more meaningful than formative domains because they 
have a clear interpretation. However, this approach is not always feasible when items have 
been selected to be part of a quality-of-life or symptoms questionnaire based on their deemed 
importance by the target population [36]. Items which cover symptoms of the same disease 
or treatment will often share covariance and thus appear to be covering the same latent 
construct, even when looking at the content of the items this makes no apparent sense (e.g. 
lack of appetite and decreased sexual interest in patients undergoing cancer treatment [36]). 
Therefore, we considered the best approach grouping together the different symptoms patients 
experience at night, as well as the variety of different ways in which sleepiness, tiredness and 
emotions might influence a patients’ social life, without subjecting them to PCA.
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To aid the use of the PRAQ in clinical practice, we developed a patient-friendly digital report 
together with patients and healthcare professionals (Figure 2). When using the PRAQ in 
clinical practice, it can be useful to look at individual item scores as well as the domain scores, 
especially in the formative domains in which item scores will generally differ more from each 
other. Therefore, both domain and individual item scores are shown in the report.
5 CONCLUSIONS
In conclusion, we have shown that the PRAQ-practice and PRAQ-outcome generally have 
acceptable measurement properties and appear to be suitable PROMs for their respective 
purposes. However, further validation research is needed in patients who suffer from higher 
levels of sleepiness, to study the validity of the sleepiness domain. The applicability of a PROM 
for use in clinical practice and for measuring outcomes on aggregate level, may be of great 
importance for the further implementation of PROMs in healthcare.
Instrument completion and validation of the PRAQ
113
5
P
R
A
Q
-r
ep
or
t
 
 
Sy
m
pt
om
s 
at
 
Sl
ee
pi
ne
ss
 
Ti
re
dn
es
s 
D
ai
ly
 
U
ns
af
e 
M
em
or
y 
&
 
Sl
ee
p 
Em
ot
io
ns
 
So
ci
al
 
H
ea
lt
h
 
 
ni
gh
t 
 
 
ac
tiv
iti
es
 
si
tu
at
io
ns
 
co
nc
en
tr
at
io
n 
qu
al
ity
 
 
in
te
ra
ct
io
ns
 
co
nc
er
ns
Is
 g
oi
ng
 w
el
l
- - - - - Is
 n
ot
 g
oi
ng
w
el
l
Fi
gu
re
 2
 T
he
 P
R
AQ
-r
ep
or
t
Chapter 5
114
REFERENCES
1. O’Donoghue, N. and E. McKay, Exploring the impact of sleep apnoea on daily life and occupational 
engagement. Br J Occup Ther, 2012. 75(11): p. 609-516.
2. Reishtein, J.L., et al., Sleepiness and relationships in obstructive sleep apnea. Issues Ment Health 
Nurs, 2006. 27(3): p. 319-30.
3. Rodgers, B., Breaking through limbo: experiences of adults living with obstructive sleep apnea. Behav 
Sleep Med, 2014. 12(3): p. 183-97.
4. Bradley, T.D. and J.S. Floras, Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 
2009. 373(9657): p. 82-93.
5. Chan, A.S., C.L. Phillips, and P.A. Cistulli, Obstructive sleep apnoea--an update. Intern Med J, 2010. 
40(2): p. 102-6.
6. Young, T., P.E. Peppard, and D.J. Gottlieb, Epidemiology of obstructive sleep apnea: a population 
health perspective. Am J Respir Crit Care Med, 2002. 165(9): p. 1217-39.
7. Bjornsdottir, E., et al., The Prevalence of Depression among Untreated Obstructive Sleep Apnea 
Patients Using a Standardized Psychiatric Interview. J Clin Sleep Med, 2016. 12(1): p. 105-12.
8. Gupta, M.A., F.C. Simpson, and D.C. Lyons, The effect of treating obstructive sleep apnea with positive 
airway pressure on depression and other subjective symptoms: A systematic review and meta-
analysis. Sleep Med Rev, 2016. 28: p. 55-68.
9. Mokhlesi, B., S.A. Ham, and D. Gozal, The effect of sex and age on the comorbidity burden of OSA: an 
observational analysis from a large nationwide US health claims database. Eur Respir J, 2016. 47(4): 
p. 1162-9.
10. Black, N., Patient reported outcome measures could help transform healthcare. BMJ, 2013. 346: p. 
f167.
11. Van Der Wees, P.J., et al., Integrating the use of patient-reported outcomes for both clinical practice 
and performance measurement: views of experts from 3 countries. Milbank Q, 2014. 92(4): p. 754-75.
12. Greenhalgh, J., et al., Functionality and feedback: a realist synthesis of the collation, interpretation and 
utilisation of patient-reported outcome measures data to improve patient care. 2017: Southampton 
(UK).
13. I.L., A., et al., The development of a patient-reported outcome measure for patients with obstructive 
sleep apnea: the Patient-Reported Apnea Questionnaire (PRAQ). Journal of Patient-Reported 
Outcomes, 2017. 1(14).
14. Mannarino, M.R., F. Di Filippo, and M. Pirro, Obstructive sleep apnea syndrome. Eur J Intern Med, 
2012. 23(7): p. 586-93.
15. Epstein, L.J., et al., Clinical guideline for the evaluation, management and long-term care of 
obstructive sleep apnea in adults. J Clin Sleep Med, 2009. 5(3): p. 263-76.
16. Grunstein, R.R., Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure 
treatment for obstructive sleep apnoea. Thorax, 1995. 50(10): p. 1106-13.
17. De Vet, H.C.W., et al., Measurement in Medicine. 2011, Cambridge, UK: Cambridge University Press.
18. Floyd, F.J. and K.F. Widaman, Factor analysis in the development and refinement of clinical assessment 
instruments. Psychological Assessment, 1995. 7(3): p. 286-299.
19. De Vet, H.C.W., C.B. Terwee, and L.M. Bouter, Clinimetrics and psychometrics: two sides of the same 
coin. J Clin Epidemiol, 2003. 56: p. 1146-1147.
20. Terwee, C.B., et al., Quality criteria were proposed for measurement properties of health status 
questionnaires. J Clin Epidemiol, 2007. 60(1): p. 34-42.
21. Mokkink, L.B., et al., The COSMIN study reached international consensus on taxonomy, terminology, 
and definitions of measurement properties for health-related patient-reported outcomes. J Clin 
Epidemiol, 2010. 63(7): p. 737-45.
Instrument completion and validation of the PRAQ
115
5
22. Johns, M.W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 
1991. 14(6): p. 540-5.
23. Abma, I.L., et al., Measurement properties of patient-reported outcome measures (PROMs) in adults 
with obstructive sleep apnea (OSA): A systematic review. Sleep Med Rev, 2016. 28: p. 18-31.
24. Hays, R.D., C.D. Sherbourne, and R.M. Mazel, The RAND 36-Item Health Survey 1.0. Health Econ, 
1993. 2(3): p. 217-27.
25. DeWalt, D.A., et al., Evaluation of item candidates: the PROMIS qualitative item review. Med Care, 
2007. 45(5 Suppl 1): p. S12-21.
26. Riley, W.T., et al., Patient-reported outcomes measurement information system (PROMIS) domain 
names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual 
Life Res, 2010. 19(9): p. 1311-21.
27. Terwee, C.B., et al., Dutch-Flemish translation of 17 item banks from the patient-reported outcomes 
measurement information system (PROMIS). Qual Life Res, 2014. 23(6): p. 1733-41.
28. Buysse, D.J., et al., Development and validation of patient-reported outcome measures for sleep 
disturbance and sleep-related impairments. Sleep, 2010. 33(6): p. 781-92.
29. Yu, L., et al., Development of short forms from the PROMIS sleep disturbance and Sleep-Related 
Impairment item banks. Behav Sleep Med, 2011. 10(1): p. 6-24.
30. Pilkonis, P.A., et al., Item banks for measuring emotional distress from the Patient-Reported Outcomes 
Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment, 2011. 
18(3): p. 263-83.
31. Pilkonis, P.A., et al., Validation of the depression item bank from the Patient-Reported Outcomes 
Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res, 
2014. 56: p. 112-9.
32. Abma, I.L., M. Rovers, and P.J. van der Wees, Appraising convergent validity of patient-reported 
outcome measures in systematic reviews: constructing hypotheses and interpreting outcomes. BMC 
Res Notes, 2016. 9: p. 226.
33. Marx, R.G., et al., Clinimetric and psychometric strategies for development of a health measurement 
scale. J Clin Epidemiol, 1999. 52(2): p. 105-11.
34. Newcombe, P.A., et al., Development of a parent-proxy quality-of-life chronic cough-specific 
questionnaire: clinical impact vs psychometric evaluations. Chest, 2008. 133(2): p. 386-95.
35. Ribera, A., et al., Is psychometric scoring of the McNew Quality of Life after Myocardial Infarction 
questionnaire superior to the clinimetric scoring? A comparison of the two approaches. Qual Life Res, 
2006. 15(3): p. 357-65.
36. Fayers, P.M. and D.J. Hand, Factor analysis, causal indicators and quality of life. Qual Life Res, 1997. 
6(2): p. 139-50.
Chapter 5
116
Appendix 1: The Patient-Reported Apnea Questionnaire (PRAQ)
Symptoms at night
During the past 4 weeks, did you have a problem with:
1. Snoring loudly?
2. Waking up frequently to urinate?
3. Waking up at night with the feeling that you are choking?
4. A feeling that you are sleeping restlessly?
5. Having a dry or painful mouth when you wake up?
6. Waking up in the morning with a headache?
Sleepiness
During the past 4 weeks, did you have a problem with:
7. Fighting to stay awake during the day?
8. Suddenly falling asleep?
9. Difficulty staying awake during a conversation?
10. Difficulty staying awake while watching something? (concert, movie, television)
11. Falling asleep at inappropriate times or places?
Difficulty staying awake while reading?a,b
Fighting to stay awake when you are driving?a,b
Did you feel like you needed to take a nap in the afternoon?a
Tiredness
During the past 4 weeks, did you have a problem with:
12. Feeling very tired?
13. Lacking energy?
14. Still feeling tired when you wake up in the morning?
Daily activities
During the past 4 weeks:
15.  How difficult was it for you to do your most important daily activity? (such as your job, studying, 
caring for the children, housework)
16.  How often did you use all your energy to accomplish only your most important daily activity? 
(such as your job, studying, caring for the children, housework)
17.  Did you feel you have a decreased performance with regard to your most important daily 
activity? (such as your job, studying, caring for the children, housework)
18. How much difficulty did you have finding energy for your hobbies?
19. How difficult was it for you to get your chores done?
Unsafe situations
During the past 4 weeks:
20. Did you have problems while driving a car due to sleepiness?b
21.  Were you concerned about your safety or that of others due to your sleepiness? (for example in 
traffic, or when operating machinery)
Memory and concentration
During the past 4 weeks:
22. Were you sometimes forgetful?
23. Did you sometimes have difficulty concentrating?
Quality of sleep
During the past 4 weeks, did you have a problem with:
24. Falling asleep when you go to bed at night?
25. Getting back to sleep after you woke up at night?
Instrument completion and validation of the PRAQ
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Appendix 1 continued
Emotions
During the past 4 weeks:
26. How often did you feel depressed or hopeless?
27. How often did you feel anxious?
28. How often did you lose your temper?
29. How often did you feel that you could not cope with everyday life?
30. How often did you feel irritated?
31. How often did you have a strong emotional reaction to everyday events?
Social interactions
During the past 4 weeks:
32. Did you sometimes feel upset because others were disturbed by your snoring?
33.  Was it a problem for you that you sometimes had no energy or no desire to do things with your 
family or your friends?
34. Did you feel guilty towards your family or friends?
35. Did you feel upset because you argued frequently?
36. Did you sometimes experience problems in the relationship with your partner?b
37. Did you feel upset because you could (maybe) not sleep in the same room as your partner?b
38. Did you sometimes think up excuses because you were tired or sleepy?
39.  Did you have a problem with unsatisfying and/or too little sexual activity? (by yourself or with 
another)b
Health concerns
40.  Were you concerned about other conditions that may be related to sleep apnea? (such as 
diabetes, high blood pressure, cardiovascular disease, being overweight)
a. The shaded items of the “sleepiness” domain were removed from this domain in the final version of the 
PRAQ.
b. These items had an additional response option “not applicable” or (for item 39) “no answer” 
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Appendix 3: Domain and reliability scores of the PRAQ clinical practice domains
Scores of the PRAQ clinical practice domainsa
Domains Average 
(range 1-7)
Standard 
deviation
Lowest score 
(1-1.5)
Highest score 
(6.5-7)
Sleepiness 3.13 1.57 20% 2.2%
Tiredness 4.85 1.71 4.4% 20.0%
Daily activities 4.33 1.64 5.0% 8.9%
Emotions 2.89 1.28 13.3% 0.0%
Symptoms at night 3.48 1.27 3.9% 1.1%
Social Interactions 3.11 1.42 13.9% 0.6%
Memory&concentration 3.85 1.34 4.4% 1.7%
Unsafe situations 2.13 1.56 57% 1.1%
Sleep quality 2.71 1.71 42.8% 6.7%
Health concerns 3.34 2.00 25.6% 8.9%
a. The clinical practice domains partially overlap with the outcome domains of the PRAQ, as shown in 
Figure 1.
Reliability scores of the PRAQ clinical practice domainsa
Domains Cronbach’s α ICC SEM
Sleepiness 0.88 0.81 0.69
Tiredness 0.93 0.86 0.64
Daily activities 0.94 0.83 0.68
Emotions 0.92 0.85 0.50
Symptoms at night - b 0.88 0.44
Social Interactions - b 0.86 0.53
Memory&concentration 0.83 0.86 0.50
Unsafe situations 0.87 0.87 0.56
Sleep quality 0.72 0.83 0.71
Health concernsc - - -
SEM = standard error of measurement
a. The clinical practice domains partially overlap with the outcome domains of the PRAQ, as shown in 
Figure 1.
b. These domains are formative, and Cronbach’s α is only relevant when a domain is one-dimensional [1].
c. This domain contains only one item, meaning these measurement properties cannot be calculated.
Instrument completion and validation of the PRAQ
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Appendix 4: Change scores of the PRAQ outcome domains after treatment with CPAP (n=53)
Domain name Baseline score Average score 
after treatment
Average change 
score a,b
Sleepiness 3.27 1.56 1.70
Energy & daily activities 4.66 2.70 1.96
Emotions 2.76 2.00 0.76
Symptoms at night 3.45 1.82 1.63
Social Interactions 2.94 1.79 1.15
a. A positive change score stands for a reduction in symptoms.
b. All change scores are significant, p-value <0.00 
REFERENCE
1. Streiner DL. Being inconsistent about consistency: when coefficient alpha does and doesn’t matter. J 
Pers Assess. 2003; 80: 217-22
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ABSTRACT
Objectives 
The objective of this exploratory study was to see how the Patient-Reported Apnea Questionnaire 
(PRAQ) may impact the daily clinical practice of sleep centers, and why it may or may not work 
as expected. The hypotheses were tested that this patient-reported outcome measure (PROM) 
makes patients more aware of which of their health complaints may be related to obstructive 
sleep apnea (OSA), and that it improves patient-centeredness of care by shifting the focus of care 
away from (only) medical problems towards the individual burden of disease and quality of life. 
Design 
Mixed methods. The quantitative study (surveys, patient records) was a before-and-after study.
Setting 
Three sleep centres in The Netherlands (secondary care).
Participants 
27 patients and 14 healthcare professionals were interviewed. 487 patients completed surveys 
pre-implementation, and 377 patients completed surveys post-implementation of the PRAQ. 
For the health records, 125 patients were included in the pre-implementation group, and 124 
other patients in the post-implementation group.
Interventions 
The PRAQ was used in clinical practice for six successive months.
Outcome measures 
Scores on individual survey items, number of patients receiving non-medical treatment, 
adjustment of treatment at first follow-up, compliance with treatment.
Results 
Patients were generally positive about the usefulness of the PRAQ before and during the 
consultation., as they felt more informed. Healthcare providers did not consider the PRAQ very 
useful, and they reported minor impact on their consultations. The surveys and health record 
study did not show an impact of the PRAQ on clinical practice.
Conclusions
Implementing the PRAQ may be beneficial to patients, but this study does not show much 
impact with regard to patient-centeredness of care. New Dutch guidelines for OSA care may 
lead to a greater emphasis on quality of life and value of care for patients, making its integration 
in clinical care potentially more useful.
Evaluation of the PRAQ in clinical practice
125
6
1. INTRODUCTION
The integration of patient-reported outcome measures (PROMs) in clinical practice has been 
gaining popularity in the past decade [1-3]. PROM data collected in clinical practice can be 
aggregated and used for quality improvement purposes, or individual scores can be used in 
daily clinical practice to improve patient care. In this latter function PROMs can be used in 
different ways, e.g. as a screening tool, a monitoring or evaluation tool, a tool to inform and 
empower patients, and/or to increase the patient-centeredness of care by shifting the focus 
of care away from (only) medical problems towards the problems patients experience in their 
daily life [4]. When using PROMs in daily clinical practice, it may be sensible to combine the use 
of a PROM on an individual patient level with application on an aggregate level [5]. There have 
been a number of studies that aimed to evaluate the usefulness of PROMs in clinical practice 
in a variety of settings, of which the results are mixed [6-8]. Though qualitative research on 
this topic has been synthesized in a recent review [4, 9] including a list of hypotheses on how 
PROMs might work, there are still many questions regarding which PROMs can be potentially 
useful in which settings.
 This study is focused on the application of individual PROM scores in sleep centers 
which diagnose and treat patients with obstructive sleep apnea (OSA), a condition for which a 
PROM could be a useful tool to improve patient-centeredness of care. OSA is a highly prevalent 
but often unrecognized condition in which frequent collapse of the upper airway causes 
breathing stops while asleep. The subsequent arousals can result in severe sleepiness and 
fatigue during the day, often affecting a patient’s cognitive function, psychological well-being, 
relationships, and ability to work [10-12]. OSA has also been shown to be an independent risk 
factor for hypertension, heart failure and diabetes [13-15]. The prevalence of OSA has been 
reported to be 6% to 38%, depending on the exact definition of OSA and the population studied, 
and is higher in men [16].
 Severity of OSA and necessity for treatment has historically been based on the number 
of (partial) breathing stops per hour: the apnea-hypopnea index (AHI) [17, 18]. However, there is 
no linear association between AHI and severity of symptoms or the presence of comorbidities 
[19-23]. There is also little evidence that treating patients with mild OSA (based on AHI) or 
patients with low sleepiness is useful in preventing cardiovascular disease or incidents [24-
27]. In the past few years there has therefore been international discussion regarding new 
approaches to diagnose “clinically relevant” OSA [28, 29]. This discussion has also made its 
way into recent Dutch guidelines for OSA, in which it is recommended that there should be a 
greater focus on the presence of potentially related comorbidities, as well as the experienced 
burden of disease for individual patients. The goal of treatment is the improvement of these 
aspects of OSA [30].
 We have developed and validated a PROM for use in clinical practice which may 
aid this new focus of care for patients with OSA: the Patient-Reported Apnea Questionnaire 
Chapter 6
126
(PRAQ) [31, 32], which measures OSA-related quality of life. The goal of this PROM is to 
improve patient-centeredness of care on an individual level by shifting the conversation away 
from the medical problems and towards and individual’s burden of disease/quality of life, and 
also to measure quality of care on an aggregate level. To develop the PRAQ, the input from 
patients and healthcare professionals was used to select the topics that were considered most 
important to discuss in clinical practice [31]. The individual PRAQ scores of each patient with 
(suspected) OSA are captured in the ‘PRAQ-report’, which was designed together with patients 
and uses colored smileys to show the results for the 10 domains of the PRAQ. The advantage of 
the PRAQ compared to other commonly used PROMs in the care for patients with OSA (such as 
the Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ), etc) 
is that it provides a comprehensive overview of the possibly impacted aspects of quality of life 
that patients with OSA may experience. It is therefore potentially suitable for shifting the focus 
of care away from (only) medical problems towards the problems patients experience in their 
daily life.
 This explorative study aims to study the impact of the PRAQ and PRAQ-report on the 
clinical practice of OSA, and explore why the PRAQ did or did not have an impact. A combination 
of both qualitative and quantitative methods is used that will add to the general knowledge on 
the circumstances under which PROMs do or do not work in clinical practice.
2. METHODS
This article describes an exploratory mixed methods study in which the PRAQ is implemented 
in the clinical practice of three sleep centers. Qualitative interviews and a patient survey were 
used to explore patients’ and healthcare providers’ experiences with the PRAQ, and to identify 
potential barriers and facilitators to its use. Additionally, data were collected from electronic 
health records to study whether the hypotheses about the potential impact of the PRAQ 
mentioned in the introduction are correct. For the patient survey and the patient record study 
we conducted a before-and-after study. The different methods are described in more detail in 
the next sections.
2.1 Hypotheses
We have several hypotheses regarding how the PRAQ may influence patients and healthcare 
professionals, and how this could impact clinical practice. First of all, completing the PRAQ 
could: 
 •   Encourage patients to consider which problems they experience that might be 
related to OSA and that they might want to discuss
 •   Aid healthcare professionals in opening a conversation about an individual patient’s 
burden of disease (apnea-related quality of life)
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 •   Aid healthcare professionals to evaluate treatment and identify problems that are 
still present
We think that this may potentially lead to:
 •   Higher patient compliance with treatment
 •   More explicit choices regarding whether clinical treatment for OSA is (potentially) 
beneficial to the patient
 •   An increase in referrals to other healthcare providers, such as psychologists
 •   More ‘holistic’ care, in which there is increased attention for the well-being of 
patients, including the psychological and social effects of OSA and its comorbidities
2.2 The PRAQ and its implementation
The PRAQ and its complementary PRAQ-report were designed with the input of patients with 
OSA and healthcare professionals [31]. The questions of the PRAQ can be found in Appendix 
1 of chapter 5. The PRAQ takes approximately 15 minutes to complete [31]. More information 
about the PRAQ-report and how the PRAQ was implemented in clinical practice can be found 
in Appendix 1.
2.3 Setting and subjects
Sleep centers of three Dutch hospitals took part in the study. The PRAQ was part of the clinical 
practice routine of these centers for six successive months. The PRAQ was distributed to 
patients attending an intake consultation for possible OSA (which takes place after a patient’s 
diagnostic sleep study), and subsequently to the subselection of these intake patients diagnosed 
with OSA who returned for a follow-up consultation after starting treatment.
2.4 Interviews
In-depth, semi-structured interviews were conducted with patients and healthcare 
professionals in the last two months of the study. The interview guides contained broad, open 
questions as well as more specific questions informed by topics previously identified in the 
literature [4]. For patients the main goal was to assess whether completing the PRAQ was 
acceptable to them, and to find out the impact that the PRAQ and PRAQ report had for them on 
the (preparation for) the consultation. For healthcare providers, questions were mostly focused 
on how they used the PRAQ and why they used it this way, and the impact the use of the PRAQ 
has on their practice. This information can provide the basis for interpreting the results of the 
electronic health record study.
 Patients were invited via email by the sleep center before their scheduled consultation, 
or by their healthcare professional directly after their consultation (for more information see 
Appendix 2). Only patients who had completed the PRAQ were invited. We interviewed 27 
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patients. Data saturation was reached. Characteristics of the interviewed patients and of the 
interviews can be found in Table 1.
 All healthcare professionals of the three participating sleep centers that had had the 
option to work with the PRAQ were invited to participate. This resulted in interviews with 14 
healthcare professionals: six pulmonologists, six physician assistants (PAs) and two nurses. 
Two pulmonologists refused an interview because they had not seen many patients for OSA, 
two others because they had not used the PRAQ at all, and one PA refused for personal reasons. 
At least four healthcare professionals were interviewed at each of the three sleep centers.
More information on the (analysis of) the interviews can be found in Appendix 2.
Table 1 Characteristics of the interviewed patients and the interviews
Patient characteristics (n=27)
Age (mean, range) 59 (31-82)
Gender (male) 18
Highest education level (range) Primary school - PhD
Interview characteristics (n=27)
Interview after intake consultation (n) 18
Interview after follow-up consultation (n) 9
Interview together with partner or other relative that attended the consultation 4
Patients who had not seen the PRAQ-report at the time of the interviewa 5
a. Viewing the PRAQ-report before the consultation was optional, and not all healthcare providers showed 
the report to the patient during the consultation
 
2.5 Surveys
The patient survey was designed for this study to study potential differences in patient 
empowerment and patient-centeredness of care before and after the implementation of 
the PRAQ. The items of the survey covered how prepared patients felt for their consultation, 
whether there was discussion of the health problems that patients consider relevant during 
the consultation, and whether patients were motivated to start their treatment. Patients could 
indicate their agreement on several statements on these topics with the statement on a 7-point 
Likert scale. The survey was checked by the members of the research team, which included a 
patient, but was not pilot tested. A translated version of the survey can be found in Appendix 3.
 Surveys were distributed by healthcare professionals to all of their patients attending 
either an intake or first follow-up consultation for (suspected) OSA. Distribution of the surveys 
took place in the two months before implementation of the intervention (control group), and in 
the last two months of the six months that the intervention was part of daily clinical practice 
(intervention group). For the intervention group, the survey also contained additional questions 
about the patient’s opinion on the usefulness of the PRAQ. Participation was voluntary and 
anonymous.
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2.6 Electronic health records
Electronic health records from one of the included sleep centers were studied to explore 
potential changes in treatment and compliance with treatment resulting from the use of 
the PRAQ. Data were collected from patients with an AHI≥5 attending an intake consultation 
during the final two months of the study period and during the same time period the previous 
year. Information was collected about treatment choice at intake, treatment adaptations and 
compliance with treatment at the first follow-up consultation, and patient characteristics. 
Compliance data is only available for patients who receive Continuous Positive Airway Pressure 
(CPAP), the most commonly prescribed treatment for patients with OSA. As part of standard 
care, hours of use are registered by the CPAP device and entered into the health record at 
follow-up consultations. CPAP compliance is expressed as average hrs CPAP use/night in the 
month before the follow-up consultation, with an average of 4 hrs/night generally being the 
minimum to be considered compliant [33].No identifying information was collected from the 
health records. The data collection procedure guaranteed that the records would at all times 
remain anonymous to the researchers.
2.7 Statistical analyses
Mann-Whitney U tests were conducted for each of the survey items that patients were asked 
to complete both pre- and post-implementation of the PRAQ. For the electronic health record 
study, treatment choice at intake was studied by aggregating the choice into two variables: 
medical treatment of OSA (e.g. CPAP, MRA, referral for surgery) and no or non-medical 
treatment (e.g. lifestyle advice), as these are the variables which we potentially expected the 
PRAQ to influence. A Chi-Square test was used to test for statistical significance. For the 
follow-up variables of the patient record study, Chi-Square tests (for dichotomous variables) 
and an independent samples T-test (for CPAP compliance in minutes) were conducted.
 No correction for multiple testing was performed because this is an exploratory study. 
A p-value of <0.05 was therefore taken as a significant difference, which can be interpreted as 
an indication that this is a potentially interesting variable for a possible future study.
2.8 Patient and Public Involvement
A board member (author MI) of the Dutch patient organisation for OSA (Apneuvereniging) 
was involved with this study from its inception, including the research question and outcome 
measures and interpretation of the results. This author was also closely involved in the 
development of the intervention itself (the PRAQ and its complementary PRAQ-report), as were 
other members of the patient organization [31]. They also approved of the burden and time 
required for the intervention. Patients were not involved in the recruitment for the study.
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3. RESULTS
3.1 Interviews
Patient perspective 
Patients were generally willing to complete the PRAQ before their consultation, and patient 
response as reported by the healthcare professionals was high. About half of the interviewed 
patients indicated that completing the PRAQ helped them prepare for their intake consultation 
by giving them more insight into their complaints and functioning and how this might relate to 
OSA, and/or made them consider what they wanted to discuss with the healthcare professional. 
Many patients completed the PRAQ with a family member which instigated discussions 
patients often considered useful. A great majority of interviewed patients indicated that they 
did not mind taking the time to complete the PRAQ, and many also considered the smileys of 
the PRAQ-report a clear and easy way of communicating the results. Box 1 contains quotes 
illustrating the statements in this paragraph.
 The interviews also revealed some unintended effects of the PRAQ. A majority of 
patients assumed that the main purpose of the PRAQ was to aid their healthcare professional 
in setting a diagnosis, by providing information about symptoms ahead of time. A few patients 
believed that discussion of patient complaints during the consultation was therefore no longer 
necessary after completing the PRAQ (Box 2), while healthcare professionals consider this 
discussion very important (see next section). What may have played a role here is that several 
interviewed patients seemed eager to hear their sleep study results, rather than (first) spend 
much time talking about their symptoms or problems.
 Additionally, there were some issues around the interpretation of the smileys in 
the PRAQ-report. Several of the interviewed patients did not seem to view the PRAQ-report 
as merely a visualization of the answers they had given, but rather as a ‘test result’. Some 
considered the number of ‘unhappy’ smileys as an indication of whether they were doing well 
or not, which made some patients reconsider the severity of their complaints (Box 2).
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Box 1
“Look, it’s just very insightful. You can see instantly where the problems are and on this 
other [page] you can see what the improvements are. Yes, it’s kinda nice.” (Centre 3, patient 
10)
 “Yes, you know I do find it useful, because you have so many… so many things that bother 
you, that you forget what it is that bothers you. Or because it has become part of you, so to 
say. So yeah in order [not] to forget things, a questionnaire like this comes in handy.” (Centre 
2, patient 1)
 “But there were quite a lot of questions where I was like, oh, sometimes I’m like, how does 
that fit with [apnea]? But most did, but there were questions where I was like, is that related 
to sleep apnea? So. Yes. Apparently.” (Centre 3, patient 7)
 “Actually I liked [seeing it beforehand], because this way I can by myself… otherwise I 
would have gone into it timidly like, tell me, what did you see? And now I could ask specific 
questions.” 
(Centre 3, patient 2)
Box 2
“I think it’s very good, because you can from the beginning very clearly indicate your 
problems. So it doesn’t need to all be done during the short conversation you have with the 
specialist. [..] It’s clear it doesn’t need to be mentioned again, because it’s clear to her as 
well what the problems are.” (Centre 1, patient 4)
 “Just that when you complete a questionnaire aimed at establishing something, then it’s 
useful that you also get a sort of result. So a preliminary… not that you should instantly think 
like nothing is wrong, nothing needs to be done, let’s get out of here. But, I did like it, yeah.” 
(Centre 1, patient 3)
 “Well, because there were only two orange [smileys], and the others were all green and 
then you think, well…. And then when you look at it again then I’m like, ‘I can live with that’.” 
(Centre 2, patient 7)
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Healthcare professional perspective
Most healthcare professionals used the PRAQ during consultations (Table 2), but usually 
briefly. Several professionals mentioned that, especially during intake consultations, they used 
it for the sake of the study. Only a few tried to provide more holistic care with the PRAQ. Some 
professionals stated that their minimal use of the PRAQ was due to unwillingness to change 
their practice, while others mentioned a general aversion to questionnaires, and/or not being 
convinced that the PRAQ would offer new or useful information considering what was already 
discussed during a regular consultation. There were also practical issues that to some extent 
hindered the uptake of the PRAQ: most notably the (limited) time available for consultations, 
and the fact that the PRAQ was not embedded in the electronic health records which hindered 
the regular workflow. There were no notable differences in attitude towards the PRAQ between 
physicians, PAs and nurses. 
Table 2 Use of PRAQ-report by interviewed healthcare professionals
Use of the PRAQ-report during intake consultations
Discussed it with patients Only looked it up Did not look at it N/Aa
8 1 3 2
Use of the PRAQ-report during follow-up consultations
Discussed it with patients Only looked it up Did not look at it Want to use itb N/Aa
3 1 3 6 1
a. Not all healthcare professionals held both intake and follow-up consultations
b. Did not see (many) patients with follow-up PRAQ but are interested in using it in this setting 
Most of the professionals that used the PRAQ did so at the end of their usual discussion 
of symptoms, to check whether all topics that were problematic had been discussed and 
potentially address more topics. As such they could still start the conversation in their usual 
way, allowing patients to explain their problems in their own words, and allowing the healthcare 
professionals to ask their standard diagnostic questions. Professionals indicated that most 
“symptoms” that are part of the PRAQ were already part of the standard diagnostic questions 
during an intake consultation (sleepiness, problems at night), and also overlapped with their 
usual (diagnostic) intake questionnaire. However, several professionals mentioned that the 
PRAQ-report increased discussion of the topic “health concerns”, which was considered 
valuable. Furthermore, the few professionals that indicated that they valued offering more 
holistic care noticed that the PRAQ was useful in drawing the conversation away from medical 
facts and more towards the underlying emotions related to a patient’s problems. However, 
many other professionals did not see much added value in actively bringing up topics like 
emotions and social interactions. They were potentially willing to discuss these issues but 
considered it up to the patient to raise them. If the PRAQ was used to identify problems, it was 
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more common for the professional to mention very briefly that these problems were likely 
to improve with treatment of OSA, without further discussing these problems. Professionals 
reported that they did not notice any increase in OSA-related knowledge in their patients, or a 
difference in whether or how patients raised health complaints or quality of life issues of their 
own accord. Box 3 contains quotes illustrating the statements in this paragraph.
 With regard to treatment choice, the professionals mentioned that the severity of 
symptoms generally only plays a role in patients with an AHI<15, for which shared-decision 
making could potentially lead to a decision not to start clinical treatment for OSA. If the AHI is 
≥15, professionals generally wish to treat a patient for health reasons irrespective of symptoms. 
Many patients also have a reason to opt for treatment: there is a motor vehicle driving ban for 
untreated patients with AHI≥15. 
 Use of the PRAQ during follow-up consultations could not be fully evaluated, because 
a limited number of patients had completed the PRAQ at follow-up at the time of the interviews. 
This was due to practical implementation issues in combination with the relatively short 
duration of the study. However, several healthcare professionals mentioned that they thought 
the PRAQ would be more useful during follow-up consultations than intake conversations, 
as it would be interesting to see which problems remained after starting treatment (Table 
2). Those that had the opportunity to use the PRAQ in this setting mentioned that it was nice 
to show patients how their problems had improved, with the improvement sometimes being 
greater than the patients had realised. This could be used as encouragement to continue with 
treatment.
Box 3
“Well I myself don’t ask ‘are you worried about your [health]’? I won’t ask that, but that is 
what it shows. So then… then it’s like ‘hey, I would otherwise not have discussed that’.” 
(Centre 3, healthcare provider 4)
 “Yes, but then in a solution-oriented way - then you will see someone with 30 apneas an 
hour and you see that and you say I hope that [your problem with emotions] will get a lot 
better with the therapy I will start for you.” (Centre 1, healthcare provider 2)
 “Especially I thought people were, uhm… that lack of initiative, not going out, right? So they 
don’t do things because of their sleep problem, that was what [the PRAQ] often showed. And 
I didn’t always get that from taking the patient history. So people maybe find that hard to tell 
me, or they have trouble indicating that it really does have an impact on them. And then they 
try to focus more on the fact than on the underlying emotion. And that would sometimes 
give added value.” (Centre 1, healthcare provider 1)
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3.2 Survey results
A total of 487 patients completed surveys pre-implementation, and 377 patients completed 
surveys post-implementation of the PRAQ. Characteristics of the survey populations pre-
implementation and post-implementation can be found in Table 3.
Table 3 Characteristics of the survey population
Intake consultations
Pre-implementation (n=239) Post-implementation (n=197)
Age (yrs) 53.9 55.4
Gender (% male) 68.4 69.5
Severity of symptomsa 6.50 6.44
Diagnosed with OSA (%) 82.8 83.2
  CPAPb  (%) 71.0 70.7
  MRAb,c (%) 13.7 19.5
  Other treatmentb (%) 10.7 7.4
  No treatmentb (%) 1.0 2.4
  Missingb (%) 3.6 0.0
Follow-up consultations
Pre-implementation (n=248) Post-implementation (n=180)
Age 57.33 58.54
Gender (% male) 75.3 69.7
Severity of remaining symptoms or 
problems with treatmenta
4.25 5.03
CPAP (%) 89.1 89.4
MRAc (%) 3.6 3.9
Otherd or missing (%) 7 5.6
CPAP = continuous positive airway pressure, MRA = mandibular repositioning device 
a. Scale 1-10, higher is more problems
b. Percentage of patients with this treatment of the total of patients diagnosed with OSA
c. Device worn over the teeth that pushes tongue and jaw forward to hold the airway open
d. Other possible treatments are surgery of the jaw or throat, and methods that will help a patient with 
positional OSA (who experiences breathing stops mainly when they lie on their backs) sleep on their side
Patients generally showed high agreement with the statements of the survey: 73.3% - 97.3% 
of patients indicated “agree” or “completely agree” per statement about the intake and follow-
up consultations (Table 4). Follow-up patients post-implementation showed significantly 
less agreement with the statement “In my opinion, my treatment is worth it for me” (p=.005). 
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* Significant difference between pre- and post-implementation (p=.005, Mann-Whitney U test)
a. Scale 1-7 (1 = completely disagree, 2 =  disagree, 3 = disagree a little, 4 = neither agree nor disagree, 
5=agree a little, 6=agree, 7= completely agree)
b. “not applicable” (see supplementary file 4) or missing 
c. Showing results for patients who indicated they had seen the PRAQ-report before their (intake or follow-
up) consultation (n=94)
d. Showing results of patients who indicated the PRAQ-report was shown during their  (intake or follow-up) 
consultation (n=161)
The main difference between pre- and post-implementation scores lies in distribution between 
scores 6 and 7 (‘agree’ and ‘completely agree’), with 68.2% of pre-implementation patients 
giving a score of 7, and 54.3% of post-implementation patients giving a score of 7. The other 
statements showed no obvious or statistically significant differences in the level of agreement 
pre- and post-implementation. 
 Patients showed high agreement with the two statements about the usefulness 
of the PRAQ-report, particularly regarding its use during a consultation (Table 4). However, 
not all patients had completed the PRAQ and seen the PRAQ-report before or during their 
consultation. Patients who did not look up the PRAQ-report before their consultation may also 
have been the ones less interested in using the PRAQ-report, so the reported results may be 
somewhat biased towards are more positive evaluation (Table 5).
Table 5 Percentage of patients that completed and viewed the PRAQ, and patient opinion on usefulness 
PRAQ
Intake (n=197) Follow-up (n=180)
Completed PRAQ before consultation 77.7% 51.1% 
Seen PRAQ-report before consultationa    40.0%    44.4%
Seen PRAQ-report during consultationa    74.1%    60.2%
a. This percentage is a sub-percentage of the patients who indicated they completed the PRAQ
3.3 Electronic health record results
125 patients were included in the pre-implementation group, and 124 other patients in the post-
implementation group. Patient characteristics are described in Table 6. No differences were found 
with regard to how many patients with OSA received non-medical treatment (either no treatment 
at all or referral to a psychologist (Table 7)), or in the number of patients for whom treatment was 
adjusted at the first follow-up consultation after starting CPAP treatment (Table 8).
 In both groups, 98 patients were prescribed CPAP. Patient characteristics did not 
differ between the two groups of patients with CPAP (data not shown). Compliance with CPAP 
treatment did not differ between the two groups (Table 8).
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Table 6 Patient file study: patient characteristics
Pre-implementation (n=125) Post-implementation (n=124)
Age (SD) 55,4 (12,0) 56,6 (15,7)
Gender 68% male 67,7% male
BMI (SD) 31,4 (6,5) 30,8 (6,1)
AHI (SD) 23,1 (16,1) 25,0 (18,5)
AHI < 15 40,8% 33,9%
ESS (SD) 8,0 (4,8) 7,4 (5,0)
Start with CPAP at intake 78,4% 79,0%
Table 7 Treatment choice at intakeq
Pre-
implementation 
(n=125)
Post-
implementation 
(n=124)
Pre- 
implementation, 
AHI <15
(n=51)
Post- 
implementation, 
AHI <15 
(n=42)
Medical treatment for OSA 
(incl CPAP) (n, %)
123 (98.4) 123 (99.2) 49 (96.1) 41 (97.6)
No medical treatment for 
OSA (n, %)
2 (1.6) 1 (0.8) 2 (3.9) 1 (2.4)
     Referred to psychologist 
(n, %)
2 (1.6) 0 (0) 2 (3.9) 0 (0)
    No treatment (n, %) 0 (0) 1 (0.8) 0 (0) 1 (2.4)
a. If nothing is indicated, no significant difference was found. 
Table 8 Treatment adjustments and compliance in patients with CPAP at the first follow-upa
Pre-implementation 
of PRAQ (n=98)
Post-implementation 
of PRAQ (n=98)
Missings
Adjustment of current treatment 45 36 N/Ab
Switch to different treatment 5 9 N/Ab
Referral to different specialization 6 2 N/Ab
 CPAP compliancec (SD) 5:47 hrs (2:11) 5:53 hrs (2:10) Pre-impl.: 11
Post-impl: 7
 CPAP compliance <4hrs 25.0% 27.5% Pre-impl.: 11
Post-impl: 7
 Stopped CPAP treatment 4.1% 5.1% N/Ab
a. If nothing is indicated, no significant difference was found.
b. If nothing was noted down in the patient health record, it was assumed this did not take place. Therefore 
missings are not applicable.
c. Hours of CPAP use by patients who had stopped treatment altogether (see “stopped CPAP treatment”) 
are not included in this number.
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4. DISCUSSION
This exploratory study showed limited success regarding the uptake of the PRAQ in the daily 
clinical practice of sleep centers, and the improvement of patient-centeredness of care. From 
the interviews it became clear that most patients were willing to complete the PRAQ and were 
generally positive about the usefulness of the PRAQ before the consultation (e.g. because of 
feeling more informed) and during the consultation (due to the clear visual representation of 
their problems). This may therefore have lead to some improvement of preparation for the 
consultation by patients, and better communication, though this is not reflected in the results 
of the patient survey. Amongst healthcare professionals the willingness to use the PRAQ-
report in consultations differed, as the perceived need was minimal. Most of the professionals 
that used the PRAQ also reported that the impact on their consultations was minor. Therefore, 
it is not surprising that comparison of health records pre- and post-implementation of the 
PRAQ did not show any differences in treatment choice and CPAP compliance.
 The interviews showed that the professionals mostly felt that they already sufficiently 
address the “symptom-like” topics of the PRAQ (sleepiness, problems at night) in their usual 
care, in the context of setting a diagnosis. The topics of the PRAQ that are not necessary for 
setting a diagnosis, but could potentially be used to motivate patients for their treatment, were 
not seen as essential to discuss by many professionals. The limited perceived benefit of the 
PRAQ is likely also mitigated by the fact that many steps of the care process have to be covered 
during the intake consultation, including discussing the sleep study results and choosing 
a treatment. This leaves little extra time to discuss a patient’s quality of life and detailed 
treatment goals. Furthermore, burden of disease plays a limited role in setting a diagnosis 
when AHI≥15, due to views on strict medical necessity of treatment, but also due to the driving 
ban for untreated patients. Therefore, adding the PRAQ to the current practice for OSA does not 
appear to be a sufficient trigger to increase attention to quality of life issues.
 Patients generally held a more positive view towards the usefulness of the PRAQ. 
From the interviews it became clear that completing the PRAQ has the potential to give patients 
more insight into their OSA-related health complaints and encourages communication between 
family members. Furthermore, the patient survey results indicated that patients thought the 
PRAQ-report was useful for their preparation for the consultation and (when it was used by the 
healthcare professional) during the consultation.
 Agreement to the patient survey statement “I feel like my treatment is worth it for me” 
was significantly lower on the post-implementation survey than on the pre-implementation 
survey. The main difference was in the number of patients indicating “agree” versus “completely 
agree”,  meaning both pre-and post-implementation of the PRAQ patients were very positive 
about their treatment. This being an exploratory study, statistically significant results should 
be interpreted with caution, and we deem the relevance of this finding to be limited.
 There appears to be room for improvement of communication around the PRAQ, 
as there was confusion for some patients around the necessity of still discussing symptoms 
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during the consultation. Whereas some patients seemed to be more interested in hearing their 
sleep study results than talk about their symptoms, for the healthcare professionals hearing 
about the patient’s symptoms in their own words is an essential part of the diagnosis. It may 
be beneficial to communicate the purpose of the PRAQ more clearly in the invitation email, 
and/or to instruct professionals to, at the beginning of their consultation, mention the PRAQ to 
patients and how its results will be addressed. More in-depth discussion with the field about 
what is most suitable or desirable in this context is needed.
In the past few years, several similar initiatives involving PROMs have been introduced in The 
Netherlands, such as the Assessment of Burden of COPD (ABC) tool [34], the Nijmegen Clinical 
Screening Instrument for COPD [35], the QLIC-ON PROfile for children [36], and MyIBDcoach for 
patients with inflammatory bowel disease [37]. Studies into these applications show promising 
results regarding their benefits [37, 38] despite some resistance from professionals who do not 
believe in the added benefit or believe the tool would be more useful for different professionals 
within the care pathway [39, 40]. However, the healthcare professionals’ skepticism about 
the potential benefits of the PRAQ seems to be more extensive. Potentially, professionals will 
see greater benefit of the PRAQ in the context of the recently released new guidelines for 
OSA [30] with their greater emphasis on (improving) burden of disease, which were not yet 
available at the time of this study. However, the question remains whether a more “holistic” 
approach to caring for OSA patients fits within the current setting of relatively short intake 
consultations which take place after the patients’ diagnostic sleep study. It may be necessary 
to move towards a reorganization of care: for example to plan the intake consultations before 
the sleep study to allow for more focus on the individual patients’ symptoms and problems, and 
to specifically evaluate the necessity of doing a diagnostic sleep study. Additionally, integrating 
the PRAQ in the electronic health record will help professionals fit the PRAQ-report better into 
their workflow.
 Another option that can be explored is to adapt the PRAQ itself or the context in which 
it is used, in order to fit better to healthcare professionals’ preferences. For example, an option 
would be to remove the domains of the PRAQ focused on symptoms that are (nearly) always 
discussed already, and instead put the focus on the additional domains. It is also possible 
to distribute the PRAQ to a more select group of patients, for example by moving the first 
measurement moment to the follow-up consultation, therefore targeting only patients with 
a diagnosis and treatment. It could then be used to identify those patients still experiencing 
problems. Downside to both of these adaptations is that they limit the option to monitor 
changes over time on all domains that are relevant for patients with OSA, while monitoring over 
time is what most interviewed healthcare professionals are interested in. Not having a baseline 
measurement would also limit the options to usefully study the PRAQ data on aggregate level. 
It may be most feasible to let sleep centers decide how they want to use the PRAQ in the context 
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of what is desirable to them, which may also evolve over time. It is hoped that they will also take 
into account the patient perspective when deciding how to use the PRAQ.
Strengths and limitations of the study
The major strength of this study is that we used mixed methods, which provides insight into the 
reasons why the PRAQ does not work as intended. Many other studies on PROMs study only 
whether  a PROM works, rather than why or how. 
 There are also limitations to the study. First, the survey used for this study was not 
tested and maybe not discriminative enough to show differences between the groups pre- 
and post-implantation of the PRAQ. Potentially, patients who have not completed the PRAQ 
do not know that, for example, their preparation for the consultation could maybe have been 
better than it currently was. Second, electronic health records were only studied in one of the 
included sleep centers. However, considering the information we collected in the interviews, 
we do not expect that we would have found different results in either of the other two sleep 
centers. Third, though technically there was enough time in this study for professionals to 
also use the PRAQ during the first follow-up consultation, practical implementation issues as 
well as a lack of initiative from healthcare professionals to actively check whether a follow-up 
PRAQ was available meant that it was not used often at this time point. Therefore we did not 
gain much insight into the potential use of the PRAQ for follow-up consultations. Lastly, only 
patients who looked up the PRAQ-report could give an opinion on its usefulness for preparing 
the consultation in the survey. However, patients who did not look up the PRAQ-report may 
also be generally less interested in these kinds of tools and, if they had looked it up, may have 
experienced it as less useful. Additionally, patients who have a more positive opinion on the 
PRAQ may be more likely to complete the items on its usefulness.
Conclusions
Using the PRAQ in the daily clinical practice of OSA is viewed as useful by patients, but the 
enthusiasm of healthcare professionals differed per individual and was generally not very 
great. Implementation of the PRAQ does not seem a sufficient trigger to focus more attention 
to quality of life during consultations, and in current practice does not show impact on 
treatment choice or CPAP compliance. However, new Dutch guidelines for OSA care that have 
recently been published may lead to a greater emphasis on quality of life for patients, making 
the integration of the PRAQ in clinical care potentially more useful.
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Appendix 1: The PRAQ-report and its implementation in clinical practice 
In the PRAQ-report, the results of each of the ten PRAQ-domains are shown in the form of a 
colored smiley, ranging from green (patient indicated very few problems) to dark red (patient 
indicated a lot of problems). Domain scores over time and individual item scores are shown 
on subsequent pages of the PRAQ-report. The included domains were: symptoms at night, 
sleepiness, tiredness, daily activities, unsafe situations, memory and concentration, quality 
of sleep, emotions, social activities, and health concerns. The PRAQ also contains a set of 
“intake questions” that were designed together with the participating centers and aimed to 
replace the diagnostic intake questionnaires that the centers usually distribute to all their 
new patients. This involved more factual, broader questions to help professionals in setting a 
correct diagnosis.
 The PRAQ was distributed via a secure online platform (VitalHealth QuestManager) 
which sent out email invitations to a patient to complete the PRAQ at ten and (if the PRAQ was 
not yet completed) three days before the patient’s consultation. After completion of the PRAQ, 
patients and healthcare professionals both had the ability to access the PRAQ-report directly 
from the online platform.
 Individual implementation plans for collecting email addresses of patients, creating 
patient accounts, and entering consultation dates were developed for each study center to 
optimally fit their usual work flow.
 Healthcare professionals received information about the content of the PRAQ and 
PRAQ-report, and instructions and a short training in how to use QuestManager. They were then 
encouraged to integrate the PRAQ into their own workflow in whichever way each individual 
professional found most convenient. After approximately two months of using the PRAQ, the 
researchers organized a meeting in each sleep centre in which the healthcare professionals 
were invited to discuss how they were using the PRAQ-report in their practice, in order to 
exchange ideas and potentially adjust their way of using the PRAQ. 
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Appendix 2: information about the interviews and coding 
Interviewers IA and MN held the patient interviews based on the interview guides, mostly 
together but MN did some patient interviews alone, and IA did some patient and some 
professional interviews alone. IA had some training in qualitative research/interviewing, and 
participated in qualitative study with interviews before. MN did not have official training but 
received some interview training from IA. IA was the developer of the PRAQ and PRAQ-report, 
and the healthcare professionals were aware of this, which may have lead to bias. However, 
this was specifically addressed before the start of the interviews, reminding the interviewees 
that this was scientific research and the researchers were looking for honest opinions in order 
to learn more about the application of PROMs in clinical practice, and negative opinions were 
also welcome. The patients were not told that IA was the developer of the PRAQ.
Patient recruitment took place in two different ways:
 •  Patients were approached via email by the sleep center before their scheduled 
consultation. The email was sent directly via the online platform as an added 
message to the invitation to complete the PRAQ, or by a team member of the sleep 
center. 
 • All patients scheduled on a certain specific day for a specific healthcare professional 
that had completed the PRAQ, were invited by their healthcare professional to participate 
directly after their consultation.
 18 patients were interviewed face to face at the sleep center after their consultation in 
a private room; 9 patients were interviewed over the phone for convenience reasons. The patient 
interviews lasted on average 15 minutes. Healthcare provider interviews lasted on average 44 
minutes and were all held at the sleep center. All interviews were audiotaped, transcribed 
verbatim and anonymised. All interviewees were provided with information about the study and 
signed an informed consent form or gave verbal informed consent on the audiotape. Transcripts 
of the interviews were not provided to the interviewees. Analysis of the interviews took place 
with a phenomenology approach via open coding, with different code books for patients and 
healthcare providers. IA and MN first coded five interviews independently for both patients 
and healthcare professional interviews. A researcher (IG) experienced in qualitative research 
and knowledgeable about PROMs, but not involved in the study, coded one of the healthcare 
professional interviews independently. IG, IA, MN and PW held a collaborative coding session in 
which the code books were constructed. MN analyzed all remaining interviews, which IA then 
read and checked to the code book. When there was a disagreement about the coding, IA and 
MN reached consensus.
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Appendix 3: Patient survey. Version: intake consultation, post-implementation of the PRAQ.
When answering the questions, keep in mind the consultation that you just
attended.
1. I knew which problems I wanted to discuss with the doctor
2. I discussed with the doctor the topics I knew I wanted to discuss
beforehand
3. Because of my conversation with the doctor, I understand better what
causes my health complaints or problems
4. The doctor and I chose the treatment together, or together chose not to
treat my apnea
5. Because of my conversation with the doctor, I understand how the
treatment can benefit me
6. I think the treatment will be worth it for me
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable*
V1
don't agree, 
don't disagree
V2
V3
V4
V5
V6
Clarifications:
* I have no complaints or problems / I did not think of anything to discuss
** I don't have sleep apnea / no choice was made yet
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable*
don't agree,
don't disagree
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable*
don't agree, 
don't disagree
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable**
don't agree, 
don't disagree
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable**
don't agree, 
don't disagree
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable**
don't agree, 
don't disagree
Appendix 3: Patient survey. Version: intake consultation, post-implementation of the PRAQ.
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Questions about the PRAQ‐report
7. Your sleep center asked you to fill out a questionnaire before attending your consultation, about
your health complaints and daily functioning (the PRAQ). Did you complete this questionnaire?
The results of the questionnaire are summarised in a report, with on the first page smileys for each
topic. The questions below are about whether you looked at this report, and whether you thought this
was useful. Answer each question in the way that fits you or your situation best. Please answer the
questions as well if you have not seen the report.
8. I looked at the report before my consultations with the doctor.
9. The report was shown during the consultation with the doctor
(for example, you looked at the smileys together and discussed your health complaints)
10. I thought the report was useful as preparation of my consultation with the doctor
(if you did not look at the report beforehand, you may answer "not applicable")
11. I thought the report was useful during my consultation with the doctor
(If the report was not shown during the consultation, you may answer "not applicable")
12. Is there anything else about the PRAQ‐questionnaire or the report that you would like to share?
We are happy to hear your opinion.
Yes, elaborately
Yes, briefly
No, not important or didn't get around to it
No, I didn't know that there was a report or how to open it
VPRAQ2
Yes, elaborately
Yes, briefly
No, not at all
VPRAQ2
Yes
Partially (go to question 12 at the bottom of this page)
No (go to question13, on the next page)
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable
don't agree,
don't disagree
completely
disagree disagree
disagree
a litte
agree
a little agree
completely
agree
not
applicable
don't agree,
don't disagree
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13. What is your age?
14. Gender: man woman
years old
Opleiding
No education (did not finish primary school)
Primary school
Basic vocational education (LTS, LEAO)
General secundary education (MAVO, VMBO)
Intermediate vocational education (MTS, MEAO, MBO)
Senior secundary general education or pre‐university education (HAVO, VWO, grammar school)
Higher professional education (HBO, HEAO, HTS)
University
Other, which is:
15. What is the highest level of education you finished with a diploma?
Klachten
1 2 3 4 5 6 7 8 9 10
16. How bothered are you by the health complaints or problems for which you attended the sleep center
today?
Not bothered
at all
Very
bothered
17. Did the doctor diagnose you with sleep apnea?
Apneu
Yes, I have sleep apnea No, I do not have sleep apnea Don't know (yet)
18. If you answered "yes" to the previous question, was a treatment chosen and if so, which
one?
Behandeling
No treatment
Yes, CPAP (mask)
Yes, MRA (device over teeth)
Yes, lifestyle advice
Other, which is:
Leeftijd
We would also like to know something about you.
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General Discussion
1 AIM AND OVERVIEW
The aim of this thesis was to provide more insight into how individual PROM results work 
when implemented in clinical practice. This was studied in the context of obstructive sleep 
apnea (OSA), a condition in which breathing stops during sleep cause a variety of symptoms 
and functional problems. The specific aims of this thesis were to study whether a PROM of 
sufficient quality is available for patients with OSA, which measures OSA-related quality of life; 
if no existing PROM measuring OSA-related quality of life is of sufficient quality: to develop a 
new PROM for patients with OSA specifically for use in clinical practice, with the goal to be 
suitable for use on an individual patient level and on aggregate level; to develop a ‘patient-
friendly’ way of presenting the results of the PROM, in order to make them easy to interpret; to 
assess the validity, reliability and responsiveness of the Dutch PROM; and to study the impact 
of individual results of the PROM on OSA care as well as reasons for this (lack of) impact. 
 First, I will discuss the main findings of this thesis. Then I will provide insight into why 
some of our expected findings were not met, and the likely role that healthcare professionals, 
patients, the development of the PRAQ, the context, technology, and efforts of the research 
team to improve implementation may have played in this. Any methodological limitations 
will be discussed in the paragraphs about these topics. I then study whether our findings 
are in line with what is already known about PROMs in clinical practice. I finish with some 
recommendations and future directions regarding PROMs in clinical OSA practice, and the 
evaluation of the impact of PROMs in clinical practice.
2 MAIN FINDINGS
Chapters two to five of this thesis describe why and how we developed the PRAQ, a PROM 
measuring OSA-related quality of life. First, we studied the measurement properties of existing 
PROMs validated in patients with OSA, and concluded that none of these was suitable and of 
sufficient quality in its current form (chapter two). Therefore, we developed a new PROM, called 
the PRAQ, with the input of patients and healthcare professionals. During the development, we 
focused on the PROMs potential usefulness in clinical practice (chapter four). In chapter four 
we also describe the development of the PRAQ-report, an overview of an individual patient’s 
PRAQ results in which colored smilies show which domains are more and less problematic for 
that patient. A final version of the PRAQ is presented in the validation article, where we also 
report the acceptable measurement properties of the PROM with regard to reliability, validity 
and responsiveness (chapter five).
 In chapter 6 of this thesis we present the outcomes of an explorative pilot study for 
the impact of the PRAQ on clinical practice, for which the PRAQ was implemented in three 
Dutch sleep centers (chapter 6). We had several expectations with regard to how the PRAQ 
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could impact clinical practice. First, we expected that completing the PROM would educate 
and empower patients with suspected OSA by making them more aware of which of their 
symptoms and problems in daily life can be related to OSA. Interviews with patients showed 
that this expectation was met: completing the PRAQ has the potential to teach patients about 
the potential impact of OSA on their lives, and through discussing the questions of the PRAQ 
with their family it also provided more insight into their own situation. Second, we expected 
that the PRAQ would shift focus during a consultation from the medical facts towards the 
subjective experiences and problems of patients with OSA. The PRAQ-report could be used as 
the starting point of a conversation about aspects of health-related quality of life to achieve 
this goal. This could help determine the burden of disease for a patient, encourage healthcare 
providers to set personal treatment goals for patients and help motivate patients for their 
(medical or for example lifestyle-focused) treatment. Additionally, a broader view of a patient’s 
health could lead to referrals to other healthcare professionals, such as psychologists. In that 
way, care could also get a more ‘holistic’ focus where solving health and related problems take 
precedence over (only) reducing experienced breathings stops. Third, we tested the hypotheses 
that through abovementioned mechanisms, patients feel more motivated for their treatment 
and therefore show a higher compliance with treatment.
 The results of the pilot study show that these hypotheses about the impact of the 
PRAQ were not met for a majority of healthcare professionals. Interviews with healthcare 
professionals showed that they were not all willing to use the PRAQ, and those that did use the 
PRAQ, reported that they let the PRAQ play only a minor role during their consultations. We also 
performed a complimentary electronic health record study, before and after implementation of 
the PRAQ, where we studied: treatment choice; referrals to other healthcare professionals; and 
patients’ compliance with treatment. We had expected that these aspects of care could change 
based on the changes in the consultations. However, we did not find any differences, which is 
in line with our qualitative findings that there was hardly any change in the consultations. The 
availability of individual OSA-related quality of life data did therefore not seem to impact care.
3 THE PRAQ IN CLINICAL PRACTICE: WHY DID IT NOT WORK AS 
INTENDED?
In chapter one, I mentioned two existing models that depict how PROMs feedback can impact 
patient care and patient health outcomes: a general model by Greenhalgh et al. [1], and a 
model specifically focused on the use of PROMs for patients with chronic conditions by Santana 
et al. [2]. In both models, changes in communication have an important (and in Santana’s 
model even crucial) role in the chain of effects of PROMs feedback. Considering that in my pilot 
study the healthcare professionals mostly reported only minor changes in their communication 
with patients during consultations, it is clear that finding any impact of the PRAQ on treatment 
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choice, referrals to other healthcare professionals, or patients’ compliance with treatment 
in the pilot study was unlikely. It remains uncertain whether the PRAQ could impact these 
process measures – and potentially also health outcomes -  if healthcare professionals do 
change their communication.
 The main question which remains, and which has also been deemed highly important 
in the literature to provide more insight into the working mechanisms of PROMs [1], is why 
the PRAQ did not change communication and patient care as expected. This may be related 
to the (development of) the innovation itself, and is likely also intertwined with the success of 
implementing it in clinical practice and getting the healthcare providers to use it. Therefore we 
have used the determinants of change that may influence implementation identified in Grol et 
al. [3] as framework for which factors are relevant to discuss: the OSA healthcare professionals 
and the context in which they work, the patients, the nature of OSA, technology, the PRAQ itself, 
and efforts of the research team to improve implementation. In the following paragraphs I will 
discuss for each of these topics whether or not they were a likely contributor to the lack of 
changes impact of the PRAQ and how or why this may be the case. The discussion of the topics 
is based on the data gathered in interviews and discussions with the sleep centers after the 
study. 
3.1 Healthcare professionals
During the interviews with healthcare professionals it became clear that there are several 
interrelated explanations as to why the PRAQ had little impact on communication during 
consultations. The first potential explanation concerns the amount of available consultation 
time in relation to the actions that need to be taken during that consultation. The 20-30 
minutes intake consultation (depending on the sleep center) for patients with OSA takes place 
after the diagnostic sleep study. This consultation is used for 1) taking a patient history focused 
on symptoms that together with the sleep study result leads to a diagnosis, 2) explaining the 
sleep study results to the patient, 3) explaining the diagnosis to the patient, and if OSA is 
diagnosed: 4) explaining the treatment options, and 5) choosing a treatment with the patient. In 
other words, allocating more time to discuss quality of life would mean that there is less time 
to explain important things to patients and for shared decision-making, while time is already 
tight.
 Then there is a second reason: the PRAQ does not seem to fit with most healthcare 
professionals’ ideas of the care they should be delivering. From the interviews it became clear 
that many healthcare professionals are not used to actively bringing up topics with patients 
(e.g. emotions) if they do not feel that they are useful for setting the diagnosis during an intake 
consultation, and they are also not necessarily convinced that this is useful. Focusing on the 
medical aspects (number of breathing stops per hour) and the most common symptoms is 
often considered sufficient: the main responsibility is to set the medical diagnosis and start a 
treatment. The impact of symptoms on a patient’s life may surface during the consultation, but 
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is a secondary issue. The same seems to be true for the follow-up consultation after starting 
treatment: the treatment is considered successful if the number of breathing stops per hour 
is reduced, symptoms are generally improved and the treatment is tolerated well. The focus 
of the follow-up consultation is often on the tolerance and potential adjustments of treatment; 
discussion of remaining problems and whether they can be treated is – unless the patient 
brings them up actively – often minimal.
3.2 The context of OSA care
The broader context in which OSA care is provided is also relevant, for example in terms of 
reimbursement structures and regulations. Financially it is more beneficial for a sleep center 
if healthcare professionals reach a quick diagnosis and prescribe (medical) treatment, rather 
than spending time discussing quality of life. This reward for prescribing medical treatment 
also discourages the potential choice of opting for no treatment or non-medical treatment 
such as lifestyle coaching, as has been shown in previous research [4]. Furthermore, there 
is one current regulation that specifically impacts OSA care. It states that patients with ≥15 
breathing stops per hour are not allowed to drive motorized vehicles until they have had medical 
treatment of their OSA for at least two months. For patients for whom driving is important, this 
in practice eliminates the option of choosing no treatment or non-medical treatment, even 
when they experience few symptoms. Therefore, even if the PRAQ would lead to changes in 
communication, this regulation limits the potential for changes in patient management.
3.3 The patients
The initiative to discuss the PRAQ results can come from the patient as well as the healthcare 
professional. During our patient interviews we did not specifically ask whether patients actively 
brought up certain topics during their consultation, triggered by the completion of the PRAQ 
or by looking at the PRAQ-report, so our information on this topic is not complete. Only one 
patient brought up, out of their own accord, that they felt the PRAQ supported them in asking 
more questions. However, what was striking about the interviews with other patients is that 
they did not seem overly eager to discuss their symptoms and problems in daily life with their 
healthcare professional. Some patients were under the impression that discussion of symptoms 
during the intake consultation was not necessary after completing the PRAQ: they seemed to 
think that the PRAQ results would provide the healthcare provider with enough information 
regarding their symptoms. Many healthcare professionals also reported this and mentioned 
resistance from patients to discuss the topics of the PRAQ-report again. Rather than leading 
to more discussion about quality of life, it may therefore be the case that the completion of the 
PRAQ had the opposite effect. Since the PRAQ is sent out during the diagnostic process, this 
may have led patients to believe that the PRAQ is diagnostic tool, though this was not what 
was communicated. Additionally, many intake patients seemed very focused on hearing about 
the results of their sleep study, and learning whether they suffered from OSA or not, whereas 
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they were less focused on discussing their personal problems. In other words, it seems that 
the way healthcare professionals view the intake consultation – namely, mostly focused on the 
diagnosis – may actually match the way patients view these consultations. Once the results of 
the sleep study are available, the ‘medical’ view of OSA seems to gain the upper hand for both 
parties.
 This focus on the diagnosis may also have influenced the patient survey results, on 
which patients mostly indicated that they discussed all the topics they wanted to discuss with 
their healthcare professional. If patients expect their intake consultation to focus on discussing 
the diagnosis, then it seems likely that their expectations concerning discussion of their 
personal situation are low. The question is whether this means that more attention to quality of 
life is not useful from the patient perspective. It is understandable that patients want to know 
the results of a performed test, but in another context patients may consider it more desirable 
to discuss aspects of their quality of life. Separating the discussion of quality of life from the 
discussion about the sleep study results may change the patient perspective.
3.4 The development of the PRAQ
During the development of the PRAQ, we involved both patients and healthcare professionals. 
We included in our development team a board member of the Dutch patient organization for 
sleep apnea (ApneuVereniging) and a pulmonologist, and we also consulted larger groups 
of patients and healthcare professionals to determine which topics were relevant to discuss 
during a consultation. Our specific development goal was to optimize the PRAQ and PRAQ-
report for its proposed use in clinical practice. This is an important step in making sure that 
the tool that is being developed for clinical practice will serve its needs. To our knowledge, no 
PROM has been developed with this particular purpose in mind, and in terms of serving the 
needs of patients this approach turned out successful.
 However, even though we involved healthcare professionals during the development 
process, our main focus was on the needs of the patients and their views on what they would 
potentially wish to discuss with a healthcare professional. We involved healthcare professionals 
by asking them to complete a survey on which they indicated their agreement to several 
statements per potential domain of the PRAQ. These statements included that the professional 
would want to be aware if patients were experiencing problems regarding a certain topic (for 
example emotions), and that they felt at least partially responsible for helping to solve these 
problems. 72%-100% of healthcare professionals participating in the survey agreed to these 
statements for the ten domains of the PRAQ. However, considering the limited perceived 
usefulness of the PRAQ by professionals in our last study, it appears that expressing the wish to 
be aware of and help tackle certain problems may not be the same as wishing to actively bring 
up these topics, nor does it necessarily mean that it is feasible in practice to do so. Additionally, 
some of the responding healthcare professionals may have felt that they already address these 
problems sufficiently and do not need a tool to aid them, which was a view that some of our 
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interviewees expressed after implementation of the PRAQ. Here, we missed a chance to gain 
insight beforehand into how different healthcare professionals viewed our idea of using a tool 
like the PRAQ-report. Setting up a shared vision with healthcare professionals in an early 
development phase about how a PROM can and should aid clinical practice and what this could 
look like during a consultation, is a step is likely to benefit a successful implementation.
3.5 The nature of OSA as a ‘different’ chronic condition
Tools for clinical practice which include the results of PROMs have been developed for several 
conditions and target groups in the past decade, and they seem to have had a more positive 
reception amongst healthcare professionals than the PRAQ-report [5-10]. Conditions for which 
tools have been developed are for example for chronic obstructive pulmonary disease (COPD), 
irritable bowel syndrome (IBD), and for children with a wide range of chronic or longer-lasting 
conditions. What these conditions have in common is that they are chronic and involve problems 
over longer periods of time. PROMs can help detect and monitor problems that are relevant to 
these patients. 
 Differences in the characteristics and treatment of these diseases compared to OSA 
can help explain why the PRAQ was less successful. COPD and IBD differ from OSA in the sense 
that treatment is for a great part focused on relieving symptoms and improving quality of life, 
while the underlying condition (COPD or IBD) remains present. However, for OSA treatment is 
regularly successful in strongly reducing the number of breathing stops, in which case the main 
(physical) problem for which they attended the sleep centre can often be considered solved. A 
patient that is successfully treated for OSA will not necessarily continue to experience chronic 
symptoms or problems, even though OSA is considered a chronic disease. Therefore, usually 
OSA is a not a closely monitored disease once successful treatment has been established 
for an individual. The percentage of patients that continue to experience problems even 
when treatment appears successful is, however, not known; and the (low) estimation of this 
percentage by healthcare professionals may be an underestimation because they tend to focus 
on whether a patient is doing better on the whole without focusing on remaining problems. 
 From the healthcare professional perspective, this focus on only the general well-
being of a patient could be viewed as sensible. If the number of breathing stops are sufficiently 
reduced with treatment and the patient is doing better, then it is possible that remaining 
problems either need more time to improve (the brain can potentially take up to two years 
to recover from the impact of OSA [11]) or that they are not directly caused by OSA. In neither 
scenario does this necessarily encourage healthcare professionals to act upon the remaining 
problems. However, there are options to give additional care to these patients: for example 
by exploring other sleep-related problems, considering whether there may be potential 
(undiscovered) comorbidities which may warrant referral back to the GP, or by referring the 
patient to a psychologist to learn how to cope better with their problems. Still, the (perceived) 
lack of tools for an OSA professional to act upon remaining problems within their own expertise 
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likely contributes to the lower experienced usefulness of this PROM for OSA compared to 
PROMs for other chronic diseases.
3.6 Technology
In existing literature about PROMs in clinical practice it is often mentioned that using the 
PROM results must fit well into the workflow of the healthcare professionals [12]. In the case 
of the PRAQ, this fit with the workflow was not optimal: the PRAQ-report was only available 
on a separate website which required the professionals to log in and bring up the patient’s 
record in that system. The professionals did not consider this process complicated, but 
it did require some extra time and effort in each consultation. For some of the interviewed 
healthcare professionals, this was one of the factors that contributed to not (always) using the 
PRAQ. Being able to access the PRAQ-report directly from the electronic health record would 
potentially have encouraged these professionals to use the PRAQ more. However, considering 
how little impact the PRAQ had on consultations even when it was used, it seems unlikely that 
this would have had a big impact on the results of this study. Still, for potential future use of the 
PRAQ, and for PROMs in general, availability of the results in the patient record is an important 
aspect of fitting it into the workflow of the professionals.
 We also made the PRAQ-report available to patients, which allowed them to see 
and reflect on their results (in comparison to their previous results, if available) before the 
consultation. Unfortunately, the way in which the website made its results available to patients 
was not very intuitive, which could not be solved in time for this study. This means that fewer 
patients viewed the PRAQ-report before their consultation than we would have hoped. Our 
survey in chapter six showed that approximately 40% of patients that had completed the PRAQ 
had seen the report before their consultation, of which approximately 70% indicated that they 
thought PRAQ-report was useful for preparing their consultation. Potentially, these results are 
biased because patients who do not find PROM information interesting or useful may not have 
looked at the PRAQ-report, and could therefore also not express their opinion on the report 
itself. Still, considering the positive opinion of those who did look at the report, the usefulness 
of sharing the PRAQ-report with patients before their consultation is worth exploring further.
3.7 Efforts of the research team to promote implementation 
We provided a training and instructions to the healthcare professionals on how to use the 
website on which the PRAQ-report could be viewed, and how to interpret the PRAQ results 
based on the smileys. We did not aim to prescribe exactly how the healthcare professionals 
had to use the PRAQ-report, but we presented information and several suggestions on how 
to use the PRAQ to the professionals. We then asked the professionals at the sleep centers 
to set up their own, collective plan on how to start using the PRAQ in their consultations. 
Motivation of the professionals to work out this plan turned out to be low. They felt that they 
had to first see and try the PRAQ in their clinical practice before being able to estimate how 
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to best use it. Therefore, the research team set up a meeting 6-8 weeks after implementing 
the PRAQ with all involved healthcare professionals and several members of the research 
team, in the three participating sleep centers. In this meeting the professionals were invited to 
discuss their current use of the PRAQ, in order for them to learn from and inspire each other. 
However, attendance and success of the sessions varied, and no clear plans were formulated. 
The sessions did encourage some professionals who were not using the PRAQ to start using it.
 Looking back on this process, we were too optimistic about the enthusiasm of the 
healthcare professionals to consider possibilities of using the PRAQ and help us in setting up 
a clear plan of use for the PRAQ. This is likely related to their ideas about the limited benefit 
of the PRAQ to their clinical practice. We had also expected professionals to be more willing to 
influence and learn from each other. In reality, our impression was that professionals had their 
own way of holding their consultations and while some were willing to try out changing their 
approach, others were not. The presence of a (more influential) clinical champion within the 
participating centers may have been beneficial in motivating the professionals to work with the 
PRAQ [3].
4 COMPARISON OF OUR FINDINGS TO EXISTING LITERATURE
Reviews that have tried to identify the factors that may hinder or benefit the effect of a PROM as 
intervention in clinical practice have mentioned many of the things that have been discussed in 
this chapter: the attitude of the healthcare professionals and the way they are instructed to use 
the PROM results [13, 14], whether the PROM provides new information, the opportunity costs 
for what professionals perceive to be more important aspects of care, and the technology and 
integration of PROM data in the electronic health record [12]. The content and type of the PROM 
has also been found to be a potentially hindering factor, for example when generic PROMs 
are employed (measuring general quality of life) that bear little connection to what patients 
and healthcare professionals consider important in their specific context [15]. In our study the 
PROM was closely aligned with the main problems of patients with OSA, but this was in itself 
not enough to make the intervention effective.
 Apart from ideas about why PROM data may or may not work, there has also been an 
effort by Greenhalgh et al. [14] to summarize the currently available evidence on how PROMs 
may impact care. They have focused on the potential for PROMs to increase the discussion of 
patient concerns, either via the route of healthcare professionals bringing up these concerns 
more often, or because of patients bring up these concerns more often. The authors then came 
to a set of theories about how this increased discussion of concerns may be triggered, and 
‘probe’ these theories by studying the results of empirical studies to test and refine them.
 Our study has provided some insights into several of the theories from Greenhalgh’s 
synthesis. One theory from the synthesis is that PROMs act as a tool to enable patients to raise 
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or share issues with clinicians. Three mechanisms could contribute to this according to the 
synthesis: patients engage in a process of self-reflection to identify what is important to them 
and what they want to talk about; the process of PROMs completion reminds patients to share 
or raise issues with clinicians; and the PROM also makes them feel that they have permission 
to raise these issues because the healthcare professional is interested. The synthesis found 
some (positive or negative) evidence for all three of these mechanisms. In our study, patients 
did reflect more on their situation, often together with their partner, but rather than planning 
to raise these issues, patients seemed to feel that sharing these issues via the PROM was 
sufficient. They expected that professionals were interested in the information they provided via 
the PROM, but often appeared to think this was for diagnostic purposes only (see also section 
3.3).
 Then, the synthesis presents a set of theories and a counter-theory regarding how 
healthcare professionals use PROMs. The theories state that PROMs feedback will lead to 
increased discussion of issues of health-related quality of life, which will then directly (because 
of changes to patient management) or indirectly (because of better communication) lead to 
improvement in patient well-being. Some studies were found to support improvement of patient 
well-being via the direct route, but not the indirect route where better communication itself will 
lead to better patient management. The counter-theory poses that healthcare professionals do 
not change their communication practices during the consultation. Studies are then presented 
in Greenhalgh’s synthesis that supported this theory, to which we can add our own study. Our 
study supports the findings of the synthesis that healthcare professionals are more likely to 
discuss more medical issues, such as symptoms, than issues that reflect broader health-
related quality of life, such as social functioning. Providing healthcare professionals with the 
information that there are issues with broader health-related quality of life for a patient, is not 
necessarily sufficient to trigger discussion of these issues.
5 THE FUTURE OF USING PROMS IN CLINICAL PRACTICE OF OSA
The main reasons of why the PRAQ did not have the expected impact seems related to 
perceptions of both professionals and patients about the necessity of discussing aspects of 
quality of life, in the context of short consultations and the nature of OSA as a chronic disease. 
 A separate intake consultation which takes place before the diagnostic sleep study 
would allow for more focus on determining which problems a patient experiences, without the 
instant focus on sleep study results. Interestingly however, these ‘early’ intake consultations 
were abolished relatively recently in some sleep centers (personal communication). There are 
benefits to merging the intake consultation with the consultation in which the diagnosis is set: 
it saves patients the time and effort of an extra visit to the hospital while they likely need to 
undergo a sleep study either way, and it makes the intake process more streamlined, which 
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for example allows healthcare professionals to see more new patients. This may save time and 
money for the sleep center. These benefits seem to have outweighed a potential loss of time to 
listen to a patient’s perspective.
 It will be interesting to see how this will develop in the future. In the past few years 
there has been an international discussion regarding new approaches to diagnose ‘clinically 
relevant’ OSA [16, 17], and how to achieve more personalized care for patients with OSA [18]. 
This discussion has also made its way into recent Dutch guidelines for OSA, in which it is 
recommended that there should be a greater focus on the presence of potentially related 
comorbidities, as well as the experienced burden of disease for individual patients. The goal 
of treatment is the improvement of these OSA aspects [19]. It is increasingly being recognized 
that having an in-depth conversation with the patient is crucial in this context [20]. The PRAQ 
could potentially fulfill a useful role in this new approach to OSA care.
 In my view, the next step lies within healthcare practice rather than science. Since 
the effectiveness of the PRAQ in clinical practice has not been shown in this study, it will be up 
to sleep centers to decide whether they consider it to be potentially useful enough to warrant 
the effort and money of implementation and continuous measurement; and also whether they 
are willing and able to provide the context in which it can be employed in a useful way on 
an individual patient level. For example, by planning more time for consultations, planning a 
separate intake consultation before the sleep study, but also by deciding as a department to 
increase focus on the patient-centeredness of care. The sleep center will then have to evaluate 
whether it is worth continuing the collection and use of PROM data, by taking into account the 
healthcare provider perspective as well as the patient perspective. In addition use for individual 
patients, sleep centers may also find benefit of the PRAQ by using its results on an aggregated 
level to study outcomes of healthcare providers or different treatments. 
 Currently, one Dutch sleep center is using individual PRAQ data in its clinical practice, 
and has shown interest in also using this data on an aggregated level.
6 PROMS IN CLINICAL PRACTICE – CHALLENGES
Gathering information on the perspective of patients on their own health to monitor and 
evaluate provided care is gaining increasing interest. In the future, the use of PROMs in clinical 
practice will therefore likely grow. As discussed before, PROMs in clinical practice can be 
used on different levels. On the level of an individual patient, individual PROM results can be 
used to inform treatment choice and monitor outcomes of that patient. Additionally, also for 
individual patients, it is possible to use aggregated PROM data of similar patients to inform 
treatment choice (e.g. patients like you improve most when they undergo a certain treatment). 
On an aggregated level, PROM data can be used to improve quality of care, or for external 
transparency. Collecting PROM data for use only on an individual or only on an aggregated level 
General Discussion
161
7
General Discussion
is possible, but collecting data for both purposes may have benefits [21]: it likely provides more 
motivation for patients to complete the PROM and it gives healthcare professionals a better 
‘feel’ for the collected data. It also allows healthcare providers to get the maximum benefit and 
information out of the collected data.
 In practice, this combination of purposes is not yet easy to achieve. Making use 
of a separate website and database to collect the PROM data, as in this thesis, offers more 
elaborate possibilities to create a patient-friendly way to present the results. However, the 
collected data cannot be readily analysed on an aggregate level because the PROM database 
and the electronic health record are not linked. This means that for example analysis of PROM 
results per treatment option or correction for patient characteristics is not possible. It may be 
possible to create this link in the future, but since there are several different patient record 
systems in use this may prove laborious and expensive. Another option that may be more 
feasible is to distribute PROMs directly via a patient record system. Ideally, this data is then 
stored in a database to allow for analyses on aggregate level, and also becomes available to the 
physicians and to patients so that the results can be used in clinical practice. There will likely 
be fewer options regarding the patient-friendly presentation of the results, but the benefits of 
this approach may still outweigh its limitations. 
 An important consideration regarding the increased future use of PROMs is also 
how to deal with increased patient burden. Patients with multiple chronic diseases may be 
asked to complete separate questionnaires before each of their consultations with different 
specialties, while the questions asked will most likely overlap. Frustrated patients and a 
decreased willingness to complete the PROMs could be the result. This could potentially 
be tackled by selecting generic measures for the domains that are relevant to measure, for 
example by making use of the Patient Reported Outcomes Measurement Information System 
(PROMIS). PROMIS contains item banks for many of the most frequently assessed patient-
reported outcomes (domains), which can be used irrespective of patient’s disease. A patient’s 
social functioning or problems due to bad sleep could then be measured with one generic 
set of items, which can be used by different specialties in one hospital, or by interdisciplinary 
teams within a hospital or between organisations. It may still be needed to add some disease-
specific domains, but this approach should still limit the patient burden.
 
7 FUTURE OF EVALUATING THE USE OF PROM DATA IN PRACTICE
The results of this thesis also raise the question whether approaching a PROM on its own as an 
intervention to bring about patient-centered care is the optimal approach. PROM information 
may be more useful when it is part of a larger intervention to increase patient-centeredness 
of care. This can involve a restructuring of the care process and/or an intervention that 
focuses on more than only PROM data. An example of this is the (effective) intervention 
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MyIBDcoach, a telemonitoring system including PROMs, promoting self-management for 
patients with irritable bowel disease [8]. Alignment of the goals of the intervention and those 
of the healthcare professionals and patients that will use the intervention is important for a 
successful implementation.
 In future evaluations of the impact of PROM data on clinical practice, academia may 
be involved through participatory research [22] in which the health care organization and 
the involved professionals share ownership of the research. Participatory research involves 
a qualitative approach in which understanding of problems and (the embedding of) the 
intervention can change during the study in order to evaluate what works best [23]. It allows 
the users of the PROM data to be in the lead, which has been indicated as a success factor 
before [21]. For complex interventions like PROMs in clinical practice, participatory research is 
likely to benefit the understanding on whether and how it works.
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The aim of this thesis was to provide more insight into how individual PROM results work when 
implemented in routine clinical practice. This was studied in the context of care for patients 
with obstructive sleep apnea (OSA), a condition in which patients experience breathing stops 
while asleep. This causes a variety of symptoms and functional problems. We had the following 
specific aims:
 •  To study whether a PROM of sufficient quality is available for patients with OSA, 
which measures OSA-related quality of life;
 •  If no existing PROM, measuring OSA-related quality of life, is available and of 
sufficient quality: to develop a new PROM for patients with OSA specifically for use 
in clinical practice, with the goal to be suitable for use on both an individual patient 
and aggregate level;
 •  To develop a ‘patient-friendly’ way of presenting the results of the PROM, in order to 
make them easy to interpret;
 •  To assess the validity, reliability and responsiveness of the PROM in a Dutch setting;
 •  To study the impact of individual results of the PROM on the care of patients with 
OSA, and study why this impact is or is not found.
Below, we summarize the chapters of this thesis, in which these aims are addressed.
Chapter two presents a systematic review which summarizes the evidence regarding the 
quality of PROMs validated in patients with OSA. We identified 22 PROMs in the literature: eight 
measuring OSA-related quality of life, eight measuring OSA-related symptoms (e.g. sleepiness), 
and six generic measures of quality of life. The results showed that most of the measurement 
properties of the PROMs were not, or not adequately, assessed. For many identified PROMs 
there was no involvement of patients with OSA during their development, or any check of 
content validity before the PROM was tested in patients with OSA. Positive exceptions are four 
PROMs measuring OSA-related quality of life that were developed with input from patients: 
the Sleep Apnea Quality of Life Index (SAQLI), Maugeri Obstructive Sleep Apnea Syndrome 
(MOSAS) questionnaire, Quebec Sleep Questionnaire (QSQ) and the Obstructive Sleep Apnea 
Patient-Oriented Severity index (OSAPOSI). For none of these PROMs there was sufficient 
evidence to properly judge their quality, and all of them need to be validated further. 
 We considered which of these PROMs we would recommend for research and clinical 
practice. The SAQLI was the PROM with the most positive evidence for its measurement 
properties. Because this PROM is interview-administered, we did not recommend it for use 
in clinical practice, but it can potentially be used in research. The QSQ, MOSAS questionnaire 
and OSAPOSI may potentially be feasible for use in research and clinical practice, if interpreted 
with caution. However, these PROMs were not developed with clinical practice in mind and 
their face validity was not studied in this review.
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In chapter three, we make recommendations for problems regarding the interpretation of 
convergent validity that we encountered while conducting the systematic review of chapter 
two. Convergent validity is a type of validity that is assessed by means of “hypothesis testing”: 
determining whether the scores of the instrument under study correlate with other instruments 
that measure related constructs to the extent that one would expect. Authors of systematic 
reviews on measurement properties for PROMs may encounter validation articles in which 
correlations are presented without hypotheses to which they should be tested. We suggest 
that in these cases, reviewers construct their own hypotheses to determine the adequacy of 
convergent validity for the PROM under study. However, constructing hypotheses and interpreting 
outcomes is not always straightforward. We made the following recommendations for authors 
of reviews: take an active role in judging the suitability of the comparator instruments; be 
transparent about which hypotheses were constructed, the underlying assumptions on which 
they are based, and whether they were constructed by authors of the validation article or the 
reviewer; discuss unmet hypotheses, especially if convergent validity is judged to be inadequate 
based on these hypotheses; and when synthesizing data, add up the results of all hypotheses 
for one instrument, rather than judging convergent validity per included study.
In chapter four, we describe the development of a new PROM for patients with sleep apnea, 
measuring apnea-specific quality of life: the patient-reported apnea questionnaire (PRAQ). The 
choice to make a new PROM was made in the working group, which consisted of a patient, a 
pulmonologist, and two researchers on this project. This working grouped judged the four 
PROMs identified in chapter two on their face validity and suitability for clinical practice. One of 
the PROMs was not publically available or retrievable via the developer (the OSAPOSI) so this 
PROM was excluded from the deliberation. The SAQLI required an interviewer for administering 
the PROM because there were many, and relatively complicated questions, which the working 
group did not deem feasible for clinical practice. The QSQ and MOSAS questionnaire we did not 
consider ideal because some aspects of quality of life potentially important for clinical practice 
were missing, and because some of the items contained unclear phrasing. Therefore, we 
decided to develop a new PROM, which also gave us the opportunity to pay specific attention to 
its usefulness in clinical practice. Because the mentioned PROMs were developed with patient 
input, the working group did consider them suitable to serve as a basis for the PRAQ. 
 Patients and healthcare professionals were intensively involved in the development of 
the PRAQ via membership of the development team, online surveys and focus groups, as well 
as two rounds of cognitive validation to check the understanding and the phrasing of the items. 
They helped us select topics and items from the existing PROMs, and add or adjust topics 
or items, based on what was considered relevant for clinical practice. This resulted in a first 
version of the PRAQ, consisting of 43 items and 10 preliminary domains. Patients indicated that 
PRAQ was comprehensive and its length acceptable.
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In chapter five we describe the further development and validation of the first version 
of the PRAQ, in the context of how we aim for the PRAQ to be used: patients complete the 
PRAQ before their OSA-consultation, where the results can be discussed with a healthcare 
professional; and the aggregate outcomes of groups of patients can then be studied by making 
use of an optimal subselection of the completed items. We conducted a study in which 180 
patients with suspected OSA completed the preliminary version of the PRAQ. The collected 
data was used to 1) perform the final item selection for individual use of the PRAQ in clinical 
practice, 2) create the domains for (aggregate) outcome measurement, and 3) assess the 
measurement properties internal consistency, test-retest reliability, convergent validity and 
responsiveness. We selected 40 items and 10 domains for the final version of the PRAQ for 
use in daily clinical practice. A subselection of 33 items in 5 domains was selected for optimal 
outcome measurement with the PRAQ. The results for the outcome measurement domains 
were: Cronbach’s α 0.88–0.95, intraclass correlation coefficient (ICC) 0.81–0.88, and > 75% of 
hypotheses correct for convergent validity and responsiveness. This lead us to the conclusion 
that the PRAQ shows good measurement properties in patients with (suspected) OSA.
 In this chapter we also describe the development of the PRAQ-report, an overview of 
an individual patient’s PRAQ results in which colored ‘smileys’ show which domains are more 
and less problematic for that patient.
In chapter six we present the outcomes of an explorative pilot study for the impact of the PRAQ 
on clinical practice, for which the PRAQ was implemented in three Dutch sleep centers. We 
had several expectations with regard to how the PRAQ could impact clinical practice. First, 
we expected that completing the PROM would educate and empower patients suspected of 
having OSA by making them more aware of which of their symptoms and problems in daily life 
can be related to OSA. Interviews with patients showed that this expectation seems to be met: 
completing the PRAQ has the potential to teach patients about the potential impact of OSA on 
their lives, and through discussing the questions of the PRAQ with their family it also provided 
more insight into their own situation. Second, we expected that the PRAQ would shift focus 
during a consultation from the medical facts towards the experiences and problems of patients 
with OSA and result in more ‘patient-centered’ care. However, the interviews with healthcare 
professionals showed that this was not met for a majority of healthcare professionals. Though 
most professionals did discuss the PRAQ with patients in some way during their consultations, 
this was usually briefly, and some mentioned they only did it for the sake of the study. Most 
professionals let the PRAQ play only a minor role during their consultations. 
 We also conducted a complimentary electronic health record study, before and 
after implementation of the PRAQ, in which we studied: treatment choice; referrals to other 
healthcare professionals; and patients’ compliance with treatment. We had expected that 
these aspects of care could change based on the changes in the consultations. However, we 
did not find any differences, in line with our qualitative findings that there was generally not 
Summary
171
much change in the consultations. The availability of individual OSA-related quality of life data 
did therefore not seem to impact care during this study.
In chapter seven, we reflect on why the PRAQ did not show the impact on clinical practice 
that we had expected. The following factors that potentially influenced the lack of impact 
are discussed: the OSA healthcare professionals and the context in which they work, the 
patients, the nature of OSA, technology, the PRAQ itself, and efforts of the research team to 
improve implementation. One of our conclusions is that even though care for patients with 
OSA is undergoing a shift towards more personalized, patient-centered care, the healthcare 
professionals in this study did for the most part not yet take this approach. This is likely in part 
due to limited time for consultations. In the future, the further shift to personalized care may 
lead to a greater interest of sleep centers and healthcare professionals in the use of the PRAQ. 
Since the effectiveness of the PRAQ in clinical practice has not been shown in this thesis, it 
will be up to sleep centers to decide whether they consider it to be potentially useful enough to 
warrant the effort and money of implementation and continuous measurement. They will also 
have to consider if they are willing and able to provide the context in which the PRAQ can be 
employed in a more useful way for individual patients, by for example planning more time for 
an intake consultation. Currently, one Dutch sleep center is using individual PRAQ data in its 
clinical practice, and has shown interest in also using this data on an aggregated level.
 We then discuss the challenges related to using PROMs in clinical practice. We argue 
for collecting PROM data for two goals at once: improving care at the level of an individual 
patient, and measuring quality with aggregated PROM data. However, the question via which 
platform this data must be collected to be able to use for both purposes is still a challenge. 
In addition, patient burden should also be taken into account, especially those with multiple 
chronic diseases who in the future may be overloaded with requests to complete PROMs. 
The interdisciplinary use of generic item banks, such as the Patient Reported Outcomes 
Measurement Information System (PROMIS), may be a solution.
 Lastly, we raise the question whether using PROM data on its own as a single 
intervention to bring about patient-centered care is the optimal approach. PROM information 
may be more useful when it is part of a larger intervention to increase patient-centeredness of 
care. This may involve a restructuring of the care process and/or an intervention that focuses 
on more than only using PROM data. In future evaluations of the impact of PROM data on 
clinical practice, academia may be involved though participatory research in which the health 
care organization and the involved professionals share ownership of the research with the 
researchers.
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Het doel van dit proefschrift was om meer inzicht te geven in hoe individuele PROM-resultaten 
een mogelijk effect bereiken wanneer ze gebruikt worden in de dagelijkse klinische praktijk. 
Dit werd onderzocht in het kader van de zorg voor patiënten met obstructieve slaapapneu 
(OSA), een aandoening waarbij de adem van een patiënt tijdens de slaap frequent stokt. Dit 
veroorzaakt een verscheidenheid aan symptomen en functionele problemen. We hadden de 
volgende specifieke doelen:
 •  Nagaan of een PROM van voldoende kwaliteit beschikbaar is voor patiënten met 
OSA, die OSA-gerelateerde kwaliteit van leven meet;
 •  Als er geen bestaande PROM is die de OSA-gerelateerde kwaliteit van leven meet, 
en van voldoende kwaliteit is: het ontwikkelen van een nieuwe PROM voor patiënten 
met OSA, specifiek voor gebruik in de klinische praktijk, met het doel om geschikt 
te zijn voor gebruik bij zowel een individuele patiënt en geaggregeerd niveau;
 •  Het ontwikkelen van een ‘patiëntvriendelijke’ manier om de resultaten van de PROM 
te presenteren, zodat ze makkelijk geïnterpreteerd kunnen worden;
 •  Het beoordelen van de validiteit, betrouwbaarheid en responsiviteit van de PROM in 
een Nederlandse setting;
 •  Het bestuderen van de impact van individuele resultaten van de PROM op de zorg 
voor patiënten met OSA, en te onderzoeken waarom deze impact wel of niet wordt 
gevonden.
Hieronder vatten we de hoofdstukken van dit proefschrift samen, waarin deze doelen aan bod 
zullen komen.
Hoofdstuk twee is een systematische review over de kwaliteit van bestaande PROMs die 
gevalideerd zijn bij patiënten met OSA. We identificeerden 22 PROMs in de literatuur: acht 
die OSA-gerelateerde kwaliteit van leven meten, acht die OSA-gerelateerde symptomen 
meten (bijvoorbeeld slaperigheid), en zes PROMs die generieke kwaliteit van leven meten. 
De resultaten lieten zien dat de meeste meeteigenschappen van de geïdentificeerde PROMs 
niet, of niet adequaat, onderzocht zijn. Veel van de geïdentificeerde PROMs waren ontwikkeld 
zonder de betrokkenheid van patiënten, en zonder beoordeling van inhoudsvaliditeit voordat de 
PROM werd getest bij patiënten met OSA. Positieve uitzonderingen daarop zijn vier PROMs die 
de OSA-gerelateerde kwaliteit van leven meten en die ontwikkeld zijn met input van patiënten: 
de Sleep Apnea Quality of Life index (SAQLI), de Maugeri Obstructive Sleep Apnea Syndrome 
(MOSAS) vragenlijst, de Quebec Sleep Questionnaire (QSQ) en de Obstructive Sleep Apnea 
Patient-Oriented Severity Index (OSAPOSI). Voor geen van deze PROMs was er voldoende 
bewijs om hun kwaliteit volledig te beoordelen, dus ze zouden allemaal verder gevalideerd 
moeten worden. 
 We hebben overwogen welke deze PROMs we zouden aanbevelen voor onderzoek 
en voor gebruik in de klinische praktijk. De SAQLI was de PROM met het meeste positieve 
bewijs voor de meeteigenschappen. Omdat deze PROM afgenomen wordt door middel van een 
interview, hebben we hem niet aanbevolen voor gebruik in de klinische praktijk. Hij is mogelijk 
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wel te gebruiken in onderzoek. De QSQ, MOSAS vragenlijst en OSAPOSI zijn mogelijk geschikt 
voor gebruik in onderzoek en de klinische praktijk, mits men hun resultaten voorzichtig 
interpreteert. Deze PROMs waren echter niet ontwikkeld met de klinische praktijk in het 
achterhoofd en hun face validity werd niet bestudeerd in deze review.
In hoofdstuk drie doen we aanbevelingen voor problemen die we tegenkwamen bij de 
systematische review van hoofdstuk twee, wat betreft de interpretatie van convergente 
validiteit. Convergente validiteit is het type validiteit dat wordt beoordeeld door middel van 
‘hypothesetesten’: in dit geval het bepalen of de scores van het onderzochte instrument 
correleren met andere instrumenten die gerelateerde constructen meten in de mate die 
men zou verwachten. Auteurs van systematische reviews over meeteigenschappen van 
PROMs kunnen validatieartikelen aantreffen waarin correlaties tussen instrumenten worden 
gepresenteerd zonder dat er hypothesen zijn opgesteld waaraan ze moeten worden getoetst. 
We stellen voor dat de reviewers in deze gevallen hun eigen hypothesen opstellen om de 
mate van convergente validiteit te bepalen voor de PROM in kwestie. Maar het opstellen 
van hypothesen en het interpreteren van uitkomsten is niet altijd eenvoudig. We hebben de 
volgende aanbevelingen gedaan voor auteurs van reviews: neem een actieve rol aan bij het 
beoordelen van de geschiktheid van de vergelijkingsinstrumenten; wees transparant over 
welke hypothesen zijn opgesteld, de onderliggende aannames waarop ze zijn gebaseerd, en 
of de auteurs van het validatieartikel ze zelf hebben opgesteld, of dat de reviewer dit gedaan 
heeft; reflecteer op hypothesen die niet juist blijken te zijn, zeker als de convergente validiteit 
van de PROM niet voldoende blijkt op basis van deze hypothesen; en tel de resultaten van alle 
hypothesen voor één instrument op, in plaats van de convergente validiteit per geïncludeerd 
onderzoek te beoordelen.
In hoofdstuk vier beschrijven we de ontwikkeling van een nieuwe PROM voor patiënten 
met slaapapneu, die apneuspecifieke kwaliteit van leven meet: de Patient-Reported Apnea 
Questionnaire (PRAQ). De keuze om een nieuwe PROM te ontwikkelen is gemaakt met een 
werkgroep bestaande uit een patiënt, een longarts, en twee onderzoekers op dit project. Deze 
werkgroep heeft de vier beste PROMs uit de review van hoofdstuk twee beoordeeld op face 
validity en op de vraag of ze geschikt lijken voor de klinische praktijk. Een van die PROMs 
was niet publiekelijk beschikbaar, noch opvraagbaar via de ontwikkelaar (de OSAPOSI), dus 
deze PROM is daarbij niet meegenomen. De SAQLI vond de werkgroep niet haalbaar voor de 
klinische praktijk, omdat deze afgenomen moet worden door een interviewer en omdat hij 
veel en relatief gecompliceerde vragen bevat. De QSQ en de MOSAS vragenlijst beschouwde 
de werkgroep niet als ideaal omdat sommige aspecten van OSA-specifieke kwaliteit van leven 
die mogelijk belangrijk zijn voor de klinische praktijk  ontbraken. Daarnaast waren sommige 
items in deze vragenlijsten onduidelijk geformuleerd. De werkgroep heeft daarom besloten 
om een nieuwe PROM te ontwikkelen. Dit gaf ons ook de mogelijkheid om bij de ontwikkeling 
specifiek aandacht te besteden aan het nut van deze nieuwe vragenlijst voor de klinische 
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praktijk. Omdat de hiervoor genoemde PROMs ontwikkeld waren met behulp van patiëntinput 
achtte de werkgroep deze wel geschikt als uitgangspunt van the PRAQ. 
 Bij de ontwikkeling van de PRAQ waren zowel patiënten als zorgprofessionals intensief 
betrokken. Ze namen deel aan het ontwikkelteam, aan online enquêtes en focusgroepen, en 
aan twee ronden van cognitieve validatie om de formulering en interpretatie van de vragen te 
controleren. Ze speelden een belangrijke rol bij het selecteren van onderwerpen en items uit 
de bestaande PROMs, en kregen de mogelijkheid om onderwerpen of items toe te voegen of 
aan te passen op basis van wat relevant werd geacht voor de klinische praktijk. Dit resulteerde 
in een eerste versie van de PRAQ, bestaande uit 43 items en 10 voorlopige domeinen. De 
geconsulteerde patiënten gaven aan dat ze de PRAQ alomvattend vonden en dat de lengte van 
de vragenlijst acceptabel was. 
In hoofdstuk vijf beschrijven we de doorontwikkeling en validatie van de voorlopige versie 
van de PRAQ, in de context van hoe we willen dat de PRAQ wordt gebruikt: patiënten vullen 
de PRAQ in vóór hun OSA-consult, zodat de resultaten kunnen worden besproken met hun 
zorgverlener; en de geaggregeerde uitkomsten van de op deze manier verzamelde PRAQ-
data kunnen gebruikt worden voor uitkomstmetingen door gebruik te maken van een (door 
ons geselecteerde) optimale subselectie van de volledige PRAQ. We hebben een onderzoek 
uitgevoerd waarin 180 patiënten met verdenking op OSA de voorlopige versie van de PRAQ 
hebben ingevuld. De verzamelde gegevens werden gebruikt om 1) de definitieve selectie 
van items uit te voeren voor individueel gebruik van de PRAQ in de klinische praktijk, 2) de 
domeinen voor (geaggregeerde) uitkomstmeting te maken, en 3) het bestuderen van de 
meeteigenschappen interne consistentie, test-hertestbetrouwbaarheid, convergente validiteit 
en responsiviteit. We selecteerden 40 items en 10 domeinen voor de definitieve versie van 
de PRAQ voor gebruik in de dagelijkse klinische praktijk. Een subselectie van 33 items in 5 
domeinen werd geselecteerd voor optimale uitkomstmetingen met de PRAQ. De waarden 
van de meeteigenschappen van de domeinen voor uitkomstmetingen waren: Cronbach’s α 
0.88-0.95, intraclass correlation coefficient (ICC) 0.81-0.88, en >75% van de hypothesen correct 
voor convergente validiteit en responsiviteit. Dit bracht ons tot de conclusie dat de PRAQ goede 
meeteigenschappen laat zien bij patiënten met verdenking op OSA.
 In dit hoofdstuk staat ook de ontwikkeling van de PRAQ-rapportage beschreven: een 
overzicht van de PRAQ-resultaten van een individuele patiënt, waarbij gekleurde ‘smileys’ laten 
zien welke domeinen voor die patiënt meer of minder problematisch zijn.
In hoofdstuk zes presenteren we de uitkomsten van een exploratieve pilotstudie naar de 
impact van de PRAQ op de klinische praktijk. Hiervoor werd de PRAQ geïmplementeerd in drie 
Nederlandse slaapcentra. We hadden een aantal verwachtingen met betrekking tot hoe de 
PRAQ de klinische praktijk zou kunnen beïnvloeden. Ten eerste verwachtten we dat het invullen 
van de PROM de positie van patiënten binnen het consult zou versterken en hen meer bewust 
zou kunnen maken van welke van hun symptomen en problemen in het dagelijks leven verband 
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kunnen houden met OSA. Interviews met patiënten lieten zien dat aan deze verwachting lijkt 
te zijn voldaan: het invullen van de PRAQ heeft de potentie om patiënten dingen te leren over 
de mogelijke impact van OSA op hun leven, en het bespreken van de vragen van de PRAQ 
met hun familie gaf hen ook meer inzicht in hun situatie. Ten tweede verwachtten we dat de 
PRAQ tijdens een consult de focus zou kunnen verleggen van medische feiten naar ervaringen 
en problemen van patiënten met OSA. Dit kan resulteren in meer ‘patiëntgerichte’ zorg. De 
interviews met zorgprofessionals toonden echter aan dat dit bij het merendeel van hen niet 
was gebeurd. Hoewel de meeste zorgprofessionals de PRAQ wel op enige manier bespraken 
met patiënten was dit meest kort, en een aantal professionals gaf aan dat ze het vooral deden 
voor de studie. De meeste zorgverleners lieten de PRAQ slechts een minimal rol spelen tijdens 
hun consulten.
 We voerden ook een aanvullende studie uit met behulp van patiëntdossiers, voor 
en na de implementatie van de PRAQ, waarin we hebben onderzocht: behandelingskeuze; 
verwijzingen naar andere beroepsbeoefenaren in de gezondheidszorg; en therapietrouw van 
de patiënt. We hadden verwacht dat deze aspecten van zorg zouden kunnen veranderen omdat 
het gebruik van de PRAQ tot veranderingen in het consult zou leiden. We vonden echter geen 
verschillen, in lijn met onze kwalitatieve bevindingen dat er weinig verandering was in de 
consulten. De beschikbaarheid van informatie over individuele OSA-gerelateerde kwaliteit van 
leven leek daarom niet van invloed te zijn op de zorg in deze studie.
In hoofdstuk zeven reflecteren we op de vraag waarom de PRAQ niet de impact op de klinische 
praktijk liet zien die we hadden verwacht. De volgende factoren die van invloed kunnen 
zijn op dit gebrek aan impact worden besproken: de OSA-zorgprofessionals en de context 
waarin zij werken, de patiënten, de aard van OSA, de gebruikte technologie, de PRAQ zelf 
en de inspanningen van het onderzoeksteam om de implementatie te verbeteren. Een van 
onze conclusies is dat, hoewel er een overgang gaande is naar meer gepersonaliseerde, 
patiëntgerichte zorg voor patiënten met OSA, de meeste zorgprofessionals in deze studie deze 
benadering nog niet hebben gevolgd. Dit heeft waarschijnlijk onder andere te maken met de 
beperkte tijd voor consulten. Mogelijk zal de PRAQ in de toekomst wel van nut zijn in slaapcentra 
en voor zorgprofessionals als er een verschuiving plaatsvindt naar een meer gepersonaliseerde 
zorg. Aangezien de effectiviteit van de PRAQ in de klinische praktijk in dit proefschrift niet is 
aangetoond, is het aan slaapcentra om te beslissen of zij de PRAQ potentieel nuttig genoeg 
vinden om de inspanning en het geld van implementatie en continue meting te rechtvaardigen. 
Ze zullen ook moeten overwegen of ze bereid en in staat zijn om de context te bieden waarin 
het gebruik van de PRAQ voor individuele patiënten zinvol is, door bijvoorbeeld meer tijd te 
reserveren voor een intakegesprek. Er is momenteel één Nederlands slaapcentrum dat werkt 
met individuele PRAQ-gegevens in de klinische praktijk, en dat belangstelling heeft om deze 
gegevens ook op geaggregeerd niveau te gebruiken.
 Vervolgens bespreken we de uitdagingen voor het inzetten van PROMs in de klinische 
praktijk. Daarbij pleiten we onder andere voor het in één keer verzamelen van PROM-data 
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voor twee doelen: het verbeteren van de zorg op het niveau van een individuele patiënt, en 
het meten van kwaliteit met geaggregeerde PROM-data. De vraag via welk digitaal systeem 
deze data verzameld moet worden om het voor beide doelen goed te kunnen gebruiken is 
echter nog een uitdaging. Daarnaast moet er ook rekening gehouden worden met patiënten, 
vooral die met meerdere chronische ziektes die in de toekomst misschien overvraagd gaan 
worden met verzoeken om PROMs in te vullen. Het interdisciplinair gebruik van generieke item 
banks, zoals bijvoorbeeld het Patient Reported Outcomes Measurement Information System 
(PROMIS) kan hier mogelijk een oplossing bieden.
 Als laatste stellen we de vraag of het afnemen van een PROM op zichzelf de optimale 
aanpak is als een enkele interventie om patiëntgerichte zorg tot stand te brengen. PROM-
informatie kan nuttiger zijn wanneer deze deel uitmaakt van een meer uitgebreide interventie 
om de patiëntgerichtheid van de zorg te verbeteren. Dit kan een herstructurering van het 
zorgproces zijn en/of een interventie die zich richt op meer dan alleen het gebruik van PROM-
gegevens. Wij zien het als een goede aanpak om in toekomstige evaluaties van de impact van 
PROM-gegevens op de klinische praktijk de academische wereld te betrekken door middel van 
participerend onderzoek. Hierbij zijn de zorgorganisatie en de betrokken zorgprofessionals 
samen met de onderzoekers eigenaar van het onderzoek. 
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DATA MANAGEMENT
For each study of this PhD involving participant data, the research protocol was submitted 
to the local Medical Ethics Committee CMO Arnhem-Nijmegen. All studies were officially 
declared  exempt from ethical approval for human subjects research. All procedures performed 
in studies involving human participants were in accordance with the ethical standards of the 
institutional and/or national research committee, and with the 1964 Helsinki declaration and 
its later amendments or comparable ethical standards.
The survey and questionnaire data described in chapters 4 and 5 were collected via a secure 
version of Limesurvey, and data collected in chapter 6 via a secure platform of VitalHealth 
Software. The contact details of the patients that completed the survey in chapter 4 have been 
discarded. All PROM, survey, and electronic health record data from chapters 5 and 6 were 
collected by the involved healthcare providers, and no identifying patient information was 
shared with the researchers. Identifying information of the participants of focus groups and 
interviews held for thesis were stored separately from the data, in a secured folder to which 
only the main researcher and the quality officer had access. The identifying information was 
deleted after finishing the respective studies. Recordings of the focus groups and interviews 
were deleted, only the (anonymised) transcripts/summaries are saved.
Until chapter 6 of this PhD has been published, the raw and processed data and accompanying 
files (descriptive files, syntaxes, etc.) of the projects of this thesis will be stored in a folder on 
the department server of IQ healthcare which is accessible only by the main researchers of 
this project. Thereafter, the data will stored on the secured IQ healthcare archive server in a 
folder called “PROMs bij slaapapneu” for 10 years, which is accessible only by the secretary of 
IQ healthcare. Since the participants of the studies in this PhD did not give informed consent 
for sharing their data publically, requests for data can be made via receptie.iqh@radboudumc.
nl. A suitable way to share the data will then be sought.
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